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1,25(OH)₂D: 1,25-Dihydroxyvitamin D 
1,25(OH)₂D3: 1,25-Dihydroxyvitamin 
D3 25(OH)D: 25-hydroxyvitamin D 
AMP: Antimicrobial peptide 
 
APC: Antigen-presenting cell 
 
Anti-TNFα: Anti-tumour necrosis factor alpha  
BMI: Body mass index 
CAMP: Cathelicidin antimicrobial peptide  
CARD-15: Caspase-activation recruitment domain  
CD: Crohn’s disease 
CDAI: Crohn’s Disease Activity Index 
 
CI: Confidence interval 
 
CLSI: Clinical and laboratory standards institute 
 
CMV: Cytomegalovirus 
 
CRP: C-reactive protein 
 
DC: Dendritic cells 
 
dL: Decilitre 
 
DSS: Dextran sulphate sodium 
 
EC: Epithelial cells 
 
ECCO: European Crohn’s and Colitis Organization 
 
GALT: Gut-associated lymphoid tissue 
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GNI: Gross national income 
 
GWAS: Genome wide association studies 
 
HBI: Harvey Bradshaw Index 
 
HLA: Human leukocyte antigen 
 
HSV: Herpes simplex virus 
 
IBD: Inflammatory bowel disease 
 
IgA: Immunoglobulin A 
 
IgE: Immunoglobulin E 
 
IgG: Immunoglobulin G 
 
IgG1: Immunoglobulin G1 
 
IgG2a: Immunoglobulin G2a 
 
IgG4: Immunoglobulin G4 
 
IL-1: Interleukin-1 
 
IL-Ra: Interleukin-1 receptor antagonist 
 
IL-Re: Interleukin-1 receptor 
 
IL-2: Interleukin-2 
 
IL-4: Interleukin-4 
 
IL-5: Interleukin-5 
 
IL-6: Interleukin-6 
 
IL-10: Interleukin-10 
 
IL-12: Interleukin-12 
 
IL-13: Interleukin-13 
 
IL-18: Interleukin-18 
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IL-21: Interleukin-21 
 
IL-23: Interleukin-23 
 
iLFs: Intestinal lymph follicles 
 
INF-γ: Interferon gamma (also abbreviated IFN-γ) 
 
IQR: Interquartile range 
 
IU: International units 
 
K: Kappa 
 
Kg: Kilogram 
 
Kg/m²: Kilograms per meter squared 
 
KO: Knock out 
 
LCN-omega-3: Long-chain omega-3 fatty acids  
LRR: Leucine-rich repeat proteins 
LP: Lamina propria 
 
MDP: Muramyl dipeptide 
 
MHC: Major histocompatibility complex 
 
mL: Millilitre 
 
MLNs: Mesenteric lymph nodes 
 
mRNA: Messenger ribonucleic acid 
 
M.tb: Mycobacterium tuberculosis 
 
NF-AT: Nuclear factor of activated T cells 
 
NFκB: Nuclear factor-κB 
 
NHIS: National health interview survey 
 
NK: Natural killer cell 
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NKT: Natural killer T cell 
 
NLR: NOD-like receptor 
 
NOD-2: Nucleotide oligomerization domain 
 
NRAMP1: Natural resistance-associated macrophage protein 1  
OR: Odds ratio 
PP: Peyer’s patches 
 
PAMP: Pathogen associated molecular pattern 
 
PCR: Polymerase chain reaction 
 
PGE₂: Prostaglandin E2 
 
PID: Participant information document 
 
PR: Prevalence ratio 
 
PRR: Pattern recognition receptors 
 
PUFAs: Polyunsaturated fatty acids 
 
ROR-γt: Retinoic-acid-receptor-related orphan receptor-γt 
RXR: Retinoid-X-receptor 
SCL11A1: Solute carrier family 11 member 1 
 
SD: Standard deviation 
 
STAT6: Signal transducer and activator of transcription 6 
 
T-bet: T-box protein expressed in T cells (also abbreviated TBX21) 
TCGF: T cell growth factor (also abbreviated TGFC) 
TCR: T cell receptor 
 
TLR: Toll like receptor 
 
TGFβ: Transforming growth factor beta 
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Treg: T-regulatory (cells) 
 
TNF-α: Tumour necrosis factor alpha 
 
TSLP: Thymic stromal lymphopoietin 
 
UC: Ulcerative colitis 
 
UV: Ultraviolet 
 
UVI: Ultraviolet index 
 
VDR: Vitamin D receptor 
 
VDRE: Vitamin D responsive element 
 
VD3: Vitamin D3 
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WHO: World Health Organization 
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Intestinal bacteria; intestinal microbiome; intestinal microflora; enteric flora. 
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Adaptive immune system: also known as the ‘acquired immunity’. The components of the 
adaptive immune system include both humoral immunity and cell-mediated immunity. The cells 
of the adaptive immune system are T and B lymphocytes (i.e. T-cells and B-cells). Unlike the 
innate immune response (see definition), adaptive immunity is highly specific to pathogens. One 
of the main functions of vertebrate adaptive immunity is the recognition of specific ‘non-self’ 
antigens in the presence of ‘self’. 
Antigen: any substance (such as a toxin or enzyme) that stimulates an immune response in the 
body (especially the production of antibodies). 
Anti-tumour necrosis inhibitors (anti-TNFα): a pharmaceutical drug that suppresses response 
to tumour necrosis factor, which is part of the inflammatory response. 
Aphthoid (Aphthous) ulcer: a common cause of benign and non-contagious mouth ulcers. 
Bioavailability: a subcategory of absorption and is the fraction of an administered does of 
unchanged drug that reaches the systemic circulation, one of the principal pharmacokinetic 
properties of drugs. 
‘Biologic’ therapy: refers to the use of medication that is specifically tailored to target an 
immune or genetic mediator of disease. 
C-reactive protein (CRP): a protein found in the blood, the concentrations of which rise in 
response to inflammation (i.e. C-reactive protein is an acute-phase protein). 
Coloureds: people of a particular mixed-ancestry. 
 
Commensal bacteria: a symbiotic relationship between two organisms of different species in 
which one derives some benefit while the other is unaffected; in this case the intestinal bacteria 
and the host. 
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Corticosteroids: a class of chemicals that includes steroid hormones naturally produced in the 
adrenal cortex of vertebrates, and analogues of these hormones that are synthesized in 
laboratories. Corticosteroids have a wide range of physiological processes, including stress 
response, immune response, and regulation of inflammation, carbohydrate metabolism, protein 
catabolism, blood electrolyte levels and behaviour. 
Crohn’s disease (CD): also known as ‘regional enteritis’ is an inflammatory disease of the 
intestines that may affect any part of the gastrointestinal tract from mouth to anus, causing a wide 
variety of symptoms. It primarily causes abdominal pain, diarrhoea, vomiting or weight loss, but 
may also cause complications outside of the gastrointestinal tract called extraintestinal 
manifestations (see definition). 
Crohn’s Disease Activity Index (CDAI): a research tool used to quantify the symptoms of patients 
with Crohn’s disease. 
Cytokines: a diverse group of soluble proteins, peptides, or glycoproteins which act as hormonal 
regulators or signalling molecules at nano- to-picomolar concentrations and help in cell signalling. 
The term ‘cytokine’ encompasses a large and diverse family of regulators produced throughout 
the body by cells of diverse embryological origin. The term ‘cytokine’ has been used to refer to 
the immunomodulating agents, such as interleukins and interferons. They are regulators of host 
responses to infection, immune responses, inflammation and trauma. 
Enteric Flora: or ‘gut flora’ consists of a complex of microorganism species that live in the 
digestive tract of animals and is the largest reservoir of human flora. In this context ‘gut’ is 
synonymous with ‘intestinal’, and ‘flora’ with ‘microbiota’ and ‘microflora’. The word 
‘microbiome’ refers to the environment in which these bacteria live. 
Enteropathy: refers to any pathology of the intestine. 
 
Ethnicity or ‘ethnic group’: a socially-defined category of people who identify with each other 
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based on common ancestral, social, cultural or national experience. 
Extra-intestinal manifestations (EIMs): occurrences situated outside the intestines. Extra- 
intestinal manifestations can involve any organ of the body, but musculoskeletal, dermatologic 
and ocular are the most commonly affected. Hepatobiliary and renal (nephrolithiasis) 
manifestations are especially seen with small bowel dysfunction. 
Fissure: a tear in the lining (of the intestine or anus). 
 
Fistula (fistulising): an abnormal connection or passageway between two epithelium-lined organs 
or vessels. 
Genotype: the inherited instructions an organism carries within its genetic code: not all organisms 
with the same genotype look or act the same way because appearance and behaviour are modified 
by environmental and developmental conditions; similarly, not all organisms that look alike 
necessarily have the same genotype. 
Harvey Bradshaw Index (HBI): a simplified version of the Crohn’s Disease Activity Index (see 
definition). 
Helminths: a polyphyletic group of eukaryotic parasites: worm-like organism living in and 
feeding on living hosts, receiving nourishment and protection while disrupting their hosts’ nutrient 
absorption, causing weakness and disease: those that live inside the digestive tract are called 
intestinal parasites. 
Hygiene hypothesis: a hypothesis that states that a lack of early childhood exposure to nfectious 
agents, symbiotic microorganisms (e.g., gut flora or probiotics), and parasites, increases 
susceptibility to allergic diseases by suppressing the natural development of the immune system. 
Ileocolonoscopy: an endoscopic examination of the large bowel, where the last part of the small 
bowel (ileum) is also examined. 
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Industrialization: the period of social and economic change that transforms a human group from 
an agrarian society into an industrial one: part of a wider modernization process, where social 
change and economic development are closely related with technological innovation, particularly 
with the development of large-scale energy and metallurgy production; the extensive organization 
of an economy for the purpose of manufacturing. 
Inflammatory bowel disease (IBD): a group of inflammatory conditions of the colon and small 
intestine; the major types of inflammatory bowel disease include Crohn’s disease and ulcerative 
colitis. 
Innate immune system: also known as the ‘non-specific immune system’: a subsystem of the 
overall immune system which defends the host from infection. One of the major functions of the 
vertebrate innate immune system is to recruit immune cells to the site of infection, through the 
production of chemical factors, including specialized chemical mediators called ‘cytokines’ (see 
definition for cytokine). Inflammation is one of the first responses of innate immunity to infection; 
it is initiated by macrophages, dendritic cells, histiocytes, Kupffer cells, and mastocytes. Unlike 
the adaptive immune system, the innate system recognizes and responds to pathogens in a generic 
way; it does not confer long-lasting or protective immunity to the host. 
Intestinal lumen: in human anatomy, the intestine (i.e. bowel or gut) is the segment of the 
alimentary canal extending from the pyloric sphincter of the stomach to the anus; and, in humans 
and other mammals, it consists of two segments, the small intestine and the large intestine. In 
humans, the small intestine is further subdivided into the duodenum, jejunum and ileum, while 
the large intestine is subdivided into the cecum and colon. 
Intestinal microbiome/microflora: the aggregate of microorganisms: a microbiome that resides 
on the surface and in deep layers of the skin, in the saliva and oral mucosa, in the conjunctiva, and 
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in the gastrointestinal tract; they include bacteria, fungi, and archaea; the intestinal microbiome is 
also referred to as the enteric flora. 
Immunoregulation: control of the immune response, as by manipulation of pathways involving 
suppressor and contra suppressor T-cells. 
Immunosuppressant agents/treatments/drugs: drugs that inhibit or prevent activity of the 
immune system; used in immunosuppressive therapy. 
Loci: in genetics, a locus (plural) is the specific location of a gene, DNA (deoxyribonucleic acid) 
sequence, or position on a chromosome. 
Microbiome: the full collection of microbial genomes (bacterial, fungal, viral, etc.) that naturally 
exist within the human body; such as the community of microbes within the human gut. 
Nucleotide oligomerization domain (NOD-2): also known as caspase recruitment domain- 
containing protein 15 (CARD15) or inflammatory bowel disease protein 1 (IBD1); a protein that 
in humans is encoded by the NOD-2 gene located on chromosome 16. NOD2 plays an important 
role in the immune system: it recognizes bacterial molecules (peptidoglycans) and stimulates an 
immune reaction. 
Non-steroidal anti-inflammatory drug (NSAID): a class of drugs that provides analgesic and 
antipyretic (fever-reducing) effects, and in higher dosages, anti-inflammatory effects. 
Pathogenesis: the ‘pathogenesis of a disease’ is the mechanism that causes the disease; the term 
can also describe the origin and development of the disease, and whether it is acute, chronic, or 
recurrent. 
Penetrating (Crohn’s disease): referring to ‘fistulising’ Crohn’s disease. See definition for fistula. 
Phenotype: any observable characteristic or trait of an organism, such as its morphology, 
development, biochemical or physiological properties, behaviour, and products of behaviour. 
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Phenotypes result from the expression of an organism’s genes as well as the influence of 
environmental factors and the interactions between the two. 
Polymorphism: a change in a nucleotide base in the DNA (deoxyribonucleic acid): a genetic 
polymorphism can also be interchangeable referred to as a ‘mutation’ or a ‘variant’. 
Race: a social concept used to categorize humans into large and distinct populations or groups by 
anatomical traits. 
Stricture (stricturing): an abnormal narrowing of the intestine (or a duct or passage). 
 
T-cells or ‘T lymphocytes’: a type of lymphocyte that plays a central role in cell-mediated 
immunity (adaptive immune system). 
Th1 response: the pro-inflammatory response associated with the adaptive immune system (see 
definition for adaptive immune system). Activation of the Th1 response leads to cell-mediated 
immunity. The Th1 responses are more effective against intracellular pathogens such as viruses 
and pathogens. 
Th2 response: an antibody-mediated response associated with the adaptive immune system (see 
definition for adaptive immune system).  Activation of the Th2 response leads to humoral 
Immunity. The Th2 responses are more effective against extracellular pathogens such as bacteria 
and parasites. 
Th17 response: a subset of T-helper cells. They create inflammation and tissue injury in 
‘autoimmune diseases’ such as multiple sclerosis, rheumatoid arthritis, psoriasis, autoimmune 
uveitis, juvenile diabetes and Crohn’s disease. Their normal role is to provide anti-microbial 
immunity at epithelial/mucosal barriers. 
Transmural: existing or occurring across the entire wall of an organ or blood vessel. 
 
Ulcerative colitis (UC): a form of colitis, a disease of the intestine, specifically the large intestine 
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or colon, which includes characteristic ulcers, or open sores, in the colon. The main symptom of 
active disease is usually constant diarrhoea mixed with blood, of gradual onset. 
Westernization of lifestyle: a social classification of people influenced by the attitude, ethics and 
history of the American culture; this lifestyle affects this population sector’s choice of recreation, 
clothing and consumption of goods. 
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ABSTRACT 
 
 
Background: A subtype of inflammatory bowel disease, Crohn’s disease is thought to represent 
a complex interaction between environmental factors, a defective immune system, the 
gastrointestinal microbiome and genetic susceptibility. 
Aim: The focus of this study was to investigate the association between  environmental exposures 
during childhood and the subsequent development of Crohn’s disease, thus the two primary aims 
were to: 1) conduct a systematic review of the literature evaluating environmental risk factors 
during childhood, defined by studies either as, age intervals (e.g., 0-5, 6-10 and 11-18 years), or 
more ‘broadly’ as 0-18 years; and 2) investigate the association between childhood environmental 
exposures during three age intervals (0-5, 6-10 and 11-18 years), as well as frequency of childhood 
infections and the future development of Crohn’s disease based on a score analysis, using a subset 
of previously collected data from a completed doctoral thesis involving a case control study design 
in study population, in the Western Cape, South Africa. The aim included a primary analysis of 
the latter dataset for childhood infections. 
Design: For the first aim of the study, a systematic search was conducted during March 2015 in 
electronic databases, such as EMBASE, EBSCOhost (Medline), Ovid, Scopus and World Cat, 
PubMed and Biomed Central, to identify epidemiological studies that examined the association 
between childhood environmental exposures and the subsequent development of Crohn’s  disease. 
Studies evaluating childhood exposure either by age intervals, or more broadly, from birth until 
18 years were included. The environmental exposures evaluated in the review were; farm animal 
contact, place of upbringing, sibship size, household pets, primary water source and hot water 
availability. Of the 181 identified articles, 16 were included in the final systematic review. 
The second aim of the study involved a post hoc analysis of a subset of findings from the 
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completed doctoral research by Abigail Basson with regard to the multiple logistic regression 
analysis evaluating environmental risk factor exposure during three age intervals; 0-5 years, 6-10 
years and 11-18 years. In the present research, two different methodological approaches were 
undertaken. Briefly, exposure variables, of similar nature, were combined into subgroups and 
assigned weighting scores. The two ‘subgroup models’ were designated as: Group A and Group 
B. Based on these premises, a score analysis was performed, and the difference in scores, between 
case and control groups, was compared. In addition, multiple logistic regression models were 
conducted on a subset of original data from the aforementioned completed doctoral study to assess 
the association between the frequency of childhood infections between 0-20 years and risk of 
Crohn’s disease development. Following this, a score analysis was again performed.  
Results: Sixteen studies were included in the systematic review. Of the five studies that 
investigated the association between place of upbringing during the age interval 0-5 years and the 
subsequent development of Crohn’s disease, three found no significant association; however of 
the three studies evaluating place of upbringing during the age intervals 6-10 and 11-18 years, 
only one study identified a significant association. Three studies investigated exposure to farm 
animals during the age interval 0-5 years, of which, two identified a significant association. Of 
the latter three studies, two investigated farm animal contact during the age intervals 6-10 and 11-
18 years, but only one reported a significant association during these age intervals. Notably, this 
was the study which had failed to identify an association during the 0-5 year age interval. Both 
studies which broadly evaluated farm animal exposure during ‘childhood’ reported that not having 
contact with animals significantly increased the risk of developing Crohn’s disease. Of the five 
studies that investigated exposure to pets during the age interval 0-5 years, only one identified 
a significant risk association, namely with exposure to cats. Of the three which investigated pet 
exposure during the age intervals 6-10 years and 11-18 years, one identified a significant 
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association, for both age intervals. Five studies investigated pet exposure during ‘childhood’; one 
found that having a pet significantly increased the risk of developing Crohn’s disease, two 
reported that not having a pet significantly increased risk in developing Crohn’s disease, whereas 
the remaining studies found no significant association. Only one study evaluated primary water 
source during the three age intervals; during the age interval 0-5 years and 11-18 years, having 
piped tap or bottled water was significantly associated with CD development. Of the four studies 
investigating primary water source during ‘childhood’, only one reported a significant association 
between primary water source and the development of Crohn’s disease. The availability of hot 
water during the age interval 0-5 years was significantly associated with Crohn’s disease 
development in one of the three relevant studies. Two studies investigated hot water availability 
during 6-10 and 11-18 years, however both failed to identify a significant association. When 
broadly evaluated, hot water availability during ‘childhood’ was significantly associated with 
Crohn’s disease risk, in two of the three relevant studies. None of the studies which investigated 
sibship size and the risk of future Crohn’s disease development during defined age intervals 
reported a significant association. Only two of the seven studies that evaluated sibship size during 
childhood reported a significant association. 
Results of the score analysis revealed a significant difference during all three age intervals 
between the case and control groups with Group A and Group B, with cases having significantly 
lower exposure scores (approximately 30% and 40% lower, respectively), when compared with 
that of controls. On multiple logistic regression analysis, subjects who never had tooth 
decay/cavity (OR = 1.78; 95% CI, 1.05-3.04), periodontitis (OR = 1.95; 95% CI, 1.10, 3.48), 
diarrhoea (OR = 2.71; 95% CI, 1.62-4.62), gastritis (OR = 2.13; 95% CI, 1.30-3.35), or mouth 
ulcers (OR = 2.02; 95% CI, 1.12-3.70), at least once per year or more, were at an increased risk 
for later development of Crohn’s disease, when compared to those who were exposed to these 
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infections at least once per year or more. There was a significant difference in exposure scores 
between the case and control groups (OR = 0.88; 95% CI, 0.82-0.94), thus indicating that cases 
had 12% less exposure to childhood infections from birth until the age of 20 years, when compared 
to the controls. 
Conclusion: The systematic review of the literature provides evidence in support of the hygiene 
hypothesis, in that delayed exposure to immunostimulatory microbes through the environmental 
exposures increases the risk for future CD development, in genetically susceptible individuals. In 
addition, the literature supports that the childhood environment plays an important role in the 
aetiology of Crohn’s disease. However, the lack of consistent findings between studies, 
particularly those which have broadly defined ‘childhood’ implies that timing of exposure plays 
a crucial role in this ever evolving paradigm. Results from the score analysis provide insight into 
the ‘compound’ effects from multiple environmental exposures in the aetiology of Crohn’s 
disease. While the present research was unable to provide any explanation for the underlying 
mechanism of disease pathogenesis, overall, the findings have important implications for future 
IBD-related studies as they demonstrate the importance of accounting for environment as a 
‘whole’ when conducting epidemiological studies, as opposed to focusing on individual 
environmental factors, as well as that it is imperative to investigate environmental exposures 
within the context of defined age intervals. 
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PREFACE 
 
 
Crohn’s disease (CD) and ulcerative colitis (UC), both subtypes of inflammatory bowel disease 
(IBD), are chronic, inflammatory disorders of the gastrointestinal tract that develop as a result of 
a deregulation of the T-cell mediated immune responses toward the intestinal bacteria. While there 
are similar overlapping features for both diseases, clinically, CD and UC are distinctly separate 
gastrointestinal disorders. The focus of this manuscript will thus be on the IBD subtype, CD in 
the adult patient. 
 
 
This dissertation comprises of two aspects on environmental exposures of Crohn’s disease based 
on the ‘hygiene hypothesis’. Chapter 1 provides the background and rationale for the three main 
components of this dissertation, while Chapter 2 constitutes comprehensive description of the 
organizational framework of the study. In relation to the research theme, a broad literature review 
has been presented in Chapter 3. Chapter 4 includes the first component of the candidates’ 
research, a systematic review of literature evaluating childhood environmental exposures of CD. 
The second component of the research is presented in Chapter 5. This includes a score analysis 
based on a subset of previously collected data from the completed PhD research (2011-2014) 
conducted by Dr Abigail Raffner Basson which focused on environmental  exposures during 
childhood and the subsequent development of Crohn’s disease in the Western Cape, South Africa. 
All tables and figures are located at the end of each chapter. The remaining components of the 
dissertation comprise the Bibliography and Appendices. The Bibliography includes all of the 
literature consulted throughout the dissertation. 
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CHAPTER 1 
INTRODUCTION 
 
 
Inflammatory bowel disease (IBD) which is comprised of Crohn's disease (CD) and ulcerative 
colitis (UC) is a group of gastrointestinal conditions that result in chronic inflammation of gut 
(Frank, DN et al. 2007). So far, susceptibility to the CD has been linked to the highly complex 
interplay between genetic, immunologic and environmental risk factors (Knights D et al. 2013; 
Hanauer, SB et al. 2006; Danese S et al. 2004). Genome-wide association studies have identified 
more than 140 different susceptibility genes, many of which have been linked to the CARD15 
(caspase-activation recruitment domain), also referred to as the NOD2 (nucleotide 
oligomerization domain) gene (Rioux, JD et al. 2007). Genetic predisposition has been linked to 
the dysregulation of the immune system of the gastrointestinal tract and dysbiosis of the intestinal 
microbiome Knights D et al. 2013; Manichanch C et al. 2012). However genetic factors fail to 
fully account for the aetiology of the disease (Shanahan F. 2002). Different susceptibility genes 
have been seen to influence the development of CD in different races and separate geographic 
populations (Shanahan F. 2002). 
 
 
Despite the intensive research conducted over the years, no single microbial or infectious agent 
has been specifically linked to the pathogenesis of CD (Morgan XC et al. 2012). The exact role 
of intestinal microbiota in the aetiology of CD has not been clearly determined, although there is 
growing evidence which suggests that an inappropriate upregulation of the immune response may 
be triggered by the commensal microbiota in the gut (Round JL and Mazmanian SK 2009; Hooper 
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LV and Gordon JI 2001). The evidence also demonstrates that gut microbiota is pivotal in the 
initiation, maintenance, and determination of disease phenotype (Nagalingam NA and Lynch SV. 
2012). The persistent antigenic stimulation ultimately results in the activation of specific 
mechanisms of the immune system that cause chronic intestinal inflammation and injury (Knights 
D et al. 2013; Baumgart DC and Carding SR. 2007). It has also been suggested that, exposure to 
pathogens in the gastrointestinal tract may be transitory to the onset of clinical disease (Eckburg 
PB and Relman DA 2007). 
 
 
An accelerated increase in the incidence of CD in developing countries, such as Asia, has 
proposed the role of environmental factors in the aetiology of the disease (Molodecky NA and 
Kaplan GG 2010; Ng SC. 2014(a)). Traditionally, developing countries have reported low 
prevalence and incidence of CD, but as these countries have become increasingly industrialised 
and ‘westernized’, an accompanying noticeable rise in the prevalence of IBD has also been 
observed (Ng SC 2014(a); Sood A et al. 2003). Moreover, evidence from migrant studies has 
demonstrated that individuals migrating from regions of low IBD prevalence to regions with a 
high prevalence of IBD subsequently develop a higher risk of developing CD, comparable to that 
of the local population (Bernstein CN. 2008; Satsangi J et al. 1994). Other evidence supporting 
the role of environmental factors in CD pathogenesis is the lack of complete concordance in 
disease development between monozygotic twins (Thompson NP et al. 1996; Halfvarson J et al. 
2003). Currently, three hypotheses have been postulated in a bid to understand the environmental 
factors underlying the pathophysiology of CD, these include; the ‘cold chain hypothesis’, the 
‘hygiene hypothesis’ and the ‘infectious hypotheses’ (Koloski NA et al. 2008). 
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Smoking is one of the environmental risk factors that has been clearly implicated in CD 
pathogenesis (Loftus EV. 2004; Somerville KW et al. 1984; Bernstein CN et al. 2006). Other 
environmental factors, such as antibiotic use, breastfeeding, childhood hygiene, diet, oral 
contraceptive use and stress have been investigated, but findings proved inconsistent, therefore a 
further in-depth evaluation to substantiate these findings are required (Klement E et al. 2004; 
Allen S et al. 1999; Card T et al. 2004; Lashner BA et al. 1989). 
 
 
Motivation for the Research 
 
 
Environment is believed to play an integral role in regulating the biological functions carried out 
by CD susceptibility genes; however, studies have come to conflicting conclusions for the same 
or similar environmental exposure. While these discrepancies may in part, be explained by 
differences in study methodology, it is also possible that the impact of different environmental 
exposures, particularly those experienced during childhood, varies according to the timing, as well 
as the extent of exposure. This notion is supported by the recent findings by Basson A. 2014. 
 
 
Primary Research Questions 
 
1) What is the association between age at time of exposure to childhood environmental factors 
and the subsequent development of CD? (Chapter 4) 
2) What is the association between multiple environmental exposures and the subsequent 
development of CD? (Chapter 5) 
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Aims of the Study 
 
The first of two primary aims of the research was to conduct a systematic review of the literature 
evaluating a number of environmental factors, with an emphasis on timing of exposure; this is 
contained in Chapter 4. The second aim was to perform a score analysis on secondary data 
collected from a case control study design by means of the completed doctoral research by Abigail 
Basson (2011-2014) (Basson A. 2014). This is presented in Chapter 5. 
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CHAPTER 2 
 
 
METHODOLOGY 
 
 
2.1 Methodology Overview 
 
The present research originally intended to investigate the association between serum 25- 
Hydroxyvitamin D (25[OH]D) concentration with 3 pro-inflammatory cytokines namely, tumour 
necrosis factor alpha (TNF-α), interleukin-2 (IL-2) and interferon gamma (IFN-γ) in light of their 
well-known interaction with the T-cell immune responses. In addition, the inflammatory marker, 
C-reactive protein (CRP) was to be evaluated. The study also aimed to evaluate whether vitamin 
D deficiency was independently associated with other known confounding factors such  as disease 
duration, body mass index (BMI), oral contraceptive use, smoking, medication use (i.e. 
immunosuppressants, biologics, corticosteroids), surgical resection, season of study enrolment 
and ethnicity. The originally proposed research project is included as Appendix 1. However, due 
to unanticipated funding limitations, evaluation of the originally proposed inflammatory markers 
could not proceed. As a result of this, it was decided to conduct a systematic review of the 
literature on the association between environmental risk factors during childhood and the 
subsequent development of CD, as well as an evaluation of a subset of data collected from a 
completed doctoral research project performed by Abigail Basson (2011-2014) on a study 
population in Cape Town, South Africa.
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Systematic Review: Methodology Overview 
 
The systematic review evaluated the association between environmental risk exposures in 
childhood and the subsequent development of CD, with the main emphasis in the timing of the 
exposure in 3 age intervals; 0-5, 6-10 and 11-18 years. The theme of this investigation was based 
on the hygiene hypothesis, including the environmental factors associated thereof. 
 
 
Secondary Data Analysis: Methodology Overview 
 
Analysis of the subset of data was conducted in a bid to evaluate the interaction of environmental 
risk factor on the development of the CD and to provide insight into the impact in which multiple 
environmental exposures may shape the intestinal immune system during childhood, through the 
weighting of environmental exposures, followed by a score analysis approach. In this process, the 
timing of exposure during 0-5, 6-10 and 11-18 years was investigated. 
 
Statistical consultation and analysis for the statistical methodology of this study was by the Bio- 
statistics Department of the Medical Research Council of South Africa through statistics 
consultants. The statistical distribution of continuous variables was appraised and expressed as 
means ± standard deviations (SD). Using an appropriate correlation structure, the predictors for 
CD were examined in a conditional logistic regression analysis. To measure the effect size, odds 
ratios and 95% confidence intervals (CI) were reported. Details of the statistical analysis 
performed have been described in the relevant chapters of the manuscript 
 
 
Original Study Design (data obtained): Methodology Overview 
 
From the original case control study conducted by Abigail Basson, 194 CD patients and 213 
healthy controls were identified, of whom; 35 (18%) and 19 (9%) were White, 152 (78%) and 
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177 (83%) were Coloured, and 7(4%) and 17 (8%) were Black, respectively. Overall, 125 (31%) 
of the cohort were male and 281(69%) were female. There was a significant difference in the 
median age between the case and control group at study enrolment [47.0 (IQR 38.0-57.0) years 
and 32.0 (IQR 24.0-44.0) years, respectively, P < 0.001]. Ninety seven percent of case and control 
subjects were born in South Africa (P = 0.02). The majority (99%) received a monthly income 
below R10, 000 (P = 0.39). Only subjects residing in the Western Cape at the time of study 
enrolment were included. Clinical examination and an evaluation of medical and pharmacy 
records were conducted by a consulting gastroenterologist. Data on clinical and demographic 
variables were collected using an interviewer-administered questionnaire. A brief overview of the 
methodological approaches used for the original research design has been described under Point 
2.3.1. 
 
 
2.2 Systematic Review 
 
A systematic review of literature was conducted on studies 16 studies focusing on childhood 
environmental risk factors of CD. Methodological and demographic data for these studies was 
compiled and evaluated. A detailed explanation of the methodology has been presented in Chapter 
4 
 
 
2.3 Secondary Data Analysis 
 
This component of the research involved analysis of a subset of data obtained from a completed 
research project. Demographic data for the cases and controls is presented as frequencies 
(percentages) for the childhood infection and as medians, and as medians (interquartile range 
(IQR)) and mean (SD) for the environmental exposure variables (environmental risks factors). 
The score analysis was conducted for the environmental risk factors over the three age intervals 
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using logistics regression. The three age intervals were between 0 to 18 years for environmental 
risk factors. The logistics regression was also used to conduct the score analysis for the childhood 
infection between ages 0 to 20 years old. A detailed explanation of the methodology has been 
presented in Chapter 5. 
 
 
The following is a brief description of original project from which the data for the present 
research was obtained: 
 
 
2.3.1 Methodology of Original Project 
 
The data used in this present research was obtained from a large case control study as part of the 
doctoral research of Abigail Basson. Recruitment of participants was performed in two ways; 
telephonically and physical approach of participants in both Groote Schuur Hospital (GSH) and 
Tygerberg Hospital (TBH) between September 2011 and January 2013. The recruitment process 
was standardized by means of verbal scripts. Data collection was conducted through an 
interviewer-administered questionnaire for both cases and controls. Clinical examination and a 
review of the CD patient medical and pharmacy records was part of the data collection process. 
The same questionnaire was employed for cases and controls, with the exception of one section 
pertaining to CD onset, CD symptoms and smoking status at CD diagnosis for the cases. 
 
 
In an attempt to minimize recall bias, the participants were allowed to complete the questionnaire 
at home if this would improve the accuracy of their responses. If it was necessary to consult 
relevant family members, patients were offered the use of a prepaid mobile phone, during the 
study interview. All inclusion and exclusion criteria were checked at the time of study enrolment, 
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then again during the interview, and finally, via patient medical records (cases). 
 
 
The review of medical and pharmacy records of CD patients were performed by two independent 
clinical investigators using a standardized form. Results were compared and discrepancies were 
corrected by a re-examination of the relevant record by both clinical examiners, who discussed 
them until consensus was reached. The participant information documents (PID) (Appendix IV), 
hospital recruitment poster (Appendix V), participant consent forms (Appendix VI), questionnaire 
(Appendix VII), the medical review form (Appendix VIII) and the participant recruitment 
telephone script (Appendix X) are included in the appendix, sections. 
 
 
Ethical permission for the amendment was granted by the Senate Research Ethics Committee of 
the University of the Western Cape (Reg No: 11/3/16), and the amended research proposal was 
approved by the Higher Degrees Committee of the University. The ethical approval letters have 
been included as Appendix III and IX. 
 
 
2.3.1.1 Statistical Analysis 
 
Registration of the research project was done with the Bio-statistics Department of the Medical 
Research Council of South Africa. Esme Jordaan provided statistical consultation for the statistical 
methodology of the study. Details of the statistical analysis performed for each manuscript are 
described in the relevant chapters. The statistical distribution of continuous variables was 
appraised and expressed as medians and interquartile ranges (IQR) or means ± standard deviations 
(SD) as deemed appropriate. Chi-square, Kruskall-Wallis or Student t-test were employed as 
appropriate for case and control comparison. Using an appropriate correlation structure, the 
predictors for CD were examined in a conditional logistic regression analysis. To measure the 
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effect size, odds ratios and 95% confidence intervals (CI) were reported. STATA 12.0; SAS 9.4; 
and R were the statistical programs used for the data analysis. 
 
 
To determine the reliability of questionnaire data, an agreement analysis was performed for all 
the pertinent variables. The kappa statistic (ranging between 0 and 1, with 0 indicating no 
agreement and 1 indicating perfect agreement between the two occasions) was used to measure 
the agreement between repeated data for the questionnaire. 
 
 
2.3.1.2 Population Description 
 
At the time of study enrolment, the case and control groups comprised of South African Black, 
Coloured and White individuals aged between 18-70 years, residing in the Western Cape in South 
Africa. 
 
 
2.3.1.3 Sample Size 
 
A total of 537 study individuals consisting of 387 randomly selected CD cases and 150 controls 
(86 unrelated healthy and 64 non-IBD controls) was at first calculated. For childhood 
environmental exposure evaluation, a total of 200 cases and 200 non-matched healthy controls 
would be sufficient to provide over 90% strength to detect a risk factor with an odds ratio of 2.7 
or greater and it would also have 80% strength to detect an odds ratio of 2.4 or greater. These 
figures were determined using data from the Western countries since no data is available for the 
South African population (Molodecky NA and Kaplan GG. 2010; Koloski NA et al. 2008). The 
final sample size achieved for the study was 194 cases and 213 controls, which was deemed 
sufficient to evaluate the final endpoints. 
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2.3.1.4 Sample Selection: Crohn’s Disease Patients 
 
Recruitment of Crohn’s disease patients was conducted at Groote Schuur Hospital (GSH) and 
Tygerberg Hospital (TBH) gastrointestinal clinics, both of which are public teaching hospitals, 
and they offer treatment to the majority of IBD patients in the city’s public health care sector. 
Approximately 900 CD follow-up patients are seen annually. These are large referral-based IBD 
centres in Sub-Saharan Africa. Of the 3.5 million persons who reside in the greater Cape Town 
area, approximately 90% rely on public-sector health services (Small K. 2008). Subjects with 
active disease, or inactive CD (i.e. ‘remission’) were enrolled in the study. Only patients with 
disease duration of more than five years, who had follow-up at the clinic within the past six 
months, were included for the study. Crohn’s disease diagnosis was done according to the 
European Consensus Guidelines on the Diagnosis and Management of Crohn’s Disease. This is 
the recommended standard of the European Crohn’s and Colitis Organization (ECCO) (Van 
Assche G et al. 2010; Stange EF et al. 2006). The guideline includes typical history, radiographic 
and/or endoscopic appearance, compatible histological features if available, and the exclusion of 
infectious diseases, such as tuberculosis and amoebiasis, by histological and bacteriological 
examinations. Medical records were employed in performing a prior diagnosis of intestinal 
tuberculosis. After that a differential diagnosis of tuberculosis would be made according to an 
algorithm by Epstein D et al through interpretation of clinical, radiographical and endoscopic 
evaluations in CD patients attending the Groote Schuur Hospital and Tygerberg Hospital 
gastrointestinal clinics (Epstein D et al. 2007). It is also mandatory for all CD patients attending 
the Groote Schuur Hospital and Tygerberg Hospital gastrointestinal clinics to have a culture for 
Mycobacterium tuberculosis on endoscopic mucosal biopsy. In addition, prior to starting any 
immunosuppressant, anti-TNF-α or biologics treatment, all patients are given prophylactic 
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tuberculosis treatment. 
 
 
2.3.1.5 Sample Selection: Control Group 
 
In a bid to conduct an appropriate case-control study, careful selection of both cases and controls 
is crucial. There is a risk of selection bias on control selection if a dissimilar mechanism is 
employed as compared to the cases. Some studies are susceptible to misclassification bias because 
the selection of controls is through referrals from CD patients or patients with other non- IBD 
gastrointestinal diseases, such as irritable bowel syndrome and at times through administrative 
databases. Therefore, in light of this, the present research identified healthy controls unrelated to 
the CD cases in the following ways: 1) visiting family and friends of patients admitted to the spinal 
injury wards of Groote Schuur Hospital and Tygerberg Hospital; 2) outpatients from Groote 
Schuur Hospital and Tygerberg Hospital orthopaedic wards; and 3) porter and security personnel 
of Groote Schuur Hospital. Only one member from a family was included in the selection. The 
spinal injury rehabilitation units of Groote Schuur Hospital and Tygerberg Hospital are large 
referral-based centres for the Western Cape, which served as catchment for control selection. 
Orthopaedic outpatients, security and porter personnel at Groote Schuur Hospital were considered 
to be similar demographically to the CD cases, with comparable environmental exposures. 
 
 
Exclusion of controls was done if any of the following were present: prior diagnosis of 
tuberculosis, IBD or any other gastrointestinal illness (e.g., irritable bowel syndrome); any 
immune-mediated (autoimmune) diseases; rheumatological disease (i.e. ankylosing spondylitis, 
enteropathy); or a family history of IBD. Exclusion criteria were determined at the time of 
participant recruitment and again at study enrolment. 
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2.3.1.6 Participant Recruitment: Crohn’s Disease Patients 
 
 
Identification of CD patients was done using the Groote Schuur Hospital and Tygerberg Hospital 
gastrointestinal clinic appointment lists for the day following the researcher’s contact meeting. 
Eligible subjects were contacted telephonically on the day before their scheduled appointment 
with the gastrointestinal physician. A standardized verbal script was used and it was conducted in 
the first language of the participant. Upon engagement, details of the study were first explained 
to the prospective participant and their willingness to participate in the study was ascertained. At 
that time (and again at study enrolment), it was made clear to the patient that: 1) all information 
provided would be confidential; 2) they were not under any obligation to participate; and 3) 
participation (or non-participation) in the study would not affect their treatment at the clinic in 
any way. Subjects were informed that they were free to withdraw from the study at any time and, 
all data given would be destroyed. On the next scheduled appointment the principal investigator 
or the research assistant provided the patient with a review of the details of the study and provided 
with the PID (participant information document) to read before consenting to the study (the PID 
is contained as Appendix IV). A questionnaire was administered in a private room after an 
informed written consent was obtained by the interviewer. 
 
 
The attending gastroenterologist captured the data during the patient’s scheduled appointment 
(refer to Point 2.3.1.8). After participating in the study, a token of appreciation of R30 (in cash) 
was provided to participants. This however was only stated after completing the study so that it 
would not to be misinterpreted as an incentive or a form of coercion to participate in the study. 
 
 
 
 
 
 
 
  
 
CHAPTER 2 
 
 
 CHILDHOOD ENVIRONMENTAL EXPOSURE AND CROHN’S DISEASE 14 
 
2.3.1.7 Participant Recruitment: Control Group 
 
 
Individuals in the waiting areas of the spinal injury and outpatient orthopaedic wards were 
randomly approached to serve as the controls for the study. A4 size posters were also employed 
to advertise the study in three local languages namely Afrikaans, English, and Xhosa for 
recruitment of controls. These were posted within the hospital wards and on general notice boards 
(the poster is contained as Appendix V). Included in the posters were the details pertaining to the 
study, and the informed consent of the study subjects. The contact details of the study coordinator 
were available on the posters, allowing interested individuals the option of telephonic or mobile 
communication with the coordinator and stating their name and preferred language, in order to 
be contacted by the coordinator. There was also an option on the same posters whereby a 
secondary contact was provided indicating where the interested individuals could provide their 
contact details within the gastrointestinal clinics. A language appropriate standard verbal script 
was used when telephonically contacting the participants (the recruitment script is contained as 
Appendix X). Upon contact, the details of the study were carefully explained to the participant. 
The participant was then given the option of having the PID sent by mail to him/her before 
scheduling an appointment in order to participate in the research. An interview appointment was 
scheduled after obtaining a verbal consent. Medical exclusion criteria for controls were 
determined during initial telephone contact, and again while administering the interview 
questionnaire. Prior to study enrolment, the participant was provided with the PID to read before 
providing written consent to the study. A review of the PID was also conducted by the interviewer 
with the subject. Participants were again informed of their right to withdraw from the study at any 
time, and that all data collected would be destroyed upon request. 
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2.3.1.8 Structured Interview Process (Case and Control Groups) 
 
 
For the sake of quality assurance, the principal investigator or a trained research assistant 
conducted the scheduled interview. The principal investigator trained the research assistant to 
ensure that structured and standardized interviews were conducted. All interview material was 
available in English, Afrikaans and Xhosa and interviews were conducted in the participant’s 
language of preference. All participants however requested the interview to be conducted in 
English. The participant was verbally inquired as to whether he/she understood the nature of the 
study and what he/she was consenting to. Information pertaining to the study such as 
confidentiality, risks involved with blood collection, and withdrawal from the study were 
reviewed. The participants were however blinded to the hypothesis of the study. When the 
research interviewer was certain that the participant fully understood the study details, the 
participant was requested to sign the written consent form (contained as Appendix VI for both 
cases and controls). 
 
On conducting each interview, the interviewer possessed two copies of the questionnaire: one was 
provided to the participant to read as the question was being posed by the interviewer, while the 
second questionnaire was used by the interviewer to read the questions aloud to the participant. 
The interviewer recorded the participant’s responses on a predesigned instrument (contained as 
Appendix VII). In a bid to standardize the interviews, a document describing and defining terms 
had been generated by the principle investigator to clarify terminology to the participant if 
necessary. Explanation outside this document was strongly discouraged for the interviewers. At 
study enrolment, anthropometric measurements were performed. Body weight was measured to 
the nearest 0.1kg using a scale (A&D Personal Precision Scale, Tokyo, Japan) and height was 
measured using a portable stadiometer to the nearest millimetre. Measurements were performed 
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twice, using the same scale and stadiometer for all participants. 
 
 
2.3.1.9 Response Rate: Crohn’s Disease Patients 
 
 
It was considered acceptable, having a participation rate of 80% out of the 255 cases originally 
calculated from those contacted, at the study centres (Groote Schuur Hospital and Tygerberg 
Hospital gastrointestinal clinics). Out of the total, only two patients declined participation in the 
research thus there was a 99% response rate. The CD patients expressed pleasure in contributing 
to the research project. The high response rate may assumedly be attributed to the following: 1) 
research involved no follow ups or additional blood sample collection and 2) the research was 
conducted within the already scheduled appointments with the subjects’ gastrointestinal 
physicians and the within the waiting period before being seen by the physician. 
 
 
2.3.1.10 Response Rate: Control Group 
 
 
Response bias occurs when the ‘exposure’ number of control participants agreeing to participate 
in the study is different from those who refuse to do so. Many studies fail to account for non- 
responders, and in general, non-responders tend to have different socioeconomic or demographic 
profiles or unhealthy lifestyle behaviours, such as smoking (Molodecky NA et al. 2011; Van Loon 
ES et al. 2003; Korkeila K et al. 2001). The majority of IBD-studies evaluating environmental 
risk factors such as the ‘hygiene hypothesis’ have not accounted for non- responders; this is a 
concern since, a systematic difference may exist in exposure between cases and controls. For 
example, there is a significant correlation between a lower socioeconomic status and hygiene 
practices (Molodecky NA et al. 2011). 
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The principal investigator or research assistant recruited the majority of control participants, by 
physically approaching the subjects at Groote Schuur Hospital. In the spinal wards, family waiting 
areas as well as the orthopaedic outpatient waiting areas is where most recruitments were 
conducted. Porter and security personnel were also approached to serve as control subjects. In the 
participant recruitment processes, a standard verbal script was employed by both the principal 
investigator and the research assistant. Response bias was counteracted by the principal researcher 
or the research assistant by randomly selecting the subjects and approaching them appropriately 
while taking into cognisance the age, ethnicity and gender. This was done to reduce the possibility 
that response may be influenced by the subjects’ perceptions of the recruiting researcher. 
 
Out of the 159 subjects who were personally approached, only nine (6%) turned down the 
invitation to participate. The fairly high response rate may be attributed to the fact that those that 
were approached had sufficient time to participate in the study at that time, or were able to 
schedule a later study enrolment date, because they would be returning to the hospital within a 
short period. The remaining 63 control subjects were recruited via the advertising posters which 
were distributed throughout the hospital. None of the control participants who contacted the 
principal investigator about the study via this method later refused to participate. 
 
 
2.3.1.11 Questionnaire 
 
For data collection the principal investigator developed the structured questionnaire. It included 
seven demographic sections namely: General Information; Environmental Factors; Inflammatory 
Bowel Disease Medical History (cases only); Medical History; Family History; Smoking History; 
and General Health. The Environmental Factors section was structured to include three age 
intervals: 0-5 years; 6-10 years; and 11-18 years. Identical questions for each age interval were 
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included and race was self-reported. Six options were available for the participants:  ‘Asian’, 
‘Black’, ‘Coloured’, ‘Indian’, ‘White’ and ‘Other’. However only Black, Coloured and White 
races were represented in the study. The questionnaire (English version only) is contained as 
Appendix VII for reference. 
 
 
2.3.1.12 Medical Review Form 
 
 
The principal investigator developed a medical review form which comprised of two sections. 
The first section would be completed during the appointment by the attending gastroenterologist 
with the CD patient, ensuring that all the required data was captured at the time of study enrolment. 
The other section would be used by the principal investigator and research assistant for gathering 
the patient’s medical history from medical and pharmacy records. For the comprehensiveness of 
the information to be obtained, the forms were piloted by two separate gastroenterologists using 
CD patient charts. These gastroenterologists were not included in the research and their data was 
not included in the final research dataset. The CD patient medical review forms are contained as 
Appendix VIII. 
 
It must be noted, that prior to the fairly recent initiation of computerized pharmacy records, data 
regarding medication use has been poorly captured in the past. As this was a retrospective study, 
details on the type of medical treatment used, duration of treatment, dosage and adherence could 
not always be determined. 
 
 
2.3.1.13 Medical Review Form 
 
 
Upon completion of data collection, 10% (n = 21) of the medical review forms were randomly 
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selected and completed by an independent investigator. This investigator was however not 
involved in the study, in a bid to ensure the reliability of the initially recorded data. There was 
minimal discrepancy between the results of the original records and the re-checked records. 
 
 
2.3.1.14 Questionnaires 
 
 
It was initially proposed in the study protocol that a Cronbach’s alpha analysis would be 
performed, and a coefficient of 0.8 would be considered satisfactory in measuring the internal 
consistency of the questionnaire, and its freedom from random errors. However, after thorough 
discussion with the head of the Biostatistics Department of the Medical Research Council of South 
Africa, it was decided that due to the objective, ‘factual’ nature of the questions within the 
questionnaire, this analysis would not be relevant, and thus was not performed. Questionnaires 
were piloted and all Consent forms, questionnaires, PIDs and telephone scripts were translated 
from English to Afrikaans and Xhosa by four separate translators, who spoke native language. 
Four translators for each language comprised of both students and staff members in the 
Department of Dietetics and the Foreign Languages Department of the University of the Western 
Cape were recruited for the study. All participants, however, preferred the English consent form, 
PID and questionnaire. The Afrikaans and Xhosa consent forms, hospital recruitment posters 
(controls), PIDs and the questionnaires for the study participant groups. Only English versions 
have been included as reference. 
 
 
2.3.1.15 Generalizability of Study 
 
 
In many IBD case control studies, cases are identified from gastrointestinal clinics, owing to 
feasibility (i.e. participants are easier to identify). In this research study, identification of CD 
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patients was hospital-based, and not population-based. However, most subjects in state practice 
in the Western Cape attend one of the two hospitals from which patients were recruited; findings 
are therefore likely to be generalizable. 
 
 
 
2.3.1.16 Ethical Clearance 
 
Ethical clearance was accorded by the Ethics Research committee of the University of the Western 
Cape (UWC) (Reg No:11/3/16), the Human Research Ethics Committee of the University of Cape 
Town (UCT) (HREC REF: 122/2011), the Provincial Ethics Committee of the Department of 
Health as well as both the ethics committees of GSH and TGH. The research was performed in 
accordance to the Ethics on Medical Research General Principles, following the guidelines 
published by the Medical Research Council of South Africa (Benatar SR et al. 2004). 
 
 
Informed Consent 
 
 
Prior to data collection, written, informed consent was obtained from participants after full 
disclosure of study details. Participation was voluntary, and participants were informed of their 
right to withdraw from the study at any time, without any consequences, or loss of any benefits 
for which participants would otherwise qualify. Only participants, who could understand the 
consent form and the conditions of the study, were enrolled. There were two separate versions of 
the consent forms, one for the cases and one for the control groups. Informed written consent was 
obtained from all participants. If a signed consent was not provided, the subject was excluded 
from the study, and no personal data was collected. 
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Participant Anonymity 
 
Anonymity and confidentiality of the participant information was maintained by removing 
identifiers from questionnaires. Medical information that was given by a participant or acquired 
from medical records was not shared with other participants such as, relatives or any other persons 
who were not co-investigators. Co-investigators only received information on a need-to- know 
basis. Questionnaires were coded using a unique number as an identifier, instead of participant 
names, or any other identifiable information. All identifiable information of the study participant 
(and participant code) was situated on the front page of the questionnaire. The rest of the 
questionnaire pages only contained the participant codes. 
 
 
All of these materials were obtained for research purposes only, and data relating to participant 
identity was kept in strict confidence. Only the principle researcher had access to patient names 
and the identifier code key, which was at all times kept separate from the questionnaires, in a 
locked filing cabinet located in a locked office, and maintained with the strictest confidentiality 
precautions by the principal researcher. Coded data was entered into a password protected 
computer. All clinical or personal data acquired remained at all times anonymous, with the front 
page of the questionnaire removed. 
 
2.4 Statistical Analysis 
 
For cases and controls, the demographic data is presented as frequencies for categorical data an 
as medians and interquartile range (IQR) for the numerical data. Environmental risk factors and 
their impact for CD were evaluated through employing the multiple logistics regression models. 
Risk factors that were significant for (P<0.05) for a specific age interval were included in the final 
modes (0-5year, 6-10years, 11-18years); were all adjusted for age at study enrolment, gender and 
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ethnicity. Odds ratios and 95% confidence intervals were reported to measure the effect size. Risk 
factors with a cell frequency below 10 for any of the four cells in the cross tabulations of the 
risk factors with CD were not included in the models. Exact logistic regression was used for 
modelling with small cell sizes. 
 
One year after study completion a total of 40 (10%) randomly selected participants completed  the 
interviewer administered questionnaire for a second time in order to measure the agreement 
between repeated data for the questionnaire using a kappa statistic. Only data pertaining to the 3 
age intervals was extracted in this process. Again, participants had the option of completing the 
questionnaire at home if they felt consulting family members may help with the accuracy of some 
responses. An agreement analysis was performed to determine the reliability of the questionnaire 
data for all the relevant variables. The kappa statistic (ranging between 0 and 1, with 0 indicating 
no agreement and 1 indicating perfect agreement between the two occasions) was used to measure 
the agreement between repeated data for the questionnaire. Standards by Landis and Koch were 
used to interpret the strength of the agreement (Landis JR and Koch GG. 1977) (Figure 1). 
 
Data has been made publicly available via Figshare: 
 
http://dx.doi.org/10.6084/m9.figshare.1159053 and http://dx.doi.org/10.6084/m9.figshare.1041586
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Figures Referred to in Chapter 2 
 
 
FIGURE 1: Interpretation of Landis and Koch’s measure of 
agreement Kappa statistic (κ) Agreement 
< 0 Less than chance agreement 
 
0.01–0.20 Slight agreement 
 
0.21– 0.40 Fair agreement 
 
0.41–0.60 Moderate agreement 
 
0.61–0.80 Substantial agreement 
 
0.81–0.99 Almost perfect agreement 
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CHAPTER 3 
 
 
LITERATURE REVIEW 
 
 
3.1 Introduction 
 
Crohn’s disease (CD) is a chronic relapsing gastrointestinal condition that is characterized by a 
pronounced inflammation of the lining of the intestines. It can be explained as a chronic 
multifactorial disease that occurs in genetically susceptible individuals, involving environmental 
influences, intestinal dysbiosis, and altered immune responses (Foster A and Jacobson K. 2013). 
The condition forms one of two inflammatory bowel disease (IBD) subtypes, the second being 
ulcerative colitis (UC) and is classified under idiopathic IBD (Silverberg MS et al. 2005). While 
the actual aetiology of the disease remains unclear, it is believed that disease onset is due to an 
interaction between a broad range of susceptibility genes and the environment. Inflammation of 
the intestinal mucosa is the result of an abnormal activation of the gut immune system due to 
bacterial and dietary antigenic stimulation (Prideaux L et al. 2012). This involves the ability of 
dendritic cells (DCs), macrophages and neutrophils to distinguish between commensal or 
‘healthy’ and pathogenic bacteria within the gut (Prideaux L et al. 2012). No infectious trigger 
has been singled out, however indirect evidence implicates mycobacteria as potential initiator of 
CD (Sechi LA et al. 2005).  
 
Recent studies are suggesting that autophagy and host cell response to intracellular 
microorganisms are linked to the pathogenesis of the disease (Rioux JD et al. 2007). The 
development of CD is characterized by an increase in the production of potent pro-inflammatory 
cytokines namely, TNF-α, INF-γ and IL-2 (Podolski DK. 1991; Lemire JM. 1992; Cantorna MT 
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et al. 2004). Recent findings have also attributed the development of CD to a new effector helper 
T cell named Th17 which is responsible for the production of interleukin-17 (IL-17) (Bendix-
Struve M et al. 2010). 
 
 
3.1.1 Crohn’s Disease Classification 
 
 
In the bid to understand this clinically heterogeneous disease, attempts have been made to classify 
it into categories such as age of onset, disease location and disease behaviour. However the 
generally accepted standard is the Montreal classification system (modified from the revised 
Vienna classification) (Satsangi J et al. 2006), which takes into consideration the critical 
phenotypic characteristics of the disease (Table 1). 
 
According to the Montreal classification system, the onset of the disease is mostly in the A2 (17- 
40years) category which is 78.6%. The onset in the A1 (≤16 years) and A3 (>40 years) categories 
are 16.8% and 6.6% respectively (Aljebreen AM et al. 2013). As for the disease location the most 
common location are the ileocolonic and the ileum which have an occurrence percentage of 48.8% 
and 43.55%, respectively. According to the system, colonic CD is not very common and has a 
7.7% occurrence. Basing on the Montreal classification the behaviour of the disease is 41.8% non-
stenotic or non-penetrating, 32.85 stenotic and 25.4% penetrating (Aljebreen AM et al. 2013). 
Crohn’s disease usually appears between the ages of 15 and 30 years (Sands BE and Grabert S. 
2009). According to a study involving 1015 CD patients, the anatomic distribution of the disease 
was reported to be as follows: 13.1% upper gastroduodenal, 27.2% right colon, 25.3% small 
intestines alone and 34.6% ileocolon (Freeman HJ. 2007). A study in Asia has revealed that 
the age of onset of the disease has an influence on the clinical features of the disease (Law ST and 
Li KK. 2013). Compared to adult-onset patients (≥29years old), young- onset patients (≤16 years 
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old) tend to exhibit more symptoms of fever, weight loss, isolated abdominal pain, lower body 
mass index (BMI), extra-intestinal manifestation (EIM) and perianal lesion (Law ST and Li KK. 
2013). However in both groups inflammatory lesion was the dominant behaviour of the disease 
and ileocolonic manifestation was the most prevalent site of involvement. 
 
 
3.1.2 Disease Activity 
 
 
Crohn’s disease is a lifelong disease that is characterized with periods of relapse and remission. 
Depending with the individual, periods of remission can span for years, even decades. Patients 
experience the disease in various ways. For instance, some patients exhibit a few symptoms and 
have long periods of remission, whereas others constantly exhibit severe symptoms. The severity 
of the disease or disease activity is measured in two formal grading systems namely; the Crohn’s 
Disease Activity index (CDAI) (Table 2) and the Harvey-Bradshaw Index (HBI) (Table 3) 
(Ullman T. 2008). 
 
 
The relapse-remitting nature of the disease is such that it demands expensive medications, such  
as corticosteroids, antibiotics, immunomodulators, biologics or even surgeries which often have 
many undesirable side effects and negatively impact the patients’ quality of life (de Zoeten EF et 
al. 2013). Currently there is no known cure to CD but pro-inflammatory cytokine suppressor drugs 
(e.g., anti-TNF inhibitors) have shown to be beneficial in attaining and maintaining disease 
remission (Cosnes J et al. 2011). However there are risks of cancers and possible infection through 
the continued use of immune-suppressing drugs hence more research on less expensive and 
relatively safer therapeutic treatments is needed. 
 
 
 
 
 
 
  
 
CHAPTER 3 
 
 
 CHILDHOOD ENVIRONMENTAL EXPOSURE AND CROHN’S DISEASE 27 
 
3.1.3 The Global Incidence and Prevalence of IBD 
 
 
There is a generally observed high prevalence and incidence rate of CD in North America, 
Northern Europe, United Kingdom and Canada. In Northern America the incidence rate of the 
disease is 6.9 (Loftus EV et al. 2000) to 15.6 (Blanchard JF et al. 2001) per 105 population per 
year. The United Kingdom and Scandinavia have an incidence rate of 8.3 (Rubin GP et al. 2000) 
and 5.8 (Moum B et al. 1996 (a)), respectively. However there is a remarkably low incidence of 
CD in south and central Europe, Africa and Asia having incidence rates of 2.3 (Tragnone A et al. 
1995), 1.8 (Wright JP et al. 1986) and 0.5 (Morita N et al. 1995) per 105 population, respectively. 
These statistics have been illustrated in Table 5. 
 
 
The prevalence of IBD is highest in Europe and Canada, with countries such as Italy recording a 
rate of 322/105 population and Canada having 319/105 population (Molodecky NA et al. 2012; 
Bernstein CN et al. 2006). In the US, the prevalence rates reported for both UC and CD are 238 
and 201/105 population, respectively (Kappelman MD et al. 2007). According to age- standardised 
report from New Zealand, the incidence rates for UC and CD are 155 and 145/105 population, 
respectively (Gearry RB et al. 2006). It is generally observed that the occurrence of IBD varies 
with geographical location. A general North-South gradient is observed in United States and 
Europe (Hovde and Moum B. 2012). However in other continents IBD is less prevalent a lower 
prevalence observed in Asia (Molodecky NA et al. 2012). This geographical difference has 
become less prominent over years and recent studies have shown the increased incidence and 
prevalence of IBD in Australia and New Zealand (Molodecky NA et al. 2012). 
 
There is a traditional view that follows the occurrence of IBD that in low incidence areas, UC is 
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seen to emerge first, then followed by CD. Throughout the world in different regions and 
locations, there are variations in the ratios between the incidences and prevalence of UC and CD. 
In Australia, Canada and the United States, CD is more predominant as compared to UC (Ng SC. 
2014(a)). Some studies reveal that UC to be more prevalent than CD in some North American 
states (Molodecky NA et al. 2012). Among the Nordic countries however, UC is shown to be 
more prevalent (Vind I et al. 2006; Lehtinen P et al. 2011). Studies from Asia have revealed a 
decrease in the ratio of UC and CD in the last two decades (Thia KT et al. 2008). In Korea the 
ratio of UC to CD has decreased from 6.8 to 2.3 and China reveals even a more drastic decrease 
that is from 41 to 15 (Wang WF 2010). The variations in the regions may be reflection of the 
differences in the environmental risk factors as well as the differences in genetic disposition of 
the individuals (Ng SC. 2014 (a)). 
 
 
3.1.4 Westernization of Lifestyle 
 
 
Inflammatory bowel disease tends to occur mainly in high socio-economic groups (Loftus EV and 
Sanborn WJ. 2003). There is a general trend of a high prevalence and incidence of CD and UC in 
heavily industrialized and developed nations such as United States, United Kingdom and 
Scandinavia. The industrialization tends to impact on lifestyle changes on individuals such as diet, 
sanitation, lifestyle, medications, microbial exposure, occupations pollution and exposure to 
industrial chemicals (Hanauer SB. 2006; Andres PG and Friedman LS. 1999; Molodecky NA and 
Kaplan GG. et al. 2010). However, IBD is emerging in nations that are becoming more 
westernized such as nations of Asia, Eastern Europe, French West Indies and North Africa (Ng 
SC. 2014 (a)). Such areas were previously reported as low incidence areas for IBD. It is also 
shown that IBD commonly occurs in urban areas as compared to rural areas therefore heavily 
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suggesting the role of environmental factors as strong determinants of IBD (Molodecky NA and 
Kaplan GG. 2010). 
 
 
3.1.5 Emigration 
 
 
Emigration studies have shown that individuals migrating from low IBD prevalent areas to high 
prevalent areas are at a greater risk of developing IBD especially the first generation children 
(Bernstein CN. 2008). Studies conducted in the United Kingdom’s industrialized cities of 
Bradford (Findlay JM and Jayarantne SD. 1986), Leicester (Probert CSJ et al. 1992) and London 
(Chong SKF and Walker-Smith JA. 1986) among Asian immigrants and their children suggest 
that these immigrants have greater susceptibility to CD and UC when compared to those residing 
in Asia (Satsangi J et al. 1994).  Among Jewish immigrants, a transition in the prevalence of IBD 
has also been observed. Compared to Sephardic Jews in the Middle East and North Africa, an 
elevated prevalence of CD and UC is observed in the Jews who migrated from Middle East and 
North Africa to Israel and the Ashkenazi Jews who migrated from Europe to Israel (Gilat T et al. 
1986). 
 
3.1.6 Ethnicity 
 
 
Notably differences in the prevalence of CD and UC between various ethnic and racial groups 
have been reported (Satsangi J et al. 1994). In general, the prevalence of IBD is higher among the 
White race, when compared to non-Whites, with the highest prevalence and incidence observed 
among Ashkenazi Jews of Europe, United States and Cape Town (Gilat T et al. 1986). The 
prevalence and incidence is lower among the Black, Latin and Native Americans, the Maoris and 
the Asians (McConnell RB and Vadheim CM. 1992), although in recent years there has been an 
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observed rise in the occurrence of IBD in these previously low risk ethnic groups. Notably 
however, the majority of earlier studies have focused on populations of higher socioeconomic 
status, suggesting a potential bias. 
 
In the United States accumulating evidence supports an increasing occurrence of IBD in Black 
and Hispanic populations (Calkins BM et al. 1984). A study by Malaty HM et al. 2010, on a 
population predominantly of low socioeconomic status in the United States revealed that 
Hispanics were more susceptible to UC than CD, and that there was greater prevalence of UC, 
when compared to their Black and Caucasian counterparts (Malaty HM et al. 2010). On the other 
hand, there was no statistically significant difference between the occurrence of CD and UC within 
the Afro-American and Caucasian population groups. However CD was more prominent in both 
groups (Malaty HM et al. 2010). The racial gap on the incidence and prevalence of the disease 
seems to be closing, and this again may be an indication that environmental factors have greater 
influence on the occurrence of the disease (Hanauer SB. 2006). 
 
 
3.1.7 Asia 
 
 
The epidemiology of Asia is of importance because more than half of the world population resides 
on this continent. For long it has been reported that the highest occurrence of IBD is in the Western 
countries. The occurrence of IBD is rising in areas which were traditionally known to have lower 
occurrence such as Eastern Europe (Lakatos L et al. 2004) and Asia (Sood A et al. 2003). The 
incidence and prevalence of IBD in Asia is however still significantly lower than in the West 
(Prideaux L et al. 2012). Nevertheless, Asia is experiencing a rise in the incidence and prevalence 
of IBD alongside an expeditious socio-economic development (Prideaux L et al. 2012). Japan (Ng 
SC. 2014 (a)) and Korea (Sood A and Midha V. 2006) are reportedly the only countries in Asia 
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which have reliable nationwide IBD registries. In the past decades, increase in the occurrence of 
IBD has been widely reported in these countries. A study conducted in Japan in the year 1991, 
revealed an incident rate of 1.95/105 population and 0.52/105 population for UC and CD, 
respectively (Morita N et al. 1995). The same study revealed a prevalence rate of 18.12/105 
population and 5.85/105 population for UC and CD respectively in that same year. A cumulative 
number of IBD cases have been recorded to be three times greater in the year 2000 and it is 
estimated that a total of 10000 people are suffering from UC in Japan (Yao T et al. 2000). 
 
It is also recorded in studies on IBD in Japan that between the years 1961 and 1991 the incidence 
rate of UC rose from 0.02 to 1.95/105 population ( Kitahora T et al. 1995; Morita N et al. 1995) 
and the incidence rate of CD rose from 0.60 in 1986 to1.20/105 population in 2008 (Yao T et al. 
2000). According to two population-based studies conducted in Korea between 1986 and 2008, 
the incidence rate of CD rose from 0.05 to 5.1/ 105 population and the rate for UC rose from 0.34 
to 5.4/105 population (Yang SK et al. 2008; Shin DH et al. 2011). A cohort study in Hong Kong 
also revealed an increase in the incidence of CD and UC from 0.4 - 1.0 and 0.8 - 1.2/105 
population, respectively between the year 1990 and 2001 (Leong RW et al. 2004). There are 
variations in the incidence rates observed between different ethnic groups and geographic 
locations. It is however important to note that in Asia there is greater incidence of UC as compared 
to CD with the highest incidence rates reported in India, Japan and the Middle East (Ng SC. 2014 
(a)). 
 
Studies in Japan spanning from 1984 to 2005 have shown a drastic increase in the prevalence of 
UC from 7.85 - 63.6 / 105 population (Morita T et al. 1995; Asakura K et al. 2009) and that of CD 
rose from 2.9-13.5/105 population (Yao T et al. 2000). The figures from South Korea reveal an 
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alarming increase of UC from 7.6 - 30.9/105 population from 1997 to 2005 (Yang SK et al. 2008). 
A further increase was also seen in CD between the year 1986 and 1998 where a prevalence rates 
rose from 2.9 - 13.5/105 population (Yao T et al. 2008). Several studies from Asia have revealed 
a general increase in the prevalence of IBD. This strongly suggests that the occurrence of IBD is 
a dynamic process in which the incidence and prevalence of the disease gradually changes in 
different geographic locations due to alterations in environmental factors. 
 
 
3.1.8 South Africa 
 
 
The prevalence and incidence of CD in Africa in general has not been well documented. Data 
found in South Africa and mainly in the Cape Town area is the one used to represent the whole 
continent of Africa. According to a study conducted at Groote Schuur hospital from 1970-1974, 
Novis BH et al. reported that diagnosis CD had become more frequent over the years and that CD 
was becoming the major IBD among the Coloured and the White community (Novis BH et al. 
1975). The reported incidences of CD during these years within the Coloured and White were 0.4 
and 0.8 / 105 population. Wright BH conducted a retrospective study at the same hospital from 
1975 to 1980. It was seen that the incidence rate of CD among the Coloured community had 
increased from 0.4/105 population (1970-1975) to 1.3/105 population (1975-1980) (Wright BH. 
1992). Likewise among the White community, a subsequent increase was observed. There was an 
increase from 0.8/105 population (1970-1975) to 1.2/105 population among the Whites (Wright 
BH. 1992). It is however interesting to note that in both studies, there was only one Black patient 
therefore suggesting that CD is less common among the Black community. It was noted that 
within the Jewish community was the highest incidence rates of CD. Incidence rates of 5.0/105 
population were noted from (1970-1975) and a rise in incidence to 7.2/105 population per year 
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(Wright BH. 1992). 
 
3.2 Inflammation 
 
 
Inflammation is the body’s first line of defence against pathogens. It is a protective reaction of 
living tissue to infection, injury or irritation often characterized by swelling, pain, redness and 
heat. Inflammation is mainly mediated by intercellular inflammatory mediators known as 
cytokines. These are soluble cell-derived polypeptides which function as positive or negative 
regulator molecules of the immune system. Cytokines are the major orchestrators of cellular 
activation and serve as the determinants of the cellular infiltrates. In addition, cytokines serve as 
pleiotropic molecules for both paracrine and autocrine functions in the body. Inflammation can 
be subdivided into two main categories: acute inflammation and chronic inflammation (Abbas AB 
and Litchman AH. 2009). 
 
Tumour necrosis factor alpha (TNF-α) is one of the key cytokines involved in the acute 
inflammation. This cytokine is produced chiefly by activated macrophages. However, it is also 
produced by mast cells, natural killer (NK) cells, T-cells and fibroblasts. Tumour necrosis factor 
alpha is an endogenous pyrogen, thus it is able to induce fever by either inducing the production 
of interleukin-1 (IL-1) or by stimulation of prostaglandin E2 (PGE₂) synthesis. This cytokine has 
a major pro-inflammatory function through its association with other cytokines (Bradley JR. 
2008). Tumour necrosis factor alpha and IL-1 stimulate interleukin-6 (IL-6) synthesis in a number 
of cells which in turn triggers a series of inflammatory reactions in association with other 
overlapping cytokines such as interleukin-11 (IL-11) and interleukin-8 (IL-8). Tumour necrosis 
factor is normally not detected in healthy individuals. However in infectious and inflammatory 
conditions exceedingly high levels are found in the blood serum and tissue samples (Robak T et 
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al. 1998). It is interesting to note that the levels of this cytokine are directly correlated to the level 
of infection (Waage A et al. 1987). Increased local production of TNF-α is the driving force 
behind effecting a chronic inflammatory response in tissue and serum (Maini RN et al. 1995). 
Tumour necrosis factor alpha can induce tissue injury in different pathways. It can have direct 
effects on the intestinal epithelial function and permeability (Gibson PR et al. 2004). An impaired 
epithelial barrier results in increased exposure to antigenic macromolecules, thereby triggering 
mucosal inflammation. This cytokine can also cause an upregulation of adhesion molecule 
expression on endothelium of the intestinal wall (Binion DG et al. 1997). Tumour necrosis factor 
alpha is pivotal in inducing the increased production of chemokines by various cell types of the 
immune system (MacDermott RP et al. 1998). The mucosal levels and the inflammatory cell 
production of TNF-α are elevated thus making it a cytokine of great significance in the 
pathogenesis of CD (Gibson PR et al. 2004). 
 
Chronic inflammation is divided into two subunits: humoral inflammatory response and cellular 
inflammatory response. Interleukin-2 (IL-2) is a glycoprotein originally referred to as T-cell 
growth factor (TCGF). It is primarily involved in the cellular inflammatory response and it also 
plays a significant role in the humoral inflammatory response. Interleukin-2 is an α-helical 
cytokine which is chiefly produced by activated T-helper cells (Shaikh PZ. et al 2011). It is vital 
in the activation and regulation of white blood cells (both leukocytes and lymphocytes) in the 
immune system. Interleukin-2 effects the differentiation of CD4+ T-cells into Th1 and Th2 cells. 
In like manner 1,25D signalling functions to repress the transcription of the genes that encode for 
the Th1 immune response such as interferon gamma (IFN-γ) and interleukin-21 (IL-21) (Baeke F 
et al. 2010). CD4+ T-cells respond differently to antigenic stimulation, adopting specific 
phenotypes which are vital for varying immune functions and immune mediated responses (Herbst 
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RS et al. 2009). Activated T-cells also express the vitamin D receptor (VDR). Interleukin-2 is 
critical in the induction and maintenance of regulatory T-cells (Tregs). These are crucial in the 
maintenance of Fox P3 and the TGF-β effects (Davidson TS et al. 2007; Setoguchi R et al. 2005). 
Likewise the vitamin D3 (VD3) signalling enhances the tolerance of the dendritic cells which in 
turn promotes the production and function of Tregs which are the potent mediators of the immune 
system tolerance (Chung C et al. 2011). Interleukin-2 also functions to inhibit the differentiation 
of Th17 cells since the re-stimulation of the differentiated cells with IL-2 eliminates the 
production of interleukin 17 (IL-17) subsequently inducing the production of IFN-γ (Hoyer KK 
et al. 2008). Interleukin-2 functions as a growth factor thereby stimulates the production of NK 
cells and macrophages (Hoyer KK et al. 2008). It is crucial in the production of memory T-cells. 
It is also important to note that the production of IL-2 is inhibited through the binding of the VDR 
onto the nuclear factor of activated T-cells (NF-AT) binding site of the promoter for IL-2. 
 
Interferon gamma falls in a category of cytokines that were originally identified and named for 
their antiviral properties. It is a type ΙΙ interferon that is mainly produced by activated T-cells and 
natural killer (NK) cells. However some studies have shown that B- cells, natural killer T (NKT) 
cells and antigen-presenting cells (APCs) are also involved in its production. Interferon gamma is 
a homodimer, serving to stimulate the effector functions of mononuclear phagocytes, as well as 
to enhance the major histocompatibility complex (MHC) Ι and ΙΙ expression on nucleated cells. 
Interferon gamma production is controlled by interleukin-12 (IL-12) and interleukin-18 (IL-18), 
by promoting the Th1 polarization. These two cytokines are produced mainly by APCs. The 
secretion of IFN-γ activates neutrophils and macrophages (Schroder K et al. 2004). Crohn’s 
disease is characterized by a Th1 and a Th17 CD4+ immune response (Strober W and Ivan JF. 
2011). Upon antigen stimulation, the CD4+ Th cells can be differentiated into Th1 and Th2 cells 
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depending on the cytokine profile. The secretion of IFN-γ in the Th1 response is induced by IL- 
12 derived from dendritic cells which is tangential to pathogen recognition receptor (PRR) 
signalling (Kaser A and Blumberg RS. 2010). The Th1 response subsets produce lymphotoxin 
(TNF-α) and IFN-γ which have been implicated in a number of immune mediated diseases 
(Boonstra A et al. 2001). A number of reports have shown IFN-γ to be produced in abundance by 
the colonic mucosal tissue and intestinal lamina propria mononuclear cells (Fais S et al. 1994). 
Studies on the wild type (WT) dextran sulphate sodium (DSS) treated mice have shown IFN-γ to 
be crucial in the induction and progression of CD-like symptoms. Interferon gamma subsequently 
provoked the infiltration of leukocytes into inflammatory lesions. The mice expressed a gigantic 
production of IFN-γ in the gut, body weight loss and a 60% mortality rate (Ito R et al. 2006). 
 
C-reactive protein (CRP) is the classic acute phase response protein that functions as a marker of 
inflammation, tissue damage and infection. Pepys MB. 1995 describes it as an exquisitely 
objective sensitive biomarker. C-reactive protein is mainly produced by the hepatocytes in the 
liver (Vermeire S et al. 2004). It is a phylogenetically highly conserved plasma protein. C-reactive 
protein functions as a pattern recognition molecule that binds to specific molecular configurations 
on the surface of pathogens and infected host cells (Black S et al. 2004). It is rapidly synthesized 
after tissue injury or infection and the plasma concentration often increases up to a thousand fold 
during inflammation. This potent non-specific innate immune response molecule is produced by 
the cytokine TNF-α, IL-1 and IL-6 (Koenig W et al. 1999). C-reactive protein functions to 
promote phagocytosis by initiating the activation of the complement cascade and binding to high 
affinity Fc gamma receptors on phagocytes. It also promotes bacterial capsular swelling, 
agglutination and complement fixation (Faraj M and Salem N. 2012). C - reactive protein serves 
as a potent marker of an immune response. It is found in large quantities in the serum during the 
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acute phase and the chronic stages of inflammation (Vermeire S et al. 2004). 
 
C- reactive protein has a half-life of 19 hours but however it remains stable and identical under 
all conditions therefore making it a reliable biomarker (Koenig W et al. 1999). This protein is up-
regulated when an acute phase response is activated. There is a striking heterogeneity in CRP 
response among inflammatory diseases such as CD and rheumatoid arthritis (RA) (Vermeire S et 
al. 2004). In CD, CRP has a number of functions. It acts as a marker for diagnosis and differential 
diagnosis of IBD (Beattie RM et al. 1995) and it also serves as a marker for disease activity (Fagan 
EA et al. 1982). C-reactive protein is also important as a marker of outcome and risk assessment for surgery 
(Rutgeerts P et al. 2003) and a marker of treatment response (Louis E et al. 2002). 
 
 
3.2.1 The Immune Response 
 
 
Along with other cell types, T lymphocytes secrete cytokines, proteins that have autocrine and 
paracrine effects on T cell function. When first presented with a specific antigen, a naїve Th cell 
will produce IL-2 and begin to expand in number (Elliott DE et al. 2000). As the Th cells expand, 
members of the population produce other cytokines such as TNF-α, IFN-γ, IL-4, IL-5, IL-10 and 
IL-13. As antigen exposure is prolonged, the cytokine profile produced by the T cells will polarize 
to either the Th1 or the Th2 immune response (Romagnani, S. 1994). The Th1 response is 
characterized by the production of TNF-α, IFN-γ, LT and Th1 cytokines mediate delayed-type 
hypersensitivity reactions, macrophage activation, cellular cytotoxicity, and switch B cell 
immunoglobulin (Ig) production to subclasses that fix complement (murine IgG2a or human 
IgG1). On the contrary, the Th2 response produces IL-4, IL-5, IL-10, IL-13 and Th2 cytokines 
mediate eosinophilia, B cell proliferation, and switch B immunoglobulin production to IgA, IgE, 
and IgG subclasses that do not fix complement (murine IgG1 or human IgG4). The Th2 cytokines 
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IL-4, IL-13, and IL-10 inhibit delayed-type hypersensitivity reactions, macrophage activation, and 
cytotoxicity (Elliott DE et al. 2000). 
 
The selection of the immune responses is mainly dependent upon the antigen dose, accessory cell 
function and costimulatory molecule display. However, the cytokine profile present during 
antigen stimulation is the controlling factor moulding the Th1 or Th2-type response (Paul WE and 
Seder RA. 1994). The presence of IL-12, IL-18, and IFN-γ promotes expansion of Th1 cells. 
Macrophages produce IL-12 and IL-18 which augment Th1 cell development and stimulates 
production of IFN-γ. Interferon-γ increases antigen presentation and IL-12 production by 
macrophages (Kubin M et al. 1994) and also increases Th1 cell high-affinity IL-12 receptor 
display (Gollob JA et al. 1997). Ultimately, IFN-γ inhibits the proliferation of Th2 cells, thus 
promoting the Th1 cells. The IL-12/IFN-γ positive feedback circuit augments Th1 while inhibiting 
Th2 cell development (Elliott DE et al. 2000). 
 
The expansion of Th2 cells is promoted by the presence of IL-4 and IL-10. Interleukin-4 is an 
autocrine growth and differentiation factor for Th2 cells and it signals through the ‘signal 
transducer and activator of transcription’ 6 (STAT6) to augment its own production in a positive 
feedback circuit (Elliott DE et al. 2000). On the other hand, IL-4 inhibits release of IL-12 and 
other cytokines from macrophages (de Waal et al. 1993). Interleukin-13 and IL-10 also act in the 
same fashion to inhibit the release of IL-12 (Moore KW et al. 1993). Interleukin-10 inhibits 
macrophage accessory cell function required by differentiated Th1 cells, but not Th2 cells 
(Fiorentino KW et al. 1991). Thus, IL-4, IL-13, and IL-10 inhibit Th1 cell development while 
championing Th2 responses. 
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3.2.2 The Intestinal Microbiome 
 
 
Commensal microbiota influences the development of the gut immune system by maintaining 
homeostasis between them and the pathogenic bacteria. The interaction between the mucosal 
innate immune system and the endogenous microflora ultimately functions to promote the 
development as well as maintain the intestinal ecosystem. The innate immune system has the 
ability to distinguish between pathogens and harmless antigens by means of pattern recognition 
receptors (PRRs) (Medzhitov R and Janeway C. 2000). Toll-like receptors (TLRs) which are 
present on immune cells such as macrophages, neutrophils, DCs and intestinal epithelial cells 
(ECs) enable the mammalian cells to recognize characteristic molecules present on microbes 
(Marshak-Rothstein A. 2006). The gut microbiome can regulate the intestinal immune system by 
modulating TLR expression on immune-sensory cells consequently triggering cytokine 
production through the activation of T cells (Purchiaroni F. 2013). 
 
Microbial exposures are believed necessary in developing the gut’s immune system. These 
exposures then optimize the acquired (adaptive) immunity and immunological memory, which 
will ultimately dictate balance between the Th1, Th2 and Th17 immune responses. It has been 
suggested that in those genetically susceptible, a limited exposure to microbes particularly early 
childhood may trigger a deregulated immune-mediated response to the commensal intestinal 
bacteria in the later stages of life. This theory is now referred to in the literature as the ‘hygiene 
hypothesis’ (Koloski NA et al. 2008). 
 
According to metagenomic research, thousands of anaerobic bacterial species mainly from the 
phyla Firmicutes, Bacteroidetes, Actinobacteria and Proteobacteria reside in the human gut in an 
overall stratified orientation (Baumgart DC and Sandborn WJ. 2012). It is well established that 
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the number of anaerobic bacteria outnumbers the aerobic (facultative anaerobes) bacteria by a 
factor of 100-1000 (Simon GL and Gorbach SL. 1986). The predominant genera of anaerobes 
found in the GI tract of human beings are Bifidobacterium, Clostridium, Bacteroides, 
Eubacterium, Peptococcus, Peptostreptococcus and Ruminococcus (Simon GL and Gorbach SL. 
1984; Salminen S et al. 1998). However there are other subdominant aerobes such as 
Enterobacter, Klebsiella, Escherichia, Enterococcus, Lactobacillus and Proteus (Simon GL and 
Gorbach SL. 1984; Moore WE and Moore LH. 1995). A healthy intestinal microbiome has an 
increased variation of microbiota, but the species diversity depends on dietary (Muegge BD et al. 
2011), individual (Claesson MJ et al. 2011) drug induced (Dethlefsen L and Relman DA. 2011) 
and temporal (Costello EK et al. 2009) factors. In comparative studies on CD, a reduction in the 
diversity of the intestinal microbiota especially those belonging to the phyla Firmicutes and 
Bacteroidetes (Frank DN et al. 2007) has been noticed and also that the bacterial aggregations 
where in the form of clusters (Qin J et al. 2010). 
 
Resident gut microflora has specific functions on the host’s physiology and pathology (Falk PG 
et al. 1998). The main functions of intestinal microbial community are: metabolic, trophic and 
protective. The main metabolic function is the fermentation of the hard non-digestible dietary 
components and the endogenous mucus that is synthesized by the epithelia. A complex system of 
enzymatic and biochemical pathways is created due to a great diversity of microbes, resulting in 
the recovery of energy and absorbance of nutrients benefiting both the host and resident microbial 
proliferation (Guarner F and Malagelada JR. 2003). Within the trophic functions of gut microflora, 
growth and differentiation of epithelial cell is of paramount importance. Differentiation and 
growth of epithelial cell is affected by interaction with the gut microflora (Hooper LV and Gordon 
JI. 2001; Gordon JI et al. 1997). Studies on murine models have suggested that intraluminal 
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bacteria affect cell growth within the colon (Alam M et al. 1994). Crypt cell production is seen to 
be greatly reduced in the colon of rats that are bred in germ-free environments. It is also shown 
that the crypts in these rats contain fewer cells as compared to those rats which have resident 
microflora. 
 
The gastrointestinal tract’s immune system is an example of mucosa-associated lymphoid tissue 
and it is also known as the gut-associated lymphoid tissue (GALT). The intestinal mucosa 
therefore makes the link between the host immune system and the external environment. The 
interaction between the host and the resident microflora is crucial in the development of an 
effective immune system (Guarner F and Malagelada JR. 2003). The composition of the GALT 
is affected by diversity of the microbial colonies in the GI tract. Gnotobiotic animals tend to  have 
low concentration of circulating immunoglobulin in the blood, fewer lymphoid cells in the gut 
mucosa and smaller specialized follicle structures (Tannock GW. 2001; Falk PG et al. 1998; 
Butler JE et al. 2000) but after exposure to the luminal microbiota, an intense expansion of all 
these is observed. Interactions between the intestinal microbiota, epithelium and the GALT serve 
in the fashioning of the memory mechanisms of the innate and adaptive immune system (Guarner 
F and Malagelada JR. 2003). It is also important to note that such an interaction needs to be 
moulded, more importantly in early life in order to develop complex and effective mucosal and 
systemic immunoregulatory circuits. In adults, the constant interaction between the host and the 
flora tends to shape the resultant immunity of the individual. Immune responses to microbes, 
depends on specific identifying components of the immune system such as immunoglobulins 
(Guarner F and Malagelada JR. 2003). Apart from macrophages and neutrophils, the innate 
immune response is also aided by the intestinal epithelial cells which coordinate the host’s defence 
mechanisms through the synthesis of inflammatory mediators and signal transmission to the cells 
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in the mucosa (Kagnoff MF and Eckmann L. 1997). However there is need to discriminate 
between commensal bacteria and potential pathogens and this is achieved through the use of TLRs 
which recognize structural patterns on bacteria, which are not found on eukaryotic cells (Aderem 
A and Ulevitch RJ. 2000). The non-pathogenic bacteria are incubated within the inflamed 
intestinal mucosa thereby triggering a different cytokine response effecting a change in the 
phenotype of the lymphocytes found in the lamina propria (LP) (Borruel N et al. 2002). 
 
Under the protective functions, the commensal bacteria act as an important line of resistance 
through the barrier effect. The presence of commensal bacteria limits the colonization of the gut 
ecological niche by exogenous microbes thus ensuring restricted growth of opportunistic bacteria. 
Equilibrium is created between the different resident bacterial species hence creating stability 
among the microbial population within the gut (Guarner F and Malagelada JR. 2003). However 
the use of antibiotics can shift the balance in favour of those bacteria which are potentially toxic 
to the host such as Clostridium difficile (Van der Waaij D. 1989). There are several different 
mechanisms which are employed to affect the barrier. Commensal bacteria aid in the competition 
for the adhesion sites situated in the brush borders of the intestinal epithelial cells, thus preventing 
the subsequent colonization by the pathogenic enteroinvasive bacteria (Bernet MF et al. 1994). 
There is also competition by bacteria for nutrients in the respective ecological niches. The host 
and the commensal bacteria have a symbiotic relationship in which the host provides the required 
amount of nutrient enrichment and the commensal bacteria indicates how much nutrient it requires 
and it consumes all the nutrients thereby maintain their habitat (Guarner F and Malagelada JR. 
2003). The provision of nutrients is limited to the needs of the commensal bacteria so that invasive 
bacteria are deprived of nutrients to thrive on. The other way of inhibiting the growth and survival 
of invasive bacteria is through the production of bacteriocins (Brook I. 1999; Lievin V et al. 2000). 
 
 
 
 
  
 
CHAPTER 3 
 
 
 CHILDHOOD ENVIRONMENTAL EXPOSURE AND CROHN’S DISEASE 43 
 
These are ribosomally synthesized proteinaceous toxins by bacteria to inhibit the growth of similar 
or closely related species. However the host is capable of controlling the production of these 
substances. 
 
 
3.2.2.1 Commensal Bacteria and Crohn’s Disease 
 
 
It has been suggested that commensal bacteria influence the inflammatory processes of CD 
(Shanahan F. 2002). According to Pirzer U et al. 1991, there is hyperactivity of T lymphocytes 
against bacterial antigens and an elevated intestinal secretion of Immunoglobulin G (IgG) type 
antibodies in CD patients (Pirzer U et al. 1991, Macpherson A et al. 1996). Immunoglobulin G 
mediated immune responses tend to damage the intestinal mucosa through the activation of the 
complement and inflammatory mediators, contrary to an Immunoglobulin A (IgA) response 
(Brandtzaeg P et al. 1989). It is seen that patients with CD have greater amounts of bacteria,  from 
different genera attached to their epithelial cell surfaces than do the healthy individuals 
(Swidsinski A et al. 2002) thus suggesting that there could be some uncontrolled activation of  the 
gut immune system by certain elements of the commensal enteric bacteria. 
 
 
3.2.2.2 The Role of Mucosal Dendritic Cells in the Gut 
 
 
The gut mucosa is susceptible to antigenic stimulation through exposure to food antigens, foreign 
pathogens and resident microbiota (Cabezon R and Benitez-Ribas D. 2013). This stimulation 
results in controlled inflammatory responses that are carefully controlled by a number of 
nonimmune and immune mechanisms. As a result the gut immune system has the capability to 
distinguish between pathogens and harmless antigens. There are three main categories of the 
host’s response to the intestinal microbiota namely: (1) the intestinal epithelium, which modulates 
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immune response through the secretion of inflammatory mediators, recruiting  dendritic cells 
(DCs) and presenting antigens to T lymphocytes, (2) the innate immunity, which includes 
anatomical barriers, secretory molecules, and cellular components, that initiate the nonspecific 
immune response, and (3) the adaptive immunity, which is facilitated by B and T lymphocytes, 
responsible for antigen specific immune responses (Cabezon R and Benitez-Ribas D. 2013). This 
mechanized regulation serves to maintain intestinal homeostasis. Defects in this carefully 
regulated mucosal immune system as suggested by many studies to result in IBD, more 
specifically CD (Niess JH. 2008). 
 
Dendritic cells are physiologically professional antigen-presenting cells linking the innate and 
adaptive immune system and they possess a pivotal role in the immunoregulation of the GALT 
(Radwan P et al. 2010; Cabezon R and Benitez-Ribas D. 2013). Dendritic cells originate from the 
bone marrow and are brought into the circulatory system as immature cells and then they are 
channelled to regions that are more susceptible to pathogens such as the intestinal mucosa 
(Radwan P et al. 2010). There, they monitor the intestinal lumen by processing the luminal 
antigens and via phagocytosis. Dendritic cells reside in mucosal tissues or recirculate in the blood 
and lymphoid tissues (Iwasaki A. 2007). 
 
Intestinal immune system is mainly controlled by the activity of the local T-cells which are 
activated by DCs. They are programmed during the initial stage of activation to either initiate 
(innate and adaptive) immune responses or to control inflammation and maintain tolerance (Niess 
JH and Reinecker HC. 2006). The LP of the small and large intestines are the effector sites of 
mucosal tissues and here DCs are ideally situated to survey the constituents of the commensal 
microflora and monitor food antigens (Bjorck P. 2001; Niess JH. 2008). The inductive sites of 
DCs are Peyer’s patches (PP), intestinal lymph follicles (iLFs), DC aggregates and mesenteric 
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lymph nodes (MLNs) (Niess JH. 2008). The phenotype of DCs is influenced by the local 
microenvironment, and can be divided into conventional DCs (CD8α+CD11b-, CD4+CD11b+, 
CD4-CD11b+) (Hochrein H et al. 2001) and plasmacytoid DCs (B220+CD11clow), characterized 
by a phenomenal plasticity between them (Kelsall BL and Rescigno M. 2004). 
 
Dendritic cells differentiate into two forms which are distinct in their functions (i.e. immature and 
mature cells). The immature DCs mainly perform phagocytosis and are found mostly in peripheral 
tissues. Mature DCs are characterized by surface costimulatory molecules that are required for the 
activation of T-cells hence they are specialised APCs (Banchereau J and Steinman RM. 1998). 
The mature DCs are derivatives of the immature cells and the process of maturation is facilitated 
by inflammatory stimuli. This result in the migration of these DCs to draining lymph nodes and 
these cells are most likely to induce tolerance to self-antigens (Steinman RM and Banchereau J. 
2007). CD4+ T-cells are divided into two groups namely T helper cells and Tregs. The T helper 
cells are subdivided into 3 classes: Th1, Th2 and Th17cells and they are distinct in function. Th1 
cells are pro-inflammatory cells which are responsible for the immunity against intracellular 
pathogens through the release of IFN-γ. Th2 cells on the other hand are anti-inflammatory cells 
and through the activation of B cells stimulate the release of B cell growth factors such as IL-4. 
Th17 cells are mainly responsible for defence against bacteria and fungi, however under certain 
pathologic conditions, they are found to exacerbate the inflammatory response (Rescigno M and 
Di Sabatiano A. 2009). Regulatory T-cells serve to suppress the function of effector T-cells 
thereby counteracting inflammation (Powrie F and Maloy KJ. 2003). In the GI tract, subsets of 
DCs stimulate the development of Tregs which are the major drivers of immune tolerance 
(Coombes JL and Powrie F. 2008). The intestinal DCs also serve in conferring gut-homing 
properties to lymphocytes or aid to promote class switch recombination to IgA (Rescigno M and 
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Di Sabatiano A. 2009). 
 
 
3.2.2.3 The Role of Mucosal Dendritic Cells in the Pathology of IBD 
 
 
Dendritic cells play an important role in intestinal homeostasis. However the role of DCs in the 
aetiology of CD remains elusive but several murine and human models have suggested that DCs 
may be implicated in immune-mediated disease. The role of mucosal DCs is strictly regulated by 
local microenvironment which is comprised of luminal bacteria, immune cells and non-immune 
cells (Rescigno M and Di Sabatiano A. 2009). Deregulation at any of these levels may affect the 
function of DCs and may result in intestinal disease. The affected DCs may prime abnormal T- 
cell responses to the enteric microflora, stimulate T-cells and maintain them in an inflamed state 
and serve as effector cells through the release of pro- inflammatory cytokines. They may also 
cause an imbalance between Th17 inducing DCs and Treg-inducing DCs, in favour of the pro- 
inflammatory Th17 cell differentiation. In T-cell-independent models of colitis DCs have a 
pathogenic role. For example, DC activation via CD40 results in gut inflammation in the absence 
of B and T-cells through the release of inflammatory cytokines such as IL-23 and IL-17 (Uhlig 
HH et al. 2006). 
 
Dextran sulphate sodium administered orally to mice induces an acute form of colitis. Diphtheria 
toxin-induced (DT-induced) denaturing of DCs in diphtheria toxin (DT) receptor-transgenic mice 
during DSS administration reverses the colitis (Abe K et al. 2007). Pre-treating mice with 
immunostimulatory DNA sequences before DSS administration, results in DCs having a 
protective function, partially because of the release of type I IFN. This cytokine serves to modulate 
the recruitment of neutrophils and monocytes and along with their inflammatory activities (Abe 
K et al. 2007). On the contrary, if DCs are ablated before DSS treatment, colitis is exacerbated 
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(Qualls JE et al. 2009), implying that DCs have a protective role in the early phases of colitis but 
have a pathogenic role in late phases of disease course. The engagement of DCs during the late 
phases of colitis development may be a result of abnormal activation of resident DCs, a 
recruitment of DCs that were not exposed to the local tolerogenic microenvironment and hence 
are immunogenic thereby causing an imbalance between tolerogenic and immunogenic DCs 
(Rescigno M and Di Sabatiano A. 2009). 
 
Dendritic cell phenotype in murine colitis has shown an increase of mature DCs expressing higher 
levels of costimulatory molecules (CD40, CD80, and CD86) and elevated amounts of IL-12p40 
and IL-23p19 upon CD40 ligation (Krajina T et al. 2003). Both, IL-12p40 and IL-23p19 form IL-
23, a critical cytokine for the growth and stabilization of Th17 cells in mice and differentiation in 
humans (Korn T et al. 2009). NOD2-mutant DCs derived from CD patients failed activate effector 
Th17 cells upon stimulation with bacterial peptidoglycan or a combination of MDP and TLR 
ligands. Thus these data then imply a pathway for IL-1 and IL-23-dependent priming of effector 
Th17 cells through NOD2-mediated detection of intracellular MDP. This therefore reveals a 
connection between the 2 systems which are implicated in the pathogenesis of CD (Stetson DB 
and Ruslan M. 2007). 
 
In IBD patients DCs accumulate at sites of inflammation (Vuckovic S et al. 2001), mainly as a 
result of upregulated mucosal expression of chemokines (Kaser A et al. 2004) or of addressins 
(Arihiro S et al. 2002). As a result of the overexpression of lymphoid chemokines, recruited 
mature myeloid DCs form clusters with proliferating T-cells in the inflamed intestinal tissue 
(Middel P et al. 2006). M-DC8+ cells, a subpopulation of DCs in human blood secreting TNF-α 
and expressing high levels of FcγRIII (CD16), are proliferated in the inflamed mucosa (de Baey 
A et al. 2003), thus demonstrating that DCs are a further source of TNF-α in CD. Activated DCs 
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may migrate from the mucosa to the MLNs in CD patients and there are at least 3 distinct myeloid 
DC populations are present in MLNs (i.e. immature DCSIGN+ DCs in the medullary cords), DCs 
expressing the myeloid marker BDCA3 (CD141) around the lymph follicles, and mature 
CD83+DCs expressing the S-100 protein in the T-cell areas (Verstege MI et al. 2008). Cross-talk 
between IECs and DCs may disrupt the intestinal immune homeostasis, thus promoting gut 
inflammation (Rescigno M and Di Sabatiano A. 2009). It was shown that IECs isolated from the 
majority of CD patients do not express Thymic stromal lymphopoietin (TSLP) and are not capable 
of controlling the DC-mediated pro-inflammatory response, thus resulting in an aberrant release 
of IL-12 by DCs, which drives Th1-type inflammatory responses (Rimoldi M et al. 2005). 
Available evidence reveals that NOD2 mutations may affect the response of CD monocyte derived 
DCs to bacteria and DCs derived from NOD2-deficient CD patients show an impaired capacity to 
induce IL-17 expression upon MDP triggering (Rescigno M and Di Sabatiano A. 2009). 
 
 
3.3 Vitamin D and Immune System 
 
 
3.3.1 Vitamin D Receptor (VDR) 
 
 
Vitamin D interacts with many organs in the body. This is due to the ligand-dependent 
transcription factor vitamin D3 (1,25(OH)₂D3) receptors VDRs, the nuclear hormone receptor on 
many different cells which belong to the albumin family (Bikle D. 2014). After binding to vitamin 
D, the receptor associates with specific recognition sequences called vitamin D responsive 
elements (VDREs). These are present in the promoter region of target genes and involved in 
regulating their transcription (Haussler MR et al. 1998). The VDR modulates the expression of 
vitamin D- responsive genes. Vitamin D receptor typically functions as a heterodimer with the 
retinoid-X-receptor (RXR) (Basson A. 2014). This is basically achieved by positively regulating 
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the expression of some genes by binding to the VDREs in their promoter regions; by antagonizing 
specific transcription factors thereby inhibiting the expression of certain genes and by binding to 
negative VDREs thus negatively regulating the expression of the genes (Bikle D. 2014). Therefore 
all biological functions of either 1,25(OH)₂D or 1,25(OH)₂D3 are regulated by the VDR (Haussler 
MR et al. 1998). 
 
All cells of the immune system including activated lymphocytes, APCs and DCs express the VDR 
and T-cell activation induces the expression of additional VDR (Cantorna MT et al. 2004). 
Exposure to 1,25(OH)₂D3 results in a dose-dependent inhibition of two lymphokines namely IL- 
2 and IFN-γ (Mathieu C and Adorini L. 2002). Interleukin-2 production is inhibited through the 
binding of the VDR onto the NF-AT binding site of the promoter for IL-2. Interferon gamma is 
inhibited in the same manner through the binding of VDR with a VDRE in the promoter region. 
These inhibitions suggest that suppression of Th1 activity is the major point by which active 
vitamin D metabolite can regulate the immune system and dictate the balance between the T-cell 
mediated immunity (Scalabrino G. 2009). 
 
Studies have shown that 1,25-dihydroxy Vitamin D3, can have an effect on tissues and cells that 
are not directly involved in calcium regulation mechanism. It has been strongly proposed that 
1,25-dihydroxyvitamin D3 can function as a regulator of immune cell differentiation and 
proliferation, thus vitamin D may have a similar function to that of immune-modulatory molecules 
such as cytokines (Hewison M. 2010). Vitamin D receptors, specific high-affinity intracellular 
receptors for 1,25-dihydroxyvitamin D3 are detectable in activated T cells, and activated 
macrophages are able to synthesize 1,25-dihydroxyvitamin D3 thus suggesting a possible 
paracrine and intracrine mechanisms of action (Hewison M. 2010). The explicit association of 
1,25-dihydroxyvitamin D3 with cytokines is however not yet fully understood, but its ability to 
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modulate immune cells in vitro and its interaction with inflammatory diseases can be predicted. 
 
3.3.2 The Effects of Vitamin D on the Innate Immunity 
 
 
3.3.2.1 Vitamin D, Macrophages and Cathelicidin 
 
 
The effects of vitamin D on macrophages have been pivotal to the observations which implicate 
vitamin D in the regulation of immune responses. Macrophages, NK cells, cytotoxic T-cells 
together with their monocyte precursors, function to initiate non-specific immune response to 
pathogens or tissue damage (cell-mediated immunity). Macrophages phagocytose pathogens and 
also interface with the adaptive immune system by utilizing phagocytic material for antigen 
presentation to T-cells. On macrophages, vitamin D stimulates differentiation of precursor 
monocytes to mature phagocytic macrophages (Abe E et al. 1983; Tanaka H et al. 1983). 
Observations showing differential expression of VDR and 1α-hydroxylase during the 
differentiation of human monocytes macrophages have supported the concept (Kreutz M et al. 
1993). Studies have shown that human macrophages are capable of synthesizing 1,25(OH)2D3 
upon stimulation with IFN-γ (Koeffler HP et al. 1985). 
 
In normal macrophages, localized activation of vitamin D, coupled with expression of endogenous 
VDR was heavily suggested to be an autocrine or intracrine system for vitamin D action. Seminal 
investigation on Mycobacterium tuberculosis (M. tb) revealed that the VDR and the gene for 1α-
hydroxylase (CYP27B1) were induced by the toll-like receptor 2/1 (TLR2/1) (Liu PT et al. 2006). 
Further experiments confirmed that precursor 25(OH)D3 was able to induce intracrine VDR 
responses in monocytes that had been treated with a TLR2/1 activator. It was shown that the 
TLR2/25(OH)D3 combination stimulated expression of the antibacterial protein cathelicidin; in a 
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way that vitamin D was able to promote monocyte killing of M. tb (Liu PT et al. 2006). It is also 
shown that vitamin D supplementation in vivo can also enhance TLR2/1- induced cathelicidin 
expression (Adams JS et al. 2009). Cathelicidin was identified as a target for transcriptional 
regulation by 1,25(OH)2D3-liganded VDR, in that its gene promoter contains a functional vitamin 
D response element (VDRE) (Gombart AF et al. 2005; Wang TT et al. 2004). 
 
Other studies have however proposed that TLR2/1 induction of 1α-hydroxylase occurs indirectly 
as a result of TLR2/1 induced interleukin-15 (IL-15) which is a potent inducer of CYP27B1 and 
1α-hydroxylase activity (Krutzik SR et al. 2008). In like manner, interleukin 17A (IL-17A) has 
been shown to enhance 1,25(OH)2D3-mediated induction of cathelicidin (Peric M et al. 2008). It 
is also important to recognize that other ligands may interact with the VDR (Makishima M et al. 
2002). Some compounds may act to disrupt normal 1,25(OH)2D3-VDR-mediated immunity. For 
example; the polycyclic aromatic hydrocarbon benzo(A)pyrene, a product of cigarette smoking, 
is seen to attenuate vitamin D-mediated induction of macrophage cathelicidin in a VDR- 
dependent fashion by stimulating expression of 24-hydroxylase, and vitamin D catabolism 
(Matsunawa M et al. 2009). 
 
The observations above show that vitamin D is an important stimulator of mechanisms associated 
with pathogen elimination. Vitamin D is associated with key feedback control pathways therefore 
it is crucial in innate immune regulation. Calcitriol has a catabolic enzyme in the form of 24-
hydroxylase which attenuates responses to 1,25(OH)2D3 and, in the case of the CYP24 splice 
variant, may also attenuate synthesis of this vitamin D metabolite (Ren S et al. 2005). Vitamin D 
(1,25(OH)2D3) has been shown to downregulate expression of monocyte TLR2 and TLR4, 
thereby suppressing the associated inflammatory responses (Sadeghi K et al. 2006). By utilizing 
both CYP24 and TLR regulatory mechanisms, vitamin D may appropriately regulate innate 
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immune responses whilst preventing an over-expression of innate immune responses and tissue 
damage. 
 
 
3.3.2.2 Vitamin D, Dendritic Cells and Antigen Presentation 
 
 
The most highly recognized group of professional APCs is DCs. Studies using DCs isolated from 
Langerhans cells provided evidence that 1,25(OH)2D3 could act to attenuate  antigen presentation 
(Dam TN et al. 1996) . In vitro, monocyte-derived DC models substantiate these effects of vitamin 
D metabolites on antigen presentation. It is shown in some studies that 1,25(OH)2D3 (Penna G 
and Adorini L. 2000) and its synthetic analogues (Griffin MD et al. 2000) inhibit the maturation 
of monocyte-derived DCs, thereby suppressing their capacity to present antigen to T-cells. It was 
therefore proposed that vitamin D could promote tolerance and this was supported by studies of 
pancreatic islet transplantation in which lower rejection rates were observed in 1,25(OH)2D3-
treated mice (Gregory S et al. 2001). This response to 1,25(OH)2D3 appeared to be due to 
decreased DC maturation and concomitant enhancement of suppressor or Tregs (Gregory S et al. 
2001). Further studies have emphasized the importance of Treg generation as part of the 
interaction between vitamin D and the immune system. 
 
 
3.4 The Immunopathology of Crohn’s disease 
 
 
Despite the fact that the cause of IBD remains elusive, it is presumed to result from dysregulation 
of the intestinal mucosal immune system. Animal models of IBD show that normal intestinal flora 
induces intestinal inflammation in animals with a dysregulated immune system (Elliott DE et al. 
2000). Inflammatory bowel disease is seen to likely result from uncontrolled immune responses 
to normal intestinal contents. Crohn’s disease appears to be an overly vigorous Th1-type 
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inflammation that produces IFN-γ and TNF-α (Fuss IJ et al. 1996). The mucosal inflammation of 
these models generates excess amounts of IFN-γ and TNF-α thereby suggesting that excess 
production of Th1-type cytokines is one mechanism underlying the pathogenesis of disease. There 
are no actual animal models of human IBD; however there are several animal models of chronic 
intestinal inflammation. Murine models with genetically altered gene deletions develop chronic 
bowel inflammation similar to IBD such as mutant mice having targeted deletions for IL-2, IL-
10, MHC class II, or T-cell receptor (TCR) genes (Elliott DE et al. 2000). Some of the models 
have shown that a dysregulated immune system itself mediates intestinal injury. Blocking Th1 
circuitry has also been shown to prevent the inflammation (Berg DJ et al. 1996; Ehrhardt RO et 
al. 1997). Therefore these models strongly suggest that CD is dysregulated Th1 responses thus 
have direct implications regarding the immunopathology of this human disease process. 
 
 
3.4.1 Th1/Th2 Paradigm in Crohn’s Disease 
 
 
Currently the view on CD is that inflammation is a result of an IL-12-driven Th1 response, which 
results in the production of the key inflammatory mediator, IFN-γ (Karczewski J et al. 2012). This 
view has been supported by multiple IBD mouse models of CD. CD4+ T cells in the intestinal 
lamina propria of CD patients produce large amount of IFN-γ and lower amount of IL-4 than that 
of healthy control (Fuss IJ et al. 1996). In CD patients, macrophages in the intestinal lamina 
propria produce large amounts of IL-12 (Monteleone G et al. 1997). Lymphocytes in the intestinal 
lamina propria of these patients also express elevated levels of IL-12R, and produce large amount 
of IFN-γ in response to IL-12 (Okazawa A et al. 2002). The peripheral blood of CD patients also 
exhibits the same pattern. Vast numbers of CD4+ T-cells that express T-box protein expressed in 
T-cells (T-bet) and STAT-4 have been found in the intestinal mucosa of CD patients (Karczewski 
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J et al. 2012). Among all the suggestions the most convincing evidence that CD is a Th1-cytokine 
mediated disease, is the efficacy of biologic therapies directed against TNF-α, IL-12 and IFN-γ 
(Rutgeerts P et al. 2009). 
 
 
3.4.2 Th17 Cells 
 
 
Recent research has given much attention to the possible involvement of Th17 cells in the 
pathogenesis of CD (Holtta V et al. 2008). The Th17 cells are a newly identified subset of T- 
helper cells distinct from Th1/Th2 which produces various pro-inflammatory cytokines, including 
IL-17A, IL-17F, IL-21, IL-22 and TNF-β. They play a pivotal role in the protective immunity 
against the extracellular pathogens such as bacteria and fungi (Weaver CT et al. 2007), as well as 
the protective immunity against intestinal pathogens (Maloy KJ and Kullberg MC. 2008). Th17 
cells differentiate in the presence of IL-6 and transforming growth factor (TGF)-β, through the 
expression of retinoic-acid-receptor-related orphan receptor (ROR)-γt (Weaver CT et al. 2007). 
IL-21 is an important cytokine for the differentiation of Th17 cells. IL-6 promotes the production 
of IL-21 from Th17 cells independent of RORγt, and then IL-21 upregulates the expression of 
RORγt by activating the STAT3 pathway thus providing a positive feedback in the differentiation 
of Th17 cells, in a process called amplification. IL-21 is however not essential for the polarization 
of Th17 cells, but it is necessary for their amplification (Karczewski J et al. 2012). 
 
 
Pivotal for stabilization and expansion of Th17 cells, is the cytokine IL-23, a member of IL-12 
cytokine family. This cytokine is secreted by professional APCs during the inflammatory response 
to both pathogenic and non-pathogenic stimuli (Abraham C and Cho J. 2009). Intestinal 
microbiota is also essential for the development of Th17 cells (Atarashi K et al. 2008). A high 
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expression of IL-23 has been found in mucosa of human ileum, as well as an upregulation of Th17 
cells in the human GALT (Maloy KJ and Kullberg MC. 2008). 
 
 
3.4.2.1 The Role of Th17 Cells in Crohn’s Disease 
 
 
Interleukin-17A, generally referred to as IL-17, is a main pro-inflammatory cytokine produced by 
Th17 cells (Karczewski J et al. 2012). It has been reported that Th17 subset is involved in the 
pathogenesis of various diseases that were previously thought to be either Th1 or Th2 dominant. 
Interleukin-17A is upregulated in and has been associated with several immune-mediated diseases 
such as IBD, rheumatoid arthritis, psoriasis, psoriatic arthritis, ankylosing spondylitis and multiple 
sclerosis, among others (Witkowski J et al. 2004). Increasing evidence from both human studies 
and mice models supports the view that Th17 cells are involved in the pathogenesis of CD. Human 
studies have shown high expression of IL-17A mRNA in intestinal mucosa of CD patients (Brand 
S. 2009). The elevated faecal IL-17A levels were found in active CD, accompanied by high 
percentage of IL-17A and IL-23 producing cells in the LP of CD patients (Holtta V et al. 2008). 
Murine studies have identified IL-23 as a major driver of intestinal inflammation via inflammatory 
mediators including IL-17Aand IL-6 (Brand S. 2009; Elson CO et al. 2007). According to a 
genome-wide association study (GWAS), IL-23R and five additional genes involved in Th17 
differentiation are associated with susceptibility to CD (Brand S. 2009). It is not clear how IL-
23R polymorphism might predispose to CD however the identification of both disease-protective 
and risk-associated variants of the gene suggests that the IL-23 signalling may play a crucial role 
in maintaining immune homeostasis in the intestine (Duerr RH et al. 2006). 
 
Clinical trials have reported that blockage of p40, the shared subunit of IL-12 and IL-23 is 
effective in CD treatment and has an identical therapeutic effect to that of anti-TNF-α therapy 
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(Mannon PJ et al. 2004; Sandborn WJ et al. 2008). The anti-p40 antibodies were thought to revoke 
IFN-γ mediated intestinal inflammation through blockage of IL-12. There is however another 
possible implication that inflammation is attributed to IL-12 is mediated by IL-23 and its 
downstream cytokines IL-17A and IL-22 (Karczewski J et al. 2012). These data have supported 
the notion that IL-17A plays a crucial role in CD pathogenesis and its inhibition might represent 
a potential approach for treating active course of the disease. The observations may suggest the 
importance of the IL-23/IL-17 axis in CD, however the exact role of IL-17 in the pathogenesis of 
disease remains unclear, since also its protective role in the intestine inflammation has been 
proposed based models of experimental colitis (O'Connor W et al. 2009 ; Ogawa A et al. 2004). 
Th17 cells induced in the presence of IL-1β, on the contrary, have a unique mRNA profile and 
increased capacity to induce inflammation (Ghoreschi K et al. 2010). In environments lacking 
TGF-β, IL-12 and IL-23 Th17 cells acquire the capacity to produce IFN-γ hence amplifying the 
pro-inflammatory effect (Karczewski J et al. 2012). 
 
Crucial for immune homeostasis is a relationship of Th17 cells with regulatory T-cells through 
their shared use of TGF-β as a differentiation factor (Mangan PR et al. 2006; Maul J et al. 2005). 
Active CD is characterized by either numerical, functional or both defects of a regulatory T-cell 
subpopulation (Veltkamp C et al. 2011). Despite their presence in the inflamed gastrointestinal 
tract of CD patients, either their number, suppression function or both is probably inadequate to 
curb chronic inflammation (Maul J et al. 2005). Th17 cells constitute a heterogonous 
subpopulation, differing in properties and functions. There is however evidence that 
differentiation of Th17 cells in the absence of IL-23 leads to Th17 cells producing a potent anti-
inflammatory cytokine, IL-10 (McGeachy MJ et al. 2007). 
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Immune regulation is maintained by a critical balance between the activities of the Th1, Th2 and 
Th17 cells. This is because the different cytokines produced by these cells tend have a counter 
(inhibitory) effect upon the different respective immune mechanism. In CD and many other 
immune-mediated diseases, we can therefore propose that the corresponding chronic 
inflammation is a result of a dysregulated immune response characterized by an imbalance 
between the Th1/Th2 immune response, the overproduction of Th1/Th17 associated cytokines or 
a combination of these immune mechanisms. 
 
 
3.5. Genetic Factors 
 
 
Crohn’s disease is a complicated genetic disorder which is characterized by a recurring 
inflammation of the gut. More than 140 susceptibility gene loci have been discovered through 
research and these have in some way improved our understanding of the disease pathogenesis (Liu 
JZ and Carl AA. 2014). The onset of CD has been linked to a number of genetic factors. However 
the ones that reflect the strongest risk are the genetic susceptibility mutations in the Caspase-
activation recruitment domain (CARD15)/Nucleotide-binding oligomerization domain (NOD2), 
ATG16L and IL23R genes. Individual gene mutations and also a combination of these mutations 
have also been demonstrated in CD patients (Csöngei V et al. 2010). 
 
3.5.1 CARD15/NOD2 
 
 
The most recognized high susceptibility gene influencing CD is the CARD15/NOD2 (Hugot JP 
et al. 2001). Its primary function is pattern recognition in the innate immune system (Economou 
M et al. 2004). The CARD15/NOD2 gene belongs to a family of nucleotide-binding domain and 
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leucine-rich-containing receptors (NLRs) which recognizes a modified peptidoglycan muramyl 
dipeptide (MDP) (a pathogen-associated molecular pattern (PAMP) from bacterial peptidoglycan 
breakdown) (Abraham C and Medzhitov R. 2011). The TLR family is involved in the recognition 
of pathogen-associated molecular patterns by the immune system. TLR4 recognises 
lipopolysaccharide using the extracellular LRR domain (Arnott IDR et al. 2004). 
 
CARD15/NOD2 has also been shown to potentiate autophagy by acting as a mediator of the 
protein (ATG16L1) which forms an integral part of this process (Garg M et al. 2012). A deficiency 
of this protein has been shown to result in an overemphasized inflammatory response (Kaser A 
and Blumberg RS. 2011). CARD15/NOD2 contains a highly conserved domain which is linked 
to a nucleotide-binding domain, and they are thought to regulate apoptosis and to activate the 
nuclear factor-κB (NFκB) (Arnott IDR et al. 2004). 
 
Upon several factors, mutations of CARD15/NOD2 are considered to be the contributing 
susceptibility mutation about 16% of CD patients (Van Montfrans C et al. 2002). Among these 
private mutations, only three occur more frequently. These alleles are the R702W, G908R and 
1007fs (Hugot JP et al. 2007). These susceptibility alleles are located in the distal third part of the 
gene, of which two are missense point mutations and the other one is a frameshift mutation. The 
result is a number non-conservative variation of the protein (Lesage S et al. 2002). 
 
3.5.2 IL-23R 
 
 
IL-23R is a protein consisting of the heterodimeric receptor complex, an IL-12β1 and an IL-23R 
chain (Zhang Z et al. 2006). The expression of this complex regulates activities of IL-23 (Hradsyk 
O et al. 2010). This protein is expressed on the cell membrane of memory T-cells and other 
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immune cells which identify antigens, such as NK cells, monocytes, and DCs (Naser SA et al. 
2012).  IL-23R is mainly involved in the mediation of pro-inflammatory activities through the 
production of IL-17 via the activation of Th17 lymphocytes (Vermeire S et al. 2002). Th17 
lymphocytes are a subset of T-helper cells, which are pivotal in the production of IL-17 and also 
produce IL-6 and TNF-α to a lesser extent (Wehkamp J et al. 2005). IL-23R interacts with IL-23, 
which is a cytokine that regulates the activity of immune cells and plays an important role in the 
inflammatory response against infection by bacteria and viruses (Naser SA et al. 2012). 
 
It is suggested that IL-23 could be a key regulator in the differentiation of Th17 lymphocytes from 
memory T-cells and that IL-23 is vital in the maintenance of the already differentiated Th17 cells 
(Veldhoen M et al. 2006). The IL-23-IL-17 cytokine axis is a key pathogenic mechanism that 
mediates the development and progress of inflammation by Th17 cells (Naser SA et al. 2012). 
The mechanism of IL-23R is clearly important to understand because it is directly associated with 
CD. 
 
 
3.5.3 ATG16L 
 
 
A number of genetic factors predispose to CD, and one of the susceptibility allele is in the 
autophagy gene ATG16L1 (Xavier RJ and Podolsky DK. 2007; Hampe J et al. 2007).  Autophagy 
is a catabolic process by which cellular components are degraded by delivery of double-
membrane-bound vesicles containing cytoplasm and cytoplasmic organelles to the lysosome to 
form autophagosomes (Levine B and Kroemer G. 2008). Autophagy has an important role in cell 
and tissue homeostasis, and has been implicated in a range of human diseases (Cadwell K et 
al. 2008). During infection autophagy is important in getting rid of foreign antigens in the cells 
by breakdown of the pathogen. Mutation on the gene responsible for autophagy can result in a 
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shift in normal flora, and resulting in many gastrointestinal problems (Naser SA et al. 2012) 
Failure by the cells to regain nutrients or fight off foreign antigens within the gastrointestinal tract 
will cause them to undergo programmed cell death. This can however result in tissue damage 
(Naser SA et al. 2012). The ATG16L1 protein contains an amino- terminal domain that functions 
in autophagy as part of a complex with autophagy proteins ATG5 and ATG12 (Fujita N et al. 
2008; Mizushima N et al. 2003). The ATG16L1 protein is expressed in many cell types such as 
in the colon, small intestine, intestinal epithelial cells, leukocytes, and spleen (Fujita N et al. 
2008). ATG16 is responsible for the subcellular localization of the autophagy machinery (Fujita 
N et al. 2008; Rioux JD et al. 2007). Studies have shown that a mutation located on chromosome 
2, on the ATG16L gene is linked to the onset of ileal CD, and therefore it is an important molecule 
in explaining the genetic aspects of the disease (Sventoraityte J et al. 2010). 
 
 
3.5.4 IL-1 
 
 
Interleukin-1α (IL-1α) and interleukin-1β (IL-1 β) have been implicated in the pathogenesis of a 
number of immune mediated diseases such as asthma, as well as IBD. These cytokines are strongly 
associated with the regulation of the inflammatory response and the immune response 
(Mwantembe O et al. 2001). Interleukin-1α and interleukin-1β are important in mucosal 
inflammation which is characterized by a massive infiltration of activated neutrophils and 
mononuclear cells. This in turn triggers the production of a cascade of other cytokines and 
inflammatory mediators (Dinarello CA and Wolff SM. 1993). The interleukin-1 receptor 
antagonist (IL-1Ra) is a modulating factor controlling the inflammatory process (Pillay V et al. 
2000). It acts as an anti-inflammatory agent inhibiting the activities of IL-1α and IL-1β (McIntyre 
KW et al. 1991). The IL-1 gene cluster on chromosome 2 comprises of genes coding for IL-1α, 
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IL-1β, IL-1Ra and interleukin-1 receptor (IL-1Re). The IL-1Ra and IL-1β have a structural 
relationship and they compete for affinity to the IL-1Re (Duff GW. 1989). It is however important 
to note that IL-1Ra functions as a competitive inhibitor, but not as a trigger of signal transduction, 
therefore it serves as an endogenous inflammatory regulator (Tarlow JK et al. 1993). The balance 
between receptor expression; cytokine production and inhibitor concentration is pivotal in 
determining the resultant inflammatory response (Pillay V et al. 2000; Mwantembe O et al. 2001). 
 
 
There is a well-known association between the 240-bp allele of the IL-1Ra and a number of 
immune-mediated diseases. A study conducted by Pillay V et al. 2000, showed that elevated levels 
of plasma IL-1Ra were corresponding to disease severity in asthma patients. A disparity between 
IL-1 and IL-1Ra in the intestinal mucosa and abdominal lavage has been shown in IBD patients 
(Andus T et al. 1997). A genetic association between IL-1Ra allele 2 and IBD has been 
demonstrated (Mansfield JC et al. 1994). 
 
 
3.5.5 HLA 
 
 
The human leucocyte antigen (HLA) genes have been implicated in many immune-mediated 
diseases. Such diseases include diabetes mellitus (Larsen CE and Alper CA. 2004), rheumatoid 
arthritis (Weyand CM et al. 2000), autoimmune hepatitis (De Silva S et al. 2006) and celiac 
disease (Green PH et al. 2003). Since the first reported HLA-IBD association many studies have 
been conducted investigate the link between HLA genes and he susceptibility and phenotype of 
IBD (Ahmad T et al. 2006). The MHC is a large genetic complex with multiple gene loci that is 
located on the short arm of chromosome 6. Genome-wide scans have revealed evidence point at 
the IBD3 (6p21.1-23), an area encompassing the HLA complex on the chromosome (6p21.3) 
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(Ahmad T et al. 2006).  The MHC possesses highly polymorphic HLA genes (Tshabalala M et al. 
2013). The polymorphic nature of HLA genes allows the presentation of a wide range of peptides 
to the immune system. HLA gene polymorphism is highly linked to the rate of disease progression 
(Just JJ. 1995). Gene loci within the MHC encode for two classes of classical glycoproteins, that 
is class I and class II HLA molecules (Tshabalala M et al. 2013). The HLA class I molecules bind 
to endogenous antigenic epitopes and present them to CD8+ T lymphocytes. Of particular 
importance to IBD are the HLA class II molecules which present antigenic peptides to CD4+ T 
lymphocytes. Their products play a pivotal role in the immune response (Stokkers PCF et al. 
1999). Class II HLA genes encode cell-surface glycoproteins which are expressed on antigen 
presenting cells such as macrophages and dendritic cells (Ahmad T et al. 2006). The class II 
molecules are comprised of an α chain and a β chain that form the grove in which the antigenic 
peptide is presented to the T-cell receptor (Jardetzky TS et al.  1994). These function mainly to 
present peptides to T-cell receptors as a precursor to T-cell activation. HLA-DR, HLA-DQ 
and HLA-DP are the three types of HLA class II molecules that are expressed by a single cell 
(Ahmad T et al. 2006). However the mechanism by which HLA class II genes influence IBD 
remains unclear. Association studies have generally implied a role for HLA-DR alleles in 
susceptibility or resistance to IBD. In CD, an association with HLA-DR7, HLA-DRB3*0301 and 
HLA-DQ4 alleles have been found to have a positive association whereas HLA-DR2 and HLA-
DR3 have a negative association (Stokkers PFC et al. 1999). However the total genetic 
contribution to disease susceptibility cannot be accounted for by the aetiological fractions 
associated with these phenotypes. 
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3.5.6 SLC11A1 
 
 
The SLC11A1 (solute carrier 11A1) was formerly known as NRAMP1 (natural resistance- 
associated macrophage protein 1), however for the purpose of this section NRAMP1 has been 
used. In humans the NRAMP gene is located on the chromosome region 2q35 and it is made up 
of 15 exons covering 16kb of DNA. This gene encodes for an intrinsic membrane protein that is 
550 amino acids long (Sechi LA et al. 2006). The protein is only expressed in the lysosomal 
compartments of monocytes and macrophages (Cannonne-Hergaux F et al. 2002). NRAMP1 gene 
polymorphisms have been associated with genetic susceptibility with M. tb and disease 
progression of tuberculosis in China (Zhang W et al. 2005). Reports have suggested a role of the 
NRAMP1 gene in immune-mediated diseases such as rheumatoid arthritis (Yang YS et al. 2000). 
Certain NRAMP1 variants have been shown to be specifically associated with CD (Hofmeister A 
et al. 1997). An association was shown between NOD2 polymorphisms and the pathogen M.tb in 
Sardinian CD patients (Sechi LA et al. 2005). An association was also shown between 
CARD15/NOD2 polymorphisms, at the 823 C/T locus and the 1729 +55del4 locus on the 
NRAMP1 gene in Sardinian patients (Sechi LA et al. 2006). 
 
 
3.6 Environmental Factors 
 
 
A vast number of epidemiological studies have indicated a rise in the incidence and prevalence of 
CD across varying geographic locations. The North-South gradient is one such indicator of the 
influence of the environment in the development of CD. However, this hypothesis has not been 
consistently substantiated and the factors not yet proved as causal. Inflammatory bowel disease 
tends to occur in high socio-economic groups (Loftus EV and Sanborn WJ. 2003). There is a 
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generally noticeable trend of a high prevalence and incidence of CD in heavily industrialized and 
modernized nations. Industrialization tends to modify the lifestyle of individuals causing changes 
in diet, exercise regiments, sanitation, and increasing exposure to occupations pollution and 
industrial chemicals (Hanauer SB. 2006; Molodecky NA and Kaplan GG. 2010). 
 
Crohn’s disease is emerging in countries that are having a transition from developing to 
developed, thus becoming more westernized of which such areas were previously reported as low 
incidence areas for CD (Ng SC. 2014 (a)). When developing countries become industrialized, 
improved sanitary conditions likewise follow, resulting in changes in the patterns of childhood 
hygiene. It is further shown that CD commonly occurs in urban areas as compared to rural areas 
therefore heavily suggesting the role of environmental factors as strong determinants of IBD 
(Molodecky NA and Kaplan GG.  2010). Emigration studies have also brought compelling 
evidence suggesting a change in the epidemiology of CD alongside changes in the environmental 
factors and lifestyle. As compared to those remaining, migrants from the low-risk countries tend 
to exhibit an elevated risk of CD when they migrate to developed nations thus suggesting a role 
of the modifiable external environment. Their children also tend to take on the risk factors of the 
new environment, thus furthermore suggesting that environmental influence during childhood is 
crucial. 
 
 
3.6.1 Vitamin D Deficiency 
 
 
Accumulating evidence now suggests that there is a strong association between low vitamin D (as 
an environmental constituent) and immune-mediated diseases such as rheumatoid arthritis, 
multiple sclerosis, insulin dependent diabetes mellitus and IBD (Kriegel MA et al. 2012). To 
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explain this, the northern hemisphere generally receives less sunlight as compared to the southern 
hemisphere and the least exposure occurs in winter months. In Canada and the northern parts of 
the United States and Europe, where these diseases are typically more prevalent, it was observed 
that the severity of multiple sclerosis fluctuates seasonally and that the disease exacerbations occur 
mostly in spring when there is very little sunlight exposure (Moum B et al. 1996 (b)). This is 
attributed to the observation that circulating concentrations of serum 25(OH)D are lower in winter 
and higher in summer, corresponding with the relevant amount of seasonal sunlight exposure 
(Maxwell JD. 1994). Vitamin D is manufactured in the skin directly from the ultraviolet (UV) 
rays of sunlight and researchers suggest that low levels of vitamin D may be an important 
environmental factor that increases the risk of CD in populations specifically in the northern 
latitudes (Butcher RO and Limdi JK. 2012). 
 
 
3.6.2 The Hygiene Hypothesis 
 
 
Hygiene is generally defined as conditions favourable to maintaining good health and preventing 
ailment, notably through cleanliness (Soanes C and Angus S. 2008). In the context of IBD, the 
hygiene hypothesis’ emanates the rising disease incidence, corresponding with improvements in 
hygiene over the last few decades. Microbial exposure in childhood is believed to program the 
enteric immune system thus moderating the future response to the specific antigen (Koloski NA 
et al. 2008). At delayed exposure to the entero-pathogenic microbial agents, an inappropriate 
immune response may be triggered. This can also be referred to as the ‘sheltered child hypothesis’ 
(Rachmilewitz D. 1986). The hygiene hypothesis predicates that individuals raised in sanitary 
environments tend to be more susceptible to develop CD as a result of limited exposure to 
environmental or immunostimulatory agents thus resulting in dysbiosis or rather a shift in the 
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balance between the commensal and the entero-pathogenic agents. It also infers that this chronic 
inflammatory reaction in genetically susceptible hosts can be as a result of the loss of saprophytic 
microbes, subsequently leading to the development of a defective maturation of regulatory T-cells 
and antigen-presenting cells. 
 
Environmental influence in the industrialized society encompasses a wide array of factors which 
are potential causative agents of CD. In the last three decades, many studies have examined 
possible associations of CD with interrelated factors as food substances, chemicals, harmful 
micro-organisms, noxious fumes, sanitation, household amenities etc. It is easy to point out that 
environmental factors may have an influence on the development of CD; however it has proved 
unyielding to isolate the specific cause. No hygienic factor also has been singled out to 
demonstrate a consistent association with CD. This can be attributed to the effect of timing of 
exposures, overlapping factors and confounding factors, which probably occurs during 
susceptible periods of development and may precede onset of the disease by lengthy periods of 
time (Foster A and Jacobson K. 2013). Table 5 shows the categories and examples of the possible 
childhood exogenous risk factors involved with CD. 
 
Environmental factors are undoubtedly important in the pathogenesis of CD. These factors act as 
potential triggers for the onset or development, and also affect the course and the response (to 
medication) of the disease. There are several factors that have been identified to have an 
association with CD in various ways. Some of these include hygiene and sanitation (Gent AE et 
al. 1994), air pollution (Kaplan GG et al. 2010), diet (Cohen AB et al. 2013), stress (Mawdsley 
JE and Rampton DS. 2005), exercise (Bernstein CN et al. 2001), industrialization (Aamodt G et 
al. 2008), breastfeeding (Barclay AR et al. 2009) and smoking (Seksik P et al. 2009). However 
the latter has been the best studied and shown to have the greatest association with the disease. 
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3.6.2.1 Injury to the Puerile Gut 
 
 
It has long been suspected that the modifiable environmental factors can create a susceptibility to 
IBD by influencing intestinal permeability, disrupting the gastrointestinal microbiota and 
modifying the enteric mucosal immune system (Loftus EV Jr. 2004). There is accumulating 
evidence that events early in life may have long term effects on health and disease. Several 
epidemiological studies have suggested a role for perinatal or childhood events in the aetiology 
of IBD (Loftus EV Jr. 2004; Marshall JK and Hilsden 2003). 
 
A study by Koletsko S et al. 1989 showed that lack of breast feeding and periods of diarrhoeal 
disease during infancy were two factors independently associated with the subsequent 
development of CD. It was shown in the same study that if breast feeding was combined with 
formula feeding in infancy, a resultant decrease in the significance of breast feeding in being 
protective against CD was observed. According to the findings of the meta-analysis by Klement 
E et al. 2004, breastfeeding has been shown to be associated with lower risks of CD. In support 
of this Goldman AS and Smith CW. 1973 posit that breast milk contains factors such as 
immunoglobulins that may be protective against gastrointestinal infections. The meta-analysis 
however revealed that many studies had methodological flaws and small sample sizes therefore 
putting a compromise to the validity of the observations. 
 
A case-control study on 51 UC patients and 57 CD patients conducted in the United Kingdom by 
Whorwell PJ et al. 1979 found bottle feeding within the first two weeks of life predisposing some 
individuals to the development of ulcerative colitis later in life but could not significantly 
implicate it to the development of CD. This study suggests that bottle feeding may injure the gut 
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by causing sensitization to milk formula or cow’s milk in the early stages of life causing increased 
permeability to macromolecules or by altering bacterial flora by introducing bacterial antigens at 
the time of sensitization. However the study revealed that independent of bottle feeding the CD 
patients had a significantly increased occurrence of gastroenteritis within the first six months of 
birth. Rotavirus infection may be the cause of the gastroenteritis which may have a prolonged 
effect resulting in an abnormal immune response and the future development of CD. 
 
 
 
3.6.2.2 Nutritional Factors 
 
 
Gastrointestinal inflammation can be triggered by the diet through immunological and 
biochemical mechanisms such as alteration of the gut microflora, offsetting prostaglandin balance 
and antigen presentation (De Filippo C et al. 2010, Sharon P et al. 1978). IBD incidence is rising 
in nations that are becoming more westernized such as nations of Asia, Eastern Europe, French 
West Indies and North Africa (Ng SC. 2014 (a)). Highly implicated to the rise is the “Western” 
diet which is characterized by a high content of saturated fats and protein (Amre DK et al. 2007). 
Many studies on the association between diet and IBD had certain methodological flaws which 
led to their findings being questioned. However modern studies have addressed the issues and 
have reported that refined sugar (Rief S et al. 1997; Matsui T et al. 1990), fat (Rief S et al. 1997) 
and fast foods (Persson PG et al. 1992) increase the risk of developing CD. On the other hand it 
was revealed that fruits (Persson PG et al. 1992; Russel MG et al. 1998), vegetables (Persson PG 
et al. 1992; Russel MG et al. 1998) lower the risk of developing CD. 
 
A Japanese epidemiological study (Shoda R et al. 1996) revealed that increased intake of animal 
fat, animal protein, milk protein, n-6 polyunsaturated fatty acids (PUFAs), and the increased ratio 
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of n-6 to n-3 fatty acid was strongly associated with the increased incidence of CD. The strongest 
independent risk factor from this study was animal protein which therefore suggests that an 
increased intake of animal protein can greatly increase the risk of developing CD. A  study by 
Amre DK et al. 2007 also reported that consumption of long-chain omega-3 fatty acids (LCN-
omega-3) was significantly associated with lower risk of developing CD (OR = 0.44, 95% CI 
0.19-1.00). 
 
 
3.6.2.3 Chemical Factors 
 
 
3.6.2.3.1Smoking 
 
 
Smoking is one of the crucial environmental factors that have been implicated through several 
studies to have an influence on the onset and course of the disease (Loftus EV. 2004). Smokers 
are at a greater risk of developing CD as compared to non-smokers (Somerville KW et al. 1984). 
Second-hand cigarette smoke exposure during childhood has been associated with an increased 
risk of CD development; however these findings have been inconsistent (Bernstein CN et al. 2006; 
Mahid SS et al. 2007; Gerry RB et al. 2010; Russel RK et al. 2005). It is also noted that CD 
patients who quit smoking had less recurrence of the disease, compared to those who continued 
with smoking (Bernstein CN et al. 2006; Cosnes J et al. 2001; Russel MG et al. 1996). The 
cessation of smoking after diagnosis of CD in an intervention study strongly suggests that smokers 
have worse disease symptoms than non-smokers (Johnson CJ et al. 2005). Ryan WR et al. 2003 
posit that smoking also tends to cause an increase in the severity and risk of CD. Smoking leads 
to a more aggressive disease course and an increased possibility of failure to respond to medical 
therapy (van der Heider F et al. 2009). Other studies revealed that smokers have a lower response 
rate and shorter response time to medication than non-smokers and also higher relapse rate of the 
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disease (Arnott IDR et al. 2003; Parsi MA et al. 2002; Rudolph SJ et al. 2008). It is also interesting 
to note that smokers have a higher chance of undergoing surgery due to CD as compared to non-
smokers (Cosnes J et al. 1996). 
 
 
In CD patients, cigarette smoking has been associated with lower serum 25(OH)D concentrations 
as compared to non-smoking patients (Gilman J et al. 2006; Siffledeen JS et al. 2003). In addition, 
when vitamin D supplemented CD patients were compared with non-supplemented CD patients, 
Jorgensen SP et al. 2013 found that the smokers had significantly lower serum 25(OH)D 
concentrations. This evidence suggests that there is an independently direct association between 
low serum 25(OH)D concentrations and smoking and disease activity. 
 
 
3.6.3.3.2 Oral Contraceptive Use 
 
 
The association between oral contraceptive use and CD has been extensively investigated through 
several case-control studies. Findings from these studies generally reveal that individuals taking 
oral contraceptives are at a greater risk of developing CD. A study conducted by Godet et al 
revealed that use of these drugs results in individuals being twice as susceptible to the risk of 
developing the disease as compared to the healthy controls (Godet PG et al. 1995). A study by 
Corrao G et al. 1998 also reveals that oral contraceptive users had a greater risk of CD. A case-
control study performed by Persson P et al. 1993 on the risk indicators of CD re-emphasises that 
oral contraceptive use is associated with CD by showing that there was a 70% increase in the risk 
among users when compared with the controls. Certain studies however suggest that there is only 
a dose-dependent association between oral contraceptive use and CD as a result, long time users 
of oral contraceptives poses greater risk (Boyko EJ et al. 1994). On the other hand certain studies 
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find no significant association between oral contraceptive and CD (Halfvarson J et al. 2006). The 
actual mechanism on how oral contraceptive use affects the gut immune response still remains 
elusive, however it has been suggested that the thrombogenic characteristics of the contraceptives 
may be associated. 
 
 
3.6.3.3.3 Antibiotics and Medication Use 
 
 
The gut microflora plays a pivotal role in the regulation of the gut immune system and it is 
considered to be an initiator as well as a mediator of the long term inflammatory mechanism in 
IBD (Hviid A et al. 2011). Early life exposure to antibiotics can potentially harm the intestinal 
microbiota thus altering the balance between mutualistic microbes and opportunistic microbes 
(Sullivan A et al. 2001). The extent of the harm is dependent on various factors such as; the type 
of the antibiotic, the chemical properties of the antibiotic, and the dose and duration of use. 
According to a nation-wide register-based Finnish case-control study conducted by Virta L et al. 
2012, the commonly used antibiotics were broad-spectrum penicillins, macrolides and 
cephalosporins. Antibiotics such as phenoxymethylpenicillin and combinations of sulphonamides 
and trimethoprim were less frequently used.  The study revealed that exposure to  cephalosporins 
was significantly associated with the risk of developing CD. It was also shown that if one was 
continued exposure to phenoxymethylpenicillin from birth to the age of 1 year was significantly 
associated with an elevated risk of CD development. No association was identified for any of the 
other antibiotics studied. 
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3.6.3.3.4 Vaccinations 
 
 
Vaccinations in early childhood have been implicated in CD and are thought to be capable of 
altering the development of the intestinal immune system (Thompson NP et al. 1995). Common 
vaccinations include vaccinations against diphtheria, measles, pertussis, polio, rubella, tetanus and 
tuberculosis. Data from a case-control study based on a Danish inception cohort showed that 
vaccination against pertussis and polio led to an increase in the risk of developing CD (Hansen 
TS. 2011). Baron S et al. 2005 showed that there was a positive association between poliomyelitis, 
smallpox and BCG vaccination and an increased risk of CD. 
 
The live attenuated vaccine for measles has been implicated in the aetiology of CD (Thompson 
NP et al. 1995). It has as well been suggested that there was an increased risk of CD among 
individuals with a persistent measles infection and those born during a measles epidemic (Ekbom 
A et al. 1994). However the study by Baron S et al. 2005 failed to confirm these findings, thus 
their results showed that measles mumps rubella (MMR) vaccine had a negative association with 
the risk of developing CD. The findings from a case-control study of measles vaccination and 
inflammatory bowel disease by Feeney M et al. 2002 also do not support the notion that measles 
vaccination predisposes an individual to subsequently develop CD. In CD patients, the matched 
odds ratios for measles vaccination was 1.08 (95% CI, 0.62-1.88). 
 
 
3.6.4 Infections 
 
 
It has been highlighted in many studies that infections in early childhood play an important role 
in as risk factor for IBD. It is generally unclear whether frequent childhood infections confer 
protection against CD or if they actually increase the risk of subsequently developing the disease. 
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Some paediatric studies however suggest that increased frequency of gastroenteritis (Whorwell 
PJ et al. 1979) and diarrhoea (Koletsko S et al. 1989) increase the susceptibility to CD. The results 
from a case control study conducted by Baron S et al. 2005 also suggests that frequent exposure 
to infections in childhood results in an increased risk of developing CD. The study by Gradel KO 
et al. 2009 confirmed that gastrointestinal infections were associated with CD development and 
the implicated microbes were Salmonella and Campylobacter. It is however important to consider 
that different infectious agents interact differently with the immune system so it is worthwhile to 
consider the interactions as separate entities. 
 
 
3.6.4.1 Viral Infections 
 
 
Frequent exposure to infections in early childhood is thought to increase the risk of developing 
CD and to augur the early onset of the disease. Wurzelmann JI et al. 1994 investigated the 
association between childhood viral infections and the IBD. The viral infections which were 
investigated are colds, measles, mumps, rubella and varicella. Findings from the study only 
implicated cold to the increased risk of developing CD. Contrary to the common hypothesis, the 
study found a weak association between measles infection and the risk of CD. 
 
 
3.6.4.1.1 Measles Virus 
 
 
Viruses have been implicated in the aetiology of IBD. The possibility that the causative agent for 
CD is a transmissible pathogen such as a virus is another plausible hypothesis (Thayer WR. 1990). 
The paramyxovirus in particular has caused great speculation in the pathogenesis of the disease. 
This is commonly known as the measles virus. Fragments of this virus have been observed in the 
mesenteric microvascular endothelium and if they persist, they result in chronic granulomatous 
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vasculitis. The measles hypothesis suggests an increased risk of CD in individuals vaccinated with 
the live attenuated measles vaccine in childhood (Thompson NP et al. 1995). The results from a 
study performed by Feeney M et al. 1997 in Dorset, UK however reveal no evidence linking live 
attenuated measles vaccination in childhood and the subsequent risk of developing CD. The study 
by Fisher NC et al. 1997 using serological techniques examined the association between measles 
virus infection in early childhood and predisposition to CD. Serum analyses for adenovirus, 
cytomegalovirus (CMV), herpes simplex virus (HSV) and measles virus were performed. Results 
from this study also confirm that the measles virus is not involved in the causation of CD, which 
seemed contrary to the accepted disease pathogenesis models of the time (Fisher NC et al. 1997). 
 
 
3.6.4.2 Bacterial Infections 
 
 
A great number of bacteria have been investigated as possible causative agents of CD. Among 
them are bacteria of the following species: Klebsiella spp, Chlamydia spp, Eubacterium spp, 
Peptostreptococcus spp, Bacteroides fragilis, Enterococcus faecalis, Escherichia coli, 
Campylobacter jejuni, Campylobacter faecalis, Listeria monocytogenes, Brucella abortus, 
Yersinia pseudotuberculosis, Yersinia enterocolitica and Mycobacteria spp (Thompson DE. 
1994). Among the different species investigated, one Mycobacterium avium paratuberculosis 
(MAP) has received greater attention. Certain studies have linked drinking water to IBD, and the 
implicated microorganisms is Mycobacterium paratuberculosis (Abubakar I et al. 2008). 
 
 
Found in ruminants, paratuberculosis is a chronic digestive disorder which is characterised by 
granulomatous enteritis that subsequently results in excessive weight loss and ultimately death. 
MAP is an extremely slow growing bacterium and this makes it difficult to isolate and grow on 
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conventional media. It can only be grown in conventional culture in 5% of cases and then only 
after months or years of incubation (Ryan P et al. 2002). Naser SA et al. 2004 found MAP in 46% 
of CD cases using the polymerase chain reaction (PCR) technique. There is still speculation on 
the association of MAP and CD, whether MAP’s presence in individuals results in the subsequent 
development of CD or that MAP colonises the gut as a result of CD. It is however important to 
note that the association between MAP and CD is still unclear. 
 
 
3.6.4.2.1 Helicobacter pylori 
 
Helicobacter pylori (H.pylori) is a bacterial infection that is often acquired in the early years of 
childhood. It has been identified that H. pylori is associated with overcrowding, poor sanitary 
conditions and large sibship size (Feeney MA et al. 2002). It has been observed that CD seems 
more prevalent in regions less commonly colonized with H. pylori infection (Molodecky NA and 
Kaplan GG. 2010). According to Luther J et al. 2010, the mechanism in which H. pylori infection 
may confer protection against CD is by increase in gene expression of Treg cell function. 
 
 
3.6.4.3Parasites Exposure 
 
 
Helminths are complex multicellular worms that play an important role in the aetiology of CD. 
Helminths which are commonly known as flatworms are more specifically termed platyhelminths. 
They parasitically inhabit the human gut and possess intricate life cycles and development 
(Mansfield LS et al. 2004). Helminths are more prevalent in warm climates and common in 
populations subject to overcrowding and poor sanitation. It is interesting to realise that IBD is less 
prevalent in helminth infested places. The common host for helminths are children who normally 
acquire them through contact with food, water or soil contaminated with the infective form of the 
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parasite (Elliott DE et al. 2000). Many helminths survive for years within the gastrointestinal tract, 
thus beginning in childhood these worms release antigenic molecules that are bound to activate 
the Th2-type cytokines which in turn inhibit the Th1 response to antigens therefore causing a 
dysregulated Th1 response (Else KJ et al. 1994). A dysregulated Th1 mucosal immune response 
over a long period of time promotes greater likelihood of developing CD. People in affluent 
communities live in increasingly hygienic environments thus making them less likely to acquire 
helminths. It is possible that the failure to acquire helminths and to experience mucosal Th2 
conditioning predisposes to CD (Urban JFJ et al. 1992). The decreasing frequency of helminthic 
colonization appears to correlate with the increasing prevalence of CD (Elliot DE et al. 2000). 
 
 
3.7 Domestic and Socio-economic Factors 
 
 
3.7.1 Environmental Upbringing 
 
 
Different environments, diverse in their unique potential exposures each based on the socio- 
economic attitudes and activities that take place in such areas, will influence the gut microbiota 
and in turn, immune development. Among those genetically susceptible, such environmental 
differences are likely to play a role in which certain immune-diseases are expressed, and thus in 
the incidence and prevalence of disease. Many studies have identified dissimilar occurrence of 
CD between urban and rural inhabitants (Bernstein CN et al. 2006; Gearry RB et al. 2006; López-
Serrano P et al. 2010; Wurzelmann JI et al. 1994). Greater occurrence was found to be in the 
urban settlement. This can possibly be attributed to the different environmental exposures, diet, 
contact with animals, levels of sanitation and pollutants within these environments. Some studies 
found no association between the place of upbringing and CD (Basson A. 2014; Castiglione F et 
al. 2012; Feeney MA et al. 2002; Malekzadeh F et al. 2009). Certain observational studies tend 
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to infer that there is increased incidence of CD in highly populated settlements (Klement E et al. 
2008; Radon K et al. 2007; Wulzermann JI et al. 1994). These differences in observations warrant 
for a better understanding of how the place of upbringing interacts with CD. 
 
 
3.7.2 The Sharing of Bathrooms and Living Spaces 
 
Early childhood is crucial in programming the immune system and exposure to microbial antigens 
helps to sensitize and regulate the immune response. It is therefore follows that lack of exposure 
to infections in early childhood may potentially increase the risk of subsequently developing CD. 
Social interactions are an important consequence of access to the natural environment and they 
serve to increase the diversity of micro-organisms to which an individual is exposed (Kuo FE et 
al. 1998). It has been observed that cohabiting individuals tend to share microbiota (Song SJ et al. 
2013). Sharing basic household amenities facilitates the transmission of microbes which are 
responsible for the triggering of the immune responses. A study on the environmental risk factors 
of IBD conducted by López-Serrano P et al. 2010, the authors reported a significant association 
between bedroom sharing and IBD. Data from this study indicated that bedroom sharing was 
associated with a lower risk of developing CD. Conversely, two studies (Basson A. 2014; 
Malekzadeh F et al. 2009) could not confirm this finding. Observations from these studies reveal 
no significant association between bedroom sharing and the subsequent development of CD. 
 
 
3.7.3 Water Source and Hot Water Availability 
 
 
Aamodt G et al. 2008 used data from a population-based cohort recruited in South-eastern Norway 
in 1990-1993, investigated the association between the quality of drinking water and the risk of 
developing CD. The main sources of drinking water in the region are lakes, reservoirs and rivers. 
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Water quality data extracted from the Norwegian waterworks included measurements of pH, 
colour, turbidity, coliform bacterial count and metal content of iron and aluminium. The risk of 
developing CD was significantly increased by 21% and this was attributed to the high iron content 
of the water. From these findings the authors suggested that the high iron content serve as a 
catalyst for oxidative stress, thus resulting in inflammation or an increased rate of cell mutations. 
Another possible explanation was that the high iron content triggers the rapid growth of bacteria, 
which in turn stimulate an inappropriate immune response in genetically predisposed individuals. 
 
Several observational studies (Basson A. 2014, Bernstein CN et al. 2006, Duggan AE et al. 1998 
and Gent AE et al. 1994) have investigated the association between drinking water and the risk of 
developing CD. Findings from these studies revealed that there was increased risk of CD in 
individuals who had access to tap water. By contrast, similar studies conducted by Baron S et al. 
2005 and Gilat T et al. 1987 could not confirm the findings. An epidemiological study conducted 
in the United Kingdom by Duggan AE et al. 1998 revealed that before the age of 11 years, the a 
fixed supply of hot water supply was significantly associated with CD development. Likewise, a 
population-based study on the Asian population also found that availability of hot tap water 
increased susceptibility to develop CD (Ng SC et al. 2014 (a)). However other studies found no 
significant association between heated water and the subsequent development of CD (Basson A. 
2014; Hampe J et al. 2003). 
 
 
3.7.4 Number of Siblings, Birth Order and Family Size 
 
 
It has been suggested that an increased number of household residents consequently results in an 
accrued likelihood of infections. This implies that individuals raised in households with fewer 
residents, as well as those with fewer siblings, have a reduced microbial exposures, including a 
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reduced chance of acquiring gastrointestinal or other such infections, believed to form crucial 
elements in the programming of intestinal immunity (Baron S et al. 2005). Nevertheless, the 
majority of studies have yielded inconsistent findings in support of this. For instance, findings 
from a case-control study conducted by Bernstein CN et al. 2006 reported that CD patients tended 
to have a smaller family size and fewer siblings, whereas another study reported the tendency for 
CD patients to be raised in families with a greater number of older siblings, when compared with 
controls (Baron S et al. 2005). Gearry RB et al. 2010 investigated the association between the age 
and number of siblings in a family with the risk of developing CD yet found no significant 
association. In like manner Han DY et al, also found no significant association between of number 
of siblings and birth order and CD risk (Han DY et al. 2010). 
 
 
3.7.5 Exposure to Animals 
 
 
The hygiene hypothesis infers that individuals who are raised in extremely hygienic conditions 
tend to have greater propensity to develop disease compared to those who are exposed to the 
various immunostimulatory microbial agents such as viruses, bacteria, and parasites (Koloski NA 
et al. 2008). The most significant phase of immune system development is the initial year of life 
and it is important for an individual to be exposed to certain microbes which are necessary in the 
programming of an effective immune system. Soon after birth, the human body requires microbial 
exposures to provide the molecular inputs of the surrounding environment (Rook GA. 2013). 
There are three main reasons why the body needs to be exposed. Firstly, exposure enables the 
body to build up immunological memory of various molecular structures of the microbial antigens 
in its surrounding which in turn aid to subsequently accelerate recognition of potentially 
dangerous organisms (Naik S et al. 2012). Secondly, the immune system has to develop regulatory 
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pathways and Tregs that are of paramount importance in preventing inappropriate immune 
responses on self, gut contents and harmless allergens (Rook GA. 2013). Thirdly, microbial 
antigens taken up in the gastrointestinal tract are vital in maintaining an optimum level of 
activation of the gut innate immune system (Clarke TB et al. 2010). 
 
Data observed from the study by Fujimura and colleagues revealed that microbiota found in dust 
from households which have dogs is more diverse than that present in households without them 
(Fujimura KE et al. 2010). In line with these findings, it was demonstrated in the study by 
Aichbhaumik N et al that exposure to dogs in early childhood, confers protection against allergic 
sensitization and disorders (Aichbhaumik N et al. 2008). A study by Bernstein CN et al indicated 
that before the age of 5 years, having pet cat was protective against CD and also displayed that 
CD patients were less likely to have had a household pet than controls (Bernstein CN et al. 2006). 
Radon K et al highlighted that contact with regular farm animals such as cattle, goats, pigs and 
sheep during the first year of childhood tends to decrease the risk of developing juvenile onset of 
disease CD (Radon K et al. 2007). This study also investigated the association between exposure 
to household pets, specifically cats and dogs and the immune system. 
 
On the contrary, Han DY et al determined that having a pet caused significant increased risk of 
subsequently developing CD and that even regularly feeding pets was not sufficient to confer 
protection against the risk (Han DY et al. 2010). In support of this notion Hlavaty T et al 
confirmed that having a cat in the home posed significant increased risk of developing CD 
(Hlavaty T et al. 2013). These findings therefore warrant more research into the hygiene 
hypothesis which might lead to the understanding the intricate aetiology underlying CD. 
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3.7.6 Appendectomy and Tonsillectomy 
 
 
Both the appendix and the tonsils are crucial elements of the gut-associated lymphoid system. 
Surgically removing these organs can possibly alter the balance between immunologic helper and 
suppressor functions therefore resulting in changes in the immune response. That makes these 
organs important in the pathogenesis CD. In a case control study performed in Crete by 
Koutroubakis IE et al. 1999, an association between CD cases and appendectomy was observed. 
However, the association did not reach statistical significance. A positive association between 
appendectomy and CD was confirmed in studies conducted by Gilat T et al. 1987 and Gent AE et 
al. 1994. 
 
In the same aforementioned study by Koutroubakis IE et al, tonsillectomy was shown to have a 
significant positive association with the prevalence of CD. Data from the study showed that 25% 
of the CD cases and 9.2% of their matched controls had undergone tonsillectomy. The results 
revealed that an individual who had undergone tonsillectomy had an 83.7% percent risk of 
developing CD as compared to one who had not undergone the operation. On multivariate logistic 
analysis, tonsillectomy was identified as a significant independent risk factor for developing CD 
(Koutroubakis IE et al. 1999). 
 
 
3.8 Summary 
 
 
Vast research has been devoted in understanding the exact aetiology of Crohn's disease; however 
the actual cause still remains unknown. Nonetheless, it has been established that susceptibility to 
the disease is a result of a combination of genetic and environmental risk factors. The assumed 
basis of environmental factors is the disruption of the gastrointestinal immune function towards 
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commensal microflora. Under environmental factors, three hypotheses have been postulated: cold 
chain; hygiene and infection hypothesis. To date the only environmental risk factor that has been 
clearly established for CD is cigarette smoking. Other environmental factors have been widely 
investigated, only to yield conflicting findings. With such different findings, the suggestion is that 
there is need to refine research on these interactions and to come up with plausible conclusions. 
Generally evaluation of environmental factors has not achieved much in identifying the cause and 
effect of the disease. More research in this area needs to be done in a bid to ascertain its 
pathophysiology. This study seeks to investigate the element of the timing of exposure and the 
possible interplay between the environmental risk factors in the subsequent development of CD.
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Tables Referred to in Chapter 3: 
 
 
The following tables from this chapter are represented: 
 
 
Table 1: Montreal Classification System 
 
 
Table 2: Crohn’s Disease Activity index CDAI) 
 
 
Table 3: Harvey-Bradshaw Index (HBI) 
 
 
Table 4: The Global Incidence of Crohn’s disease 
 
 
Table 5: Potential Risk factors of Crohn’s Disease
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TABLE 1: Montreal classification scheme 
 
Age at diagnosis (years) 
 A1 ≤16 
 A2 17- 40 
 A3 > 40 
Disease location 
 L1 Isolated to the terminal ileum 
 L2 Isolated to the colon 
 L3 Ileum and colonic involvement 
 L4* Upper gastrointestinal tract 
Disease behaviour 
 B1† Inflammatory; non-stricturing, non-penetrating 
 B2 Stricturing 
 B3 Penetrating disease, with or without stricturing, excludes 
perianal penetrating disease 
 p‡ Perianal disease modifier 
*Upper gastrointestinal (GI) modifier (L4) can be added to L1-L3 when concomitant upper 
GI disease present. 
† B1 category should be considered ‘interim’ until a pre-specified time has elapsed from time 
of diagnosis. Suggested time period is between 5-10 years. 
‡ ‘p’ is added to B1-B3 when concomitant perianal disease is present.
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TABLE 2: Crohn’s Disease Activity Index (CDAI) 
 
Score Definition 
CDAI <150 In-active or quiescent disease (i.e. ‘remission’) 
CDAI 150-220 Mild disease characterized by <10% weight loss, potentially increased 
CRP levels above the upper limit of normal, with no presentation of 
dehydration, fever, abdominal mass, tenderness or obstruction. 
CDAI 220-450 Moderate disease characterized by weight loss >10%, presence of tender 
mass (no overt obstruction), or unsuccessful response to treatment and 
elevated CRP. 
CDAI >450 Severe disease characterized by intestinal obstruction, abscess, elevated 
CRP, cachexia (BMI <18 kg/m²), in treated yet persistently symptomatic 
patients. 
CRP, C-reactive protein; BMI, Body mass index. 
 
 
Developed by WR Best and colleagues in 1976, The CDAI consists of eight factors, each 
summed after adjustment with a weighting factor.* Often used in research purposes, the score 
is then used to classify patient disease activity. 
*For full details, refer to Best WR et al., 1976 (Best WR., et al. 1976). 
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TABLE 3:  Harvey Bradshaw Index (HBI), a simple index of Crohn’s disease activity 
 
 Response/ Variable Possible 
score 
Received 
score 
1.General Well-being (yesterday) 
 Very well 0  
 Slightly below par 1  
 Poor 2  
 Very poor 3  
 Terrible 4  
2.Abdominal Pain (yesterday) 
 None 0  
 Mild 1  
 Moderate 2  
 Severe 3  
 
3.Number of liquid stools per day (yesterday) 
 
  stools 
4.Abdominal mass 
 None 0  
 Dubious 1  
 Definite 2  
 Definite and tender 3  
5.Complications (check any that apply below; score one per item except for first box) 
 None 0  
 Arthralgia 1  
 Uveitis 1  
 Erythema Nodosum 1  
 Aphthous ulcers 1  
 Pyoderma gangrenosum 1  
 Anal fissure 1  
 New fistula 1  
 Abscess 1  
Harvey Bradshaw index score = (add scores of questions 1-5) TOTAL:  
HBI Scoring Key: 
Remission <5  
Mild disease 5-7  
Moderate disease 8-16  
Severe disease >16  
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Table 4: The Global Incidence of Crohn’s disease 
 
Place Time period CD incidence 
Per 100000 
North America   
Loftus EV et al 1984-1993 6.9 
Blanchard JF et al 1987-1996 15.6 
Scandinavia 
 
Moum B et al 
 
 
1990-1993 
 
 
5.8 
United Kingdom 
 
Rubin GP et al 
 
 
1985-1994 
 
 
8.3 
Southern/Central Europe 
 
Tragnone A et al 
 
 
1989-1992 
 
 
2.3 
Asia 
 
Morita N et al 
 
 
1991 
 
 
0.5 
Africa 
 
Wright JP et al 
 
 
1980-1984 
 
 
1.8 
*Adopted from Viazis N. 2006 (incidence cases per 100000)
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Table 5: Potential Risk factors of Crohn’s Disease 
 
Injury to the 
puerile gut 
Nutritional 
Factors 
Chemical 
Factors 
Infectious 
Factors 
Domestic / Socio- 
economic Factors 
Bottle feeding Food Antibiotics Viral infections Bathroom sharing 
Gastroenteritis Additives Immunization Bacterial Bedroom sharing 
Diarrhoea GMOs Medications infections Swimming 
 Sugar Smoking Parasites Family size 
 Cholesterol Pollution exposure Running water 
 Modified  Pet exposure Hot water supply 
 fats  Farm animal Sibship 
   exposure Birth order 
    Surgery 
    Rural/urban 
    environment 
    Central heating 
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CHAPTER 4: THE ASSOCIATION BETWEEN ENVIRONMENTAL EXPOSURES 
DURING CHILDHOOD AND THE SUBSEQUENT DEVELOPMENT OF CROHN’S 
DISEASE: A SYSTEMATIC REVIEW 
 
 
4.1 Background 
 
 
Environmental risk factors in childhood are believed to play a role in the subsequent development 
of CD. Numerous studies have evaluated the different environmental exposures during childhood, 
albeit findings for many have been inconsistent. These inconsistencies may be attributed to 
differences in both the timing and the extent of the various environmental exposures during 
childhood, as well as the heterogeneity in CD susceptibility mutations both between and within 
individual population groups. Alternatively, these findings may be a result of methodological 
issues such as study sample size, participant characteristics (i.e. demographics, socioeconomic 
factors), identification of inappropriate control subjects, or the failure to account for potential 
confounding environmental variables. Therefore, in a bid to explore the available evidence 
surrounding childhood environmental risk factors and the association with future development of 
CD, a systematic review of the literature was conducted, with a specific emphasis on timing of 
exposure. 
 
 
4.2 Aim 
The aim of this systematic review was to investigate the association between childhood 
environmental risk factors, timing of exposure and the subsequent development of CD. 
Comparisons aimed to evaluate exposures during three specific age intervals; 0-5years, 6- 10years 
and 11-18years. However due to the limited number of studies identified in the initial literature 
search, in which these age interval definitions had been used, the original aim was amended to 
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also include studies which had broadly defined ‘childhood’ (0-18 years); in the literature this was 
found to be defined either as 0-12 years, or as 1-18 years; to evaluate the association between 
childhood environmental exposures and future CD development. 
 
 
4.3 Objective 
 
The objective of the systematic review was to: 
 
 Determine the environmental factors associated with CD development. 
 
 
Under the original objective; the environmental risk factors during childhood included: 
 
 
Antibiotic use 
 
Availability of heated water  
Bathing in a swimming pool  
Bathroom sharing 
Bedroom sharing  
Breastfeeding  
Childhood infections  
Exposure to pets 
Farm animal contact 
Feeding pets 
H. pylori status 
 
Having a sand pit at home 
 
Having a vegetable garden at home  
Place of upbringing 
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Preschool/Day-care attendance  
Primary water source 
Proportion of carpet in home 
Sibship size 
Type of toilet facility 
 
 
4.3.1 Amended Objective 
 
The final number of possible variables included in the systematic review was limited as a result 
of the inconsistencies in environmental variables investigated between the identified studies 
(under the amended aim). 
 
 
The objective of the systematic review was to: 
 
 Determine the environmental factors associated with CD development. 
 
 
Under the amended objective; the environmental risk factors during childhood included: 
 
Availability of running tap water 
Availability of hot tap water 
Exposure to household pets 
Farm animal contact 
Place of upbringing 
Sibship size 
 
 
4.4 Materials and Methods 
 
A systematic review of the literature including all original case-control, cross-sectional, cohort 
studies and controlled trials was conducted. 
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4.4.1Search strategy 
 
 
A systematic search of the literature was conducted using a research protocol developed by the 
candidate. During March 2015, a comprehensive search was conducted in electronic databases, 
such as: EMBASE, EBSCOhost (Medline), Ovid, Scopus and World Cat, PubMed and BioMed 
Central. Additional search terms were constructed after a review of the relevant literature. A 
manual search of reference lists of retrieved articles was also performed. In addition, a systematic 
search of the grey literature was performed, although no articles were identified using this method. 
 
 
4.4.2 Methodology 
 
 
A systematic search for literature using a controlled vocabulary of Medical Subject Headings 
(MeSH) was undertaken to identify articles published after 1 January 1950 and up to 25 June 
2015. Identification of eligible articles was performed by two reviewers (V. Sabe and A. Basson) 
and screening was conducted by reading of abstracts and titles. Only original studies were 
considered and selection encompassed cross-sectional, cohort and case-control studies, as well as 
controlled trials. The search was limited to human studies and both retrospective and prospective 
evaluations were considered. Elimination of articles was performed on the basis of the following; 
diagnostic accuracy, publications reporting on experimental animal research or articles that were 
not based on original research, including all systematic reviews and meta-analysis reports 
(Appendix XIII). Duplicated studies were also excluded from the selection. 
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Set of search entry terms 
 
 
Three sets of entry terms were applied separately and combined in the database search. The list 
of the sets of search entry terms is shown in Table 6. 
 
 
4.4.3Variables of Interest and Definitions 
 
 
Availability of running tap water: having access to the water that comes out of the taps that 
are connected to the main supply of the local water system as the primary water source. 
 
Availability of hot tap water: having access to heated water that comes out of taps that are 
connected to the main supply of the local water system. 
 
Exposure to household pets: having direct or indirect contact with any household pets within 
the household. 
 
Farm animal contact: having a farm animal on the property. 
 
 
Place of upbringing: the place where an individual was raised during childhood. 
 
 
Sibship size: the number of individuals born of the same parents living in the same household. 
 
 
 
 
4.4.4 Selection Criteria 
 
 
Inclusion criteria 
 
 
 All retrospective and prospective: case control, cohort and cross-sectional studies, as well 
as controlled trials 
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 Studies evaluating the association between one or more childhood environmental 
exposures and the subsequent development of CD. 
 
 
 Studies which evaluated childhood exposure defined as age intervals (e.g. 0-5, 6-10 and 
11-18 years). 
 
 
 Studies which evaluated ‘childhood exposure’ broadly defined as 0-18 years. 
 
 
 Studies published from 1 January 1950 (inclusive) and until the date of the literature search 
(March 2015). 
 
 
Exclusion criteria 
 
 
 All non-English language literature. 
 
 
 Unpublished articles without an available abstract or full text. 
 
 
 All systematic reviews, meta-analyses and studies of diagnostic accuracy. 
 
 
 
 Articles reporting on paediatric onset (diagnosed under the age of 16). 
 
 
 Articles investigating CD remission, as the primary outcome. 
 
 
 Articles investigating dietary habits, as the primary outcome. 
 
 
 
 
 
 
 
  
 
CHAPTER 4 
 
 
 CHILDHOOD ENVIRONMENTAL EXPOSURE AND CROHN’S DISEASE 102 
 
Search findings 
 
 
Of an initial 181 articles, 153 were considered after the removal of duplicates, and 16 were 
selected for the data extraction and quality appraisal process in this review. A flow diagram of 
how the literature was identified is shown in Table 7. This process has been described under Point 
4.5.5.1 (Literature Search Discussion). All included literature has been and listed within the 
bibliography (listed at the end of the present dissertation). 
 
 
Analysis of identified literature 
 
 
The researchers carefully screened and examined all titles and abstracts of the articles identified 
from the search. Articles which did not meet the inclusion criteria were automatically excluded 
from the batch. Full text copies were obtained of all articles meeting the initial inclusion criteria 
based on the title and abstract. After a thorough review of the preliminary articles by both 
reviewers and a consensus was reached, the data extraction process was initiated. The data 
extraction tool was performed developed according to PRISMA (preferred reporting items for 
systematic reviews and meta-analyses) guidelines (Appendix XVIII) and the PICOS (participants, 
interventions, comparisons, outcomes, study design) (Appendix XIV). A template of the data 
extraction tool is presented in Table 8. After performing the data extraction, a quality appraisal 
was carried out by the investigators prior to data collection (Table 10 and 11). One investigator 
performed data extraction and quality appraisal while the other analysed the results. The authors 
of the articles were contacted via email and specific questions pertaining to their study were asked. 
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Data extraction 
 
 
A standardized form, developed by the candidate was employed for the process of data extraction 
(Table 8). 
The following specific data points were collected for each study: 
 
 
 Study setting 
 
 Methodological approaches for data collection (i.e. questionnaires, medical records) 
 
 Data sampling frame 
 
 Number of IBD case and control participants 
 
 Method of participant recruitment 
 
 Demographic information of participants 
 
 Environmental exposures investigated 
 
 Age interval(s) and/or age range(s) used for environmental variable investigated 
 
 Study findings and data analysis methods 
 
 
After the data extraction process was completed, authors of the identified articles were then 
contacted via email based on the contact details provided within their respective publication. 
Emails included an attachment of a formal letter requesting the following (specific to each author); 
1) missing statistical results, methodological details pertaining to the study design which were not 
mentioned in the publication, or other variables the authors may have investigated during their 
study, but did not include in the original publication, and 2) where needed, any clarification from 
the author on various aspects of the study design (e.g., participant demographics, age at time of 
study enrolment) which was not mentioned in the original publication. Of the 16 included 
publications, 6 had missing statistical results. In an attempt to source all statistical data, authors 
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were contacted. From a total of 16 letters sent to the respective authors, 7 responded to the call. 
Two among the seven authors responded by providing a copy of their doctoral thesis. However, 
of the latter 2 authors that supplied a copy of their doctoral thesis, only one was written in the 
English language and translation of the second proved difficult. Four of the authors responded by 
saying that their study had been conducted so long ago that they no longer had a copy of the 
information,  beyond what was available in the original publication. The letter template is as 
shown in Appendix II. 
 
 
Data Extraction Outcome 
 
 
The data extraction outcome is presented in Table 9. Based on the data extraction outcome of the 
included articles, the environmental exposures that were considered as environmental exposure 
variables for this systematic review of the literature were; exposure to household pets, farm animal 
contact (including having a donkey/horse/sheep or cow living permanently on the property), place 
of upbringing, sibship size, primary source of water (i.e. availability of tap water) and the 
availability of hot water. The childhood environmental exposure variables considered in the 
present review are in line with the hygiene hypothesis and specifically relate to the immediate 
household and the surrounding environment to act as potential avenues for both microbial 
exposure and antigen immunostimulation. 
 
 
Although environmental risk factors such as, breastfeeding (Klement E et al. 2004), passive 
cigarette smoke exposure (Mahid SS et al. 2006) and antibiotic use (Khan KJ et al. 2011) scored 
relatively high according to the data extraction analysis of variables, these variables were excluded 
from the present systematic review in light of the fact that systematic reviews, focusing 
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specifically on these exposures, have recently been published. After reviewing the available 
literature, it was also decided that surgical history and childhood infections and antibiotic use 
would be excluded from review. The other reason for this was because the great majority of studies 
were limited by recall bias and data had not been confirmed by medical records. Dietary factors 
(in general) were not investigated in the systematic review for three reasons, namely; 1) the focus 
of the review was intended on the hygiene hypothesis 2) methodological issues associated with 
this variable, including the strong recall bias which often entails retrospective dietary intake 
reports, and 3) there has been a fairly recent systematic review on this variable (Hou JK et al. 
2011). The interaction between dietary compounds and the gut microbiome cannot be discounted, 
particularly given the dynamic differences in diet between population groups; however this was 
outside the scope of the present systematic review. 
 
4.4.5 Data Synthesis 
 
 
Data Collection 
 
The majority of studies (n=12) used either interviewer administered or self-administered 
questionnaires as the main method of data collection. Four studies also included patients’ medical 
records as a means of data collection (Appendix XI and XII). 
 
Article Coverage 
 
The observational studies that were under investigation seem to representative of the world, since 
all the continents are covered (Appendix XI and XII). 
 
 
4.4.6 Literature Search Discussion 
 
 
After careful review, 20 full text articles remained eligible for inclusion into the systematic 
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review; however another 4 were later excluded based on a consensus reached by both reviewers 
(Appendix XI; XII and XIII). Of the 16 included publications, 6 had missing statistical results. In 
an attempt to source all statistical data, authors were contacted. From a total of 16 letters sent to 
the respective authors, 7 responded to the call. Two among the seven authors responded by 
providing a copy of their doctoral thesis. However, of the latter 2 authors that supplied a copy of 
their doctoral thesis, only one was written in the English language and translation of the second 
proved difficult. Four of the authors responded by saying that their study had been conducted so 
long ago that they no longer had a copy of the information,  beyond what was available in the 
original publication. 
 
The study by Guo AY et al was eliminated because it examined the association of early life 
exposures and the modification of risk of IBD (Guo AY et al. 2014). The main focus of the study 
was how early environmental risk factors were associated with the risk of surgery in CD patients, 
which was not the focal point of the present systematic review. The case-control study performed 
in Sweden by Hildebrand J et al examined the early-life exposures associated with antibiotic use 
and the risk of subsequent development CD (Hildebrand H et al. 2008). The study included cases 
that had an early diagnosis of CD, before the age of 16 years. Given that early onset CD is 
associated with a more severe form of the disease compared to that of later onset, as well as that 
different classification models are used for adults when compared with paediatric CD patients, to 
distinguish disease phenotype, the latter using the Paris classification model, the study was 
excluded from the present systematic review. 
 
Corrao G et al conducted a nationwide case-control study in Italy (Corrao G et al. 1998). The 
study examined the risk of IBD attributable to smoking (Mahid SS et al. 2006), oral contraceptive 
use (Cornish JA et al. 2008) and breastfeeding (Klement E et al. 2004), aspects which have 
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been considered in earlier systematic reviews. In addition, oral contraceptive use is not considered 
to be a childhood environmental risk factor. 
 
The Swedish-Danish population based co-twin control study conducted by Halfvarson J et al was 
excluded as the study evaluated variables which were not the focus of this systematic review, 
namely; diet, smoking, oral contraceptive use and appendectomy (Halfvarson J et al. 2006). In 
addition, it was felt that recall bias was a strong limitation to the findings surrounding childhood 
infections and childhood hospitalization as this information was collected via questionnaire and 
not confirmed via medical records of patients. 
 
 
Overview 
 
 
The summary overview of the literature under examination has been presented in Appendices XI-
XVII. Among the 16 observational studies that were under examination, 2 of them were cohort 
studies and the rest were either population-based or hospital-based case-control studies. It is 
important to note that only 4 articles performed investigated environmental risk factors based on 
predefined age intervals; either as 0-5, 6-11 and 12-18 years, or as; 0-5, 6-10  and 11-18  years 
(Basson A. 2014; Gearry RB et al. 2010; Han DY et al. 2010; Wurzelmann JI et al. 1994). The 
remaining studies evaluated exposures in the ‘broad childhood’ category which articles defined 
as; 0-12 years, 0-16 or 1-18 years. 
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4.5 Results 
 
 
Place of Upbringing 
 
 
0-5 years 
 
 
Of the 5 studies that investigated the association between the place of upbringing during the age 
interval 0-5 years and the subsequent development of CD, 3 found no significant association. In a 
population based case-control study conducted in Cape Town, South Africa by Basson A 
including 194 CD patients and 213 controls, there was no significant difference in the risk of CD 
development between individuals who lived in a suburban or urban type of community and those 
who lived in a rural, farm or informal settlement [(OR = 1.21; 95% CI, 0.71-2.10); (κ = 0.86; 95% 
CI, 0.79-0.92)] (Basson A. 2014). Notably, one year after study completion a total of 40 (10%) 
randomly selected participants completed the interviewer administered questionnaire for a second 
time in order to measure the agreement between repeated data for the questionnaire using a kappa 
statistic. The κ statistic for the majority of findings ranged between 0.70-0.99, strongly supporting 
the reliability of their data. In a matched case-control pair study conducted at a district general 
hospital in the United Kingdom including 139 CD patients and outpatient controls, Feeney MA et 
al also found no association of the urban environment with  the risk of developing CD (OR = 0.59; 
95% CI, 0.28-1.24) (Feeney MA et al. 2002). Similarly, a case-control study performed in 
Canterbury, New Zealand by Gearry RB et al involving 638 CD patients and 600 controls, 
revealed that there was no difference in association between city dwellers (OR = 1), town dwellers 
(OR = 0.88; 95% CI, 0.67-1.16) and country dwellers (OR = 0.86; 95% CI, 0.65-1.14), with the 
future development of CD (Gearry RB et al 2010). In this study, each established predictor for 
CD was adjusted for age, sex, ethnicity and social class. 
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By contrast, in a large population-based cohort study conducted in Northern Europe by Timm S 
et al, the authors showed that being born, and raised on a livestock farm before the age of 5 years 
was protective against developing CD [(OR = 0.54; 95% CI, 0.31-0.94); (HR = 0.55; 95% CI, 
0.31-0.98)] (Timm S et al. 2014). In the same study however, village life [(OR = 0.71; 95% CI, 
0.49-1.03); (HR = 0.75; 95% CI, 0.52-1.10)] and city life (OR = 1; HR = 1) conferred no protective 
effect against future CD development. The study was performed in three phases of follow-up, and 
study population identification. The first, was conducted during 1989-1992, with a population of 
21 802 responders. This was followed by the second phase conducted during 1999-2001 and 
included 16 202 responders. The last phase included 15 167 responders, and was conducted during 
2010-2012. After considering all the variables of interest, the final study population included 10 
864 participants. Statistical analysis included both multiple logistic regression and multiple Cox 
regression models. Sub analysis of the multiple logistic regression model of place of upbringing 
and CD was further stratified by the year of birth and also adjusted for BMI, sex and smoking. It 
was revealed that individuals born after the year 1952 and living on a livestock farm (OR = 0.25; 
95% CI, 0.11-0.61), as well as those living in a village (OR = 0.52; 95% CI, 0.34-0.79), were less 
likely to develop CD, when compared to their city-dwelling counterparts. However there was no 
significant difference in the association with developing CD between dwelling on a livestock farm 
(OR = 1.64; 95% CI, 0.64-4.20), living in a village (OR = 1.60; 95% CI, 0.71-3.60) and city 
dweller [(OR = 1; (95% CI, data not available)] for the individuals born during, or prior to 1952 
(Timm S et al. 2014). In line with these findings, a study performed by Wurzelmann JI et al in 
North Carolina, United States found that city dwelling was associated with the future development 
of CD (Wurzelmann JI et al. 1994). The authors performed a case-control study, including 322 
CD patients obtained from the membership rolls of the North Carolina chapters of the Crohn’s 
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and Colitis Foundation of America and 403 controls who were the patient’s closest neighbour. It 
was established that the risk of developing CD significantly increased as the environment became 
more ‘urbanised’; rural (OR = 1.32; 95% CI, 0.76-2.29), small town (OR = 1.34; 95% CI, 
0.82-2.18), suburb (OR =1.43; 95% CI, 0.77-2.67) and city (OR = 1.81; 95% CI, 1.07-3.03). 
 
6-11 years 
 
 
Three studies investigated place of upbringing during the age interval 6-11 years; Basson A 
maintained a lack of association between place of upbringing and the risk of developing CD [(OR 
= 1.58; 95% CI, 0.91, 2.76); (κ = 0.68; 95% CI, 0.53-0.75)] (Basson A. 2014). However, during 
this age interval Gearry RB et al identified town and country dwelling to be protective against CD 
development when compared to city dwelling. Interestingly, the positive association between 
town dwelling and CD development was only significant  after adjusting for age, sex, ethnicity 
and social class [(OR = 0.79; 95% CI, 0.60-1.04) vs (OR = 0.69; 95% CI, 0.51-0.94), respectively], 
whereas a significant positive association was identified for country dwellers both before and after 
adjustment [(OR = 0.70; 95% CI, 0.53-0.92) and (OR = 0.64;  95% CI, 0.46-0.89), respectively] 
(Gearry RB et al. 2010). Wulzermann JI et al also found that, compared to individuals living in 
rural (OR = 1.34; 95% CI, 0.77-2.35), small town (OR = 1.04; 95% CI, 0.62-1.7), and city (OR = 
1.57; 95% CI, 0.92-2.67) areas, ‘suburbanites’ living was significantly associated with CD 
development (OR = 2.05; 95% CI, 1.12.-3.77). Notably, there remained a general trend of the risk 
increasing with the urban environ (Wurzelmann JI et al. 1994). 
 
 
11-18 years 
 
 
Three studies investigated place of upbringing during the age interval 11-18 years; Basson A. 
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continued to find no significant association between the place of upbringing and CD  risk  [(OR 
= 0.97 95% CI 0.55-1.70); (κ = 0.74; 95% CI, 0.35-0.67)]  (Basson A. 2014). As with the previous 
age interval, Gearry RB et al the protective association for town dwelling and CD risk was only 
significant after adjustment [(OR = 0.82; 95% CI, 0.62-1.07) vs (OR = 0.69; 95% CI, 0.51-0.94), 
respectively]. Country living still remained consistently protective against CD, both prior to (OR 
= 0.67; 95% CI, 0.50-0.90) and after (OR = 0.64; 95% CI, 0.46-0.89) adjustment (Gearry RB et 
al. 2010). Wulzermann JI et al also continued to show that city dwelling was significantly 
associated with CD development (OR = 1.73; 95% CI, 1.01-2.97) (Wurzelmann JI et al. 1994). 
 
 
Childhood (0-18 years) 
 
 
Of the 4 reports which broadly evaluated exposure during ‘childhood’, Bernstein CN et al 
demonstrated that living on a farm (OR = 0.62; 95% CI. 0.46-0.85) to be protective against CD 
development. The authors performed a case-control study in Canada through questionnaire using 
data from the Manitoba Health Registry (Bernstein CN et al. 2006). Childhood was defined as the 
age younger than 12 years.  The study included 364 CD patients and 433 controls matched by age, 
gender and geographic residence. In a 2010 Spanish hospital-based case-control study by López-
Serrano P et al urban dwelling was significantly associated with risk of CD (OR = 4.58 95% CI 
2.17-10.0), when compared to rural dwelling (López-Serrano P et al. 2010). The study included 
124 CD patients and 235 age and sex matched controls. Data was collected via both self-
administered questionnaires and medical records. By contrast, Castiglione F et al found no 
significant association between urban upbringing and the subsequent development of CD (OR = 
0.73; 95% CI, 0.52-1.02) in a multi-centre case-control study conducted in Southern Italy 
including 468 CD patients and 562 controls, the latter consisting of  physicians, nurses and  health 
 
 
 
 
  
 
CHAPTER 4 
 
 
 CHILDHOOD ENVIRONMENTAL EXPOSURE AND CROHN’S DISEASE 112 
 
support service professionals (Castiglione F et al. 2012). Similarly, an Iranian case-control study 
by Malekzadeh F et al, including 199 CD cases and 207 age-matched controls, the authors failed 
to find a significant association between place of upbringing and the risk of future CD 
development (Malekzadeh F et al. 2009). Overall, 89% of cases and 85% of controls reported an 
urban rather than rural upbringing. 
 
 
Farm Animal Contact 
 
 
0-5 years 
 
 
During the age interval 0-5 years, Timm S et al revealed that farm animal contact, by means of 
living on a livestock farm, was protective against the subsequent development of CD (OR = 0.54; 
95% CI, 0.31-0.94) (Timm S et al 2014). Basson A. found no association for never having a cow, 
donkey, horse or sheep living permanently and the risk of developing CD [(OR = 1.67; 95% CI, 
0.83-3.45); (κ = 0.64; 95% CI, 0.19-1.00)] (Basson A. 2014), whereas Gearry RB et al identified 
a weak association between CD and contact with farm animals (data not available) (Gearry RB et 
al. 2010). 
 
 
6-10 years 
 
 
Two studies investigated the risk association between farm animal contact during the age interval 
6-10 years and CD development. On multiple logistic regression analysis Basson A. identified a 
significant-risk association for never having a cow, donkey, horse or sheep living permanently on 
the property and future CD development [(OR = 3.10; 95% CI, 1.42-7.21); (κ = 0.84; 95% CI, 
0.12-1.00)]. In addition, an independent risk-association was identified for never having a donkey, 
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horse, sheep or cow on the property (OR = 2.48; 95% CI, 1.09-5.98) during the age interval 6-10 
years (Basson A. 2014). On the other hand, Gearry RB et al reported no significant association 
between farm animal contact and future risk of CD development (Gearry RB et al. 2010). 
 
 
11-18 years 
 
During the age interval 11-18 years, the aforementioned observations remained consistent for both 
studies; [Basson A: (OR = 4.31; 95% CI, 1.36-16.14); (κ = 1.00; 95% CI, 1.00-1.00)], although 
the publication by Gearry RB et al did report data on the non-significant association between farm 
animal contact and future risk of CD development (Basson A. 2014; Gearry RB et al. 2010). 
 
 
 
Childhood (0-18 years) 
 
 
Of the 2 studies evaluating the association between farm animal exposure during ‘childhood’  and 
CD risk, Hlavaty T et al found that not having contact with animals significantly increased the 
risk of developing CD (Hlavaty T et al. 2013). The 2013 case-control study was conducted at 
Bratislava University hospital through self-administered questionnaires to 190 CD patients, age 
and sex matched with 355 healthy volunteers. Statistical analysis examined the frequency of the 
individual’s contact with either dogs, cats, poultry, cattle, horses, pigs or small rodents, and 
revealed that having little or no contact with cattle (p = 0.05), cats (p = 0.03) and dogs (p = 0.02) 
during childhood (0-20 years) significantly exposed one to the risk of developing CD. Bernstein 
CN et al investigated living on a farm, as well as whether primary activity was either cattle or pig 
or poultry husbandry. The authors found that CD patients were significantly less likely to have 
contact with farm animals (OR = 0.62; 95% CI, 0.46-0.85) compared to the controls. However for 
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the individuals who lived on a farm, there was no significant difference between either living on 
a cattle farm or pig farm or poultry farm and the controls (data not available) (Bernstein CN et al. 
2006). 
Exposure to pets 
 
 
0-5 years 
 
 
Five studies investigated the association between exposure to pets during the age interval and CD 
risk, of which only that of Bernstein CN et al identified a significant association. The authors 
revealed that before the age of 5 years CD patients were less likely to have had a pet as  compared 
to the controls (65% vs 71.9%, respectively), and that exposure was protective (OR = 0.73; 95% 
CI, 0.53-1.0) against CD risk. Further analysis also revealed that prior to the age of 5 years, fewer 
CD patients had pet cats within the household, when compared to controls (33.8% vs 44.1%, 
respectively), and that exposure was protective against CD risk (OR = 0.68; 95% CI, 0.50-0.92)]. 
Comparison among only those who had pets at home the study found that CD patients (50.8%) 
were less likely to have cats than controls (61.3%), however these findings were not significant 
(OR = 0.72; 95% CI, 0.51-1.03). It must be noted that Bernstein CN et al evaluated only select 
variables during  the age interval  0-5 years, while evaluating others under  a more broad definition 
of ‘childhood’ (0-12 years) (Bernstein CN et al. 2006). 
 
 
Feeney MA et al investigated the association between various household pets, namely cat, dog, 
bird and rodent and CD risk; however  no significant risk association was identified for any of  
the variables [(Cat in home: OR = 0.81; 95% CI, 0.41-1.63), (Dog: OR = 0.65; 95% CI, 0.34-
1.24), (Bird: OR = 1.76; 95% CI, 0.75-4.14), and (Rodent: OR = 0.89; 95% CI, 0.43-1.81)] 
(Feeney MA et al. 2002). Results of a questionnaire-based, case-control cohort of 315 CD patients 
 
 
 
 
  
 
CHAPTER 4 
 
 
 CHILDHOOD ENVIRONMENTAL EXPOSURE AND CROHN’S DISEASE 115 
 
and 536 controls, conducted by Han DY et al in North Island, New Zealand, revealed no 
significant association between exposure to pets prior to the age of 5 years (OR = 1.26; 95% CI, 
0.92-1.73) and the risk of developing CD (Han DY et al. 2010). None of the other studies 
identified a significant association between pet exposure and the development of CD (Basson A. 
2014; Gearry RB et al. 2010). The statistical data was presented as in the studies as: Basson A. 
[(OR = 1.47; 95% CI, 0.92-2.34); (κ = 0.69; 95% CI, 0.46-0.91)] and Gearry RB et al (no data 
given). 
 
6-10 years 
 
 
For the age interval 6-10 years, only the study by Han DY et al reported a significant association 
between childhood exposure to pets and the development of CD (OR = 1.98 95% CI 1.28-3.06) 
(Han DY et al. 2010). The remaining two studies found no significant association [Basson (OR = 
1.13; 95% CI, 0.71-1.79); (κ = 0.72; 95% CI, 0.51-0.94)] and Gearry RB et al (no data shown)] 
(Basson A. 2014; Gearry RB et al. 2010). 
 
 
11-18 years 
 
 
During the age interval 11-18 years, Han et al remained the only study to identify a significant 
association between childhood pet exposure and CD development (OR = 1.61 95% CI 1.07-2.42) 
(Han DY et al. 2010), while the other two studies [Basson A (OR = 1.01; 95% CI, 0.64- 1.59); (κ 
= 0.74; 95% CI, 0.53-0.94), and Gearry RB et al (no data available)] continued to report  no 
significant association between exposure to pets and CD risk (Basson A. 2014; Gearry RB et al. 
2010). 
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Childhood (0-18 years) 
 
 
Among the 5 studies investigating childhood exposure to pets during ‘childhood’, López-Serrano 
P et al found that having a pet significantly increased the risk of developing CD (OR = 0.5;  95% 
CI, 0.3-0.9) (López-Serrano P et al. 2010). By contrast, Hlavaty T et al found that not having a 
cat significantly increased risk in developing CD (OR = 0.6; 95% CI, 0.4-0.9 (Hlavaty T et al. 
2013). In a recent multi-centre, case-control study including 186 CD patients and 940 controls 
conducted by Ng SC et al, the authors reported that having a pet dog significantly decreased the 
risk of developing CD before the age of 15 years (OR = 0.54; 95% CI, 0.43-0.91). This Asia-
Pacific study included Australia, China, Hong Kong, Indonesia, Macau, Malaysia, Singapore, Sri 
Lanka and Thailand. Statistical analysis was adjusted for sex, age and country income based on 
gross national income (GNI). Findings for Asia only were significant both prior to (OR = 0.50; 
95% CI, 0.33-0.76), and after adjustment, supporting the notion that dogs were protective against 
CD (OR = 0.54; 95% CI, 0.35-0.83). In addition, a significant association was observed after 
adjustment for both Asia, and Asia and Australia (OR = 0.64; 95% CI, 0.44-0.94), whereas a weak 
association was revealed for cats, rodents, birds and aquarium fish with the development of CD 
(Ng SC et al. 2014 (b)). On the other hand, both Castiglione F et al (OR = 0.96; 95% CI, 0.75-
1.24) and Malekzadeh F et al (data not available) found no association (Castiglione F et al. 2012; 
Malekzadeh F et al. 2009). 
 
Water Source 
 
 
0-5, 6-10, 11-18 years 
 
 
Only one study evaluated the association between source of water during the 3 age intervals (0-5, 
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6-10 and 11-18 years) and CD risk. Basson A defined primary water source as either piped or 
bottled water, or that of an outside tap, borehole, well water, or a river or a dam. During the age 
interval 0-5 years and 11-18 years, having piped tap or bottled water was significantly associated 
with CD development [(OR = 2.10; 95% CI, 1.20-4.00); (κ = 0.63; 95% CI, 0.37-0.89) and (OR 
= 1.92; 95% CI, 0.80-4.60); (κ = 0.89; 95% CI, 0.69-1.00), respectively]. No significant 
association was identified for the age interval 6-10 years (OR = 2.05; 95% CI, 1.10-4.10); (κ = 
0.65; 95% CI, 0.30-0.74) (Basson A. 2014). 
 
 
Childhood (0-18 years) 
 
 
Of the 4 studies investigating primary water source during ‘childhood’, only Bernstein CN et al 
identified a significant association between primary water source and the development of CD. The 
study revealed that in childhood, CD subjects were more likely to have had primary source  of 
water being a tap rather than being a well, lake or other non-tap source as compared to the controls 
(data not available) (Bernstein CN et al. 2006). However, Hampe J et al reported that there was 
no significant association between tap water as a primary water source and developing CD (OR = 
0.94; 95% CI, 0.53-1.66) (Hampe J et al. 2003). In agreement with these findings Hansen TS et 
al failed to identify a significant association when defined as having access to running water at 
home (OR = 0.50; 95% CI, 0.05-5.51) (Hansen TS et al. 2011). Ng SC et al also reported no 
significant association between in-house tap water and CD development in Asia [(unadjusted: OR 
= 1.21; 95% CI, 0.80-1.82); (adjusted: OR = 0.76; 95% CI, 0.48-1.22)]. The results failed to reach 
significance when analysed for both Asia and Australia (OR = 0.85; 95% CI, 0.53-1.34) (Ng SC 
et al. 2014 (b)). 
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Heated Tap Water 
 
 
0-5 years 
 
 
In a 2 year double blinded case-control study including 1468 CD patients and 3364 unaffected 
family members as controls in Germany, Hampe J et al demonstrated that there is no significant 
association between heated tap water and the development of CD before the age of 5 years (OR = 
1.25; 95% CI, 0.78-2.00), although a general trend towards a high risk of developing CD and the 
availability of hot tap water was observed by the authors (Hampe J et al. 2003). Similar findings 
were reported by Basson A who found no association between heated tap water and CD [(OR = 
1.18; 95% CI, 0.71-2.00); (κ = 0.81; 95% CI, 0.73-0.89)] (Basson A. 2014). 
 
Feeney MA et al however found the availability of hot tap water to be significantly associated 
with developing CD, and this was reported by over 95% of all subjects (data not available) 
(Feeney MA et al. 2002). 
 
 
6-10 years 
 
 
In the age interval 6-10 years only one study (Basson A. 2014) examined the association although 
found no significant association [(OR = 1.52; 95% CI, 0.92-2.54); (κ = 0.86; 95% CI, 0.89-0.90)] 
between heated tap water and developing CD. 
 
 
11-18 years 
 
 
Basson A again found no significant association between the availability of hot tap water and the 
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subsequent development of CD in this category [(OR= 1.52; 95%CI, 0.93, 2.51); (κ = 0.70; 95% 
CI, 0.69-0.76)] (Basson A. 2014). A case-control study performed by Duggan AE et al at 
Nottingham University hospital, United Kingdom, including 110 CD patients and 337 controls 
(surgical inpatients having elective surgery with no history of IBD) also did not identify a 
significant association between heated tap water and CD development [Unadjusted: (OR = 0.84 
95% CI, 0.3-1.4); and Adjusted: (OR = 1.74 95% CI, 0.8-3.8)] (Duggan AE et al. 1998). 
 
 
Childhood (0-18 years) 
 
Of the 3 studies which investigated the association between the availability of hot tap water and 
CD, 2 identified a positive association. Duggan AE et al analysed childhood exposure between 0-
11 years and showed a significant, independent  association  (at  5%  level)  between the availability 
of hot tap water and CD risk, after adjustment (OR = 0.56; 95% CI, 0.3-0.9), after adjustment for 
age and sex (Duggan AE et al. 1998). In the Asia-Pacific study, Ng SC et al identified a positive 
significant association in the Asian population (OR = 1.48; 95% CI, 1.01-2.13), however no 
association was observed in the Australian population; after adjusting for sex, age and country 
income (Ng SC et al. 2014 (b)). Conflicting findings were also demonstrated by the study 
conducted by Malekzadeh F et al which found no significant association between heated water and 
the development of CD (data not available) (Malekzadeh F et al. 2009). 
 
 
Sibship Size 
 
 
0-5 years 
 
 
Feeney MA et al focused on the association of family characteristics and the development of CD 
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before the age of 5 years. No significant difference in association was observed between being a 
single child (OR = 0.71; 95% CI, 0.18-2.77) in the family and having been two or more siblings 
(OR = 0.48; 95% CI, 0.1-2.01) with CD development. In addition, no significant association was 
seen for individuals not having older siblings (OR = 1.38; 95% CI, 0.37-5.20), for individuals 
with one older sibling (OR = 0.96; 95% CI, 0.25-3.65), or those who had two or more older 
siblings (OR = 1.71; 95% CI, 0.48-6.16) (Feeney MA et al. 2002). 
 
 
Gearry RB et al investigated the association between sibling number and older sibling number 
with CD risk, finding no significant association (data not available) (Gearry RB et al. 2010). Han 
DY et al reported a weak effect of number of siblings and birth order on the risk of developing 
the disease (data not available) (Han DY et al. 2010). 
 
 
6-10 years 
 
 
During this age interval, both Gearry RB et al and Han DY et al investigated the association 
between number of siblings in the family and birth order or the older sibling number with risk of 
CD development, however both authors reported finding no significant association (data not 
available) (Gearry RB et al. 2010; Han DY et al. 2010). 
 
 
11-18 years 
 
 
During the age interval 11-18 years, both Gearry RB et al and Han DY et al continued to report 
no significant association between number of siblings in the family and birth order, or the older 
sibling number with risk of CD development (data not available) (Gearry RB et al. 2010; Han DY 
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et al. 2010). 
 
Childhood (0-18 years) 
 
 
Castiglione F et al found no significant association between having one, or less brothers or  sisters 
and having 2 or more brothers or sisters (OR = 1.02; 95% CI, 0.76-1.37) with risk of developing 
CD (Castiglione F et al. 2012). Similarly, Hampe J et al reported that having 2 or more siblings 
had no significant association with the risk for CD (χ2 = 0.48, 1df, p > 0.20) (Hampe J et al. 2003), 
while López-Serrano P et al found no significant association between number of siblings and CD. 
The latter study displayed that there was no difference between having none or one sibling versus 
having two or more siblings, hence no significant association with the disease (OR = 0.6; 95% CI, 
0.2-1.7) (López-Serrano P et al. 2010). These findings were supported by the study performed by 
Malekzadeh F et al in which sibship size was analysed as co-factor for exposure to domestic 
refrigeration in childhood. No association with CD identified (data not available) (Malekzadeh F 
et al. 2009). In a Swedish study, Persson PG et al also demonstrated no association between either 
having, or not having siblings (OR = 1.8; 95% CI, 1.0-3.4) with the subsequent development of 
CD (Persson PG et al. 1993). In contrast to these findings, 2 studies confirmed a positive 
association between sibship size and the risk of developing CD. Bernstein CN et al analysed the 
association based on the sex of the siblings, taking into separate account the number of brothers 
and the number of sisters the individual. Results of the study showed that, compared to controls, 
CD patients were less likely to have brothers [(mean:   2.12 vs 1.67, respectively); (OR = 0.78; 
95% CI, 0.67-0.9)] or sisters   [(mean: 2.11 vs 1.77, respectively); (OR = 0.82; 95% CI, 0.7-0.96)] 
(Bernstein CN et al. 2006). Hlavaty T et al also established that CD patients had significantly less 
number of siblings compared to controls (1.6+/-1.3 vs 1.9+/-1.3, respectively) (statistical results 
not available) (Hlavaty T et al. 2013). 
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4.6 Discussion 
 
 
Overall, results from the studies examined in this systematic review show congruence with the 
hygiene hypothesis, in that delayed exposure to immunostimulatory microbes through the 
environmental exposures associated with improved sanitation, is associated with increased risk 
for future CD development, in genetically susceptible individuals. In addition, the literature 
supports that the childhood environment plays an important role in the aetiology of CD. However, 
the lack of consistent findings between studies, particularly those which have broadly defined 
‘childhood’ implies that timing of exposure plays a crucial role in this ever evolving paradigm. 
 
The human gut offers an optimum environment for growth and proliferation of mutualistic 
microbes known as the gut microbiota (Ley RE et al. 2006; Whitman WB et al. 1998), which are 
critical in maintaining the well-being of the host (O’Hara AM and Shanahan F. 2006), by 
regulating the host’s immunologic, metabolic and trophic functions (Hooper LV and Macpherson 
AJ. 2010; Stecher B and Hardt WD. 2011; Renz H et al. 2012). There is complex interaction 
between the host and gut microbiota which is vital for the maintenance of the gut homeostasis that 
is the development and regulation of the gut immune system (Chow J et al. 2010; Chung H and 
Kasper DL 2010; Hill DA and Artis D. 2009). Studies carried out on germ-free (GF) animals 
establish that the gut microbiota is requisite for the development of the gut mucosal immunity. It 
has been shown that microbiota-driven immune response can counteract the development of 
inappropriate inflammation. This therefore promotes the survival of the microbiota in the absence 
of unnecessary inflammation. Nevertheless, dysbiosis of the gut microbiota can lead to the 
development of immune-related disorders (Min YW and Rhee PL. 2015). 
 
 
 
 
 
 
  
 
CHAPTER 4 
 
 
 CHILDHOOD ENVIRONMENTAL EXPOSURE AND CROHN’S DISEASE 123 
 
Place of Upbringing and Farm Animal Contact 
 
 
The results of the present systematic review revealed notable findings on how the place of 
upbringing influences CD development in relation to contact with farm animals. There is an 
indication that there is greater risk of developing CD in people who have a more urban upbringing 
as compared to those with a rural background where there is livestock. Urban areas, in general, 
are places typified with high “hygiene” standards and less contact with farm animals. Exposure 
to farm animals would increase exposure to immunostimulatory antigens thereby programming 
the gastrointestinal (GI) immune system. As a result of that, we see consonance between city 
dwelling and limited exposure to farm animals in childhood as cogent causative agents of future 
development of CD.  For instance, Hlavaty T et al revealed that being raised on a cattle farm 
specifically offers protection against the development of the disease (Hlavaty T et al. 2013). It is 
also important to note from the present results that, exposure to farm animals, regardless of the 
child’s developmental stage from birth up to adolescence, appears to confer protection against the 
development of CD, as demonstrated in the study by Wulzermann JI et al (0-18 years) 
(Wurzelmann JI et al. 1994). On the other hand, the timing of this exposure is unclear, and it is 
possible that the protective effect reflects exposure either early in childhood, or late in childhood, 
or a combination of both. Therefore, it is interesting to observe the parallels between the study by 
Basson A and Gearry RB et al. Both studies examined the association within the 3 childhood age 
interval and both studies found no significant association for never having farm animal contact 
and place of upbringing below the age of 5 years (Basson A. 2014; Gearry RB et al. 2010). 
From the findings of the study performed by Hlavaty T et al that cattle specifically confer 
protection, it may be argued that Basson A. broadly grouped the farm animals which could have 
watered down the association in this age category (Hlavaty T et al. 2013). Had the study examined 
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the influence of the farm animals as individual species, the findings could have come out 
differently. It is important also to consider that below the age of 5 years, an individual is less 
mobile within the surroundings making both urban and farm dwellers to have almost the same 
blanket of protection from farm animal contact therefore making the influence of animal contact 
to be limited thus the weak association at this age. Although during the age interval 6-18 years, 
the study by Basson A showed no significant association between place of upbringing and CD 
development, the study confirmed an association between farm animal contact and the 
development of CD (Basson A. 2014). Specifically, during the age intervals 6-10 and 11-18 years, 
Basson A identified a significant association for never having a cow, horse, donkey or sheep living 
permanently on the property, including the identification of an independent risk association for 
the latter exposure during the interval 6-10 years. The latter may be explained by the fact that in 
Cape Town, South Africa (Western Cape),  it is not unusual to find farm animals roaming ‘freely’ 
within urban areas, implying that the exposures to farm animals in both urban and rural areas, is 
somewhat uniform, thus limiting differences between the association with the variable.  
 
Vice versa, while the study by Gearry RB et al showed a significant association between place of 
upbringing and CD development, it confirmed no association between farm animal contact and 
the eventual development of the disease (Gearry RB et al. 2010). It is of paramount importance to 
also note that Gearry RB et al defined contact with animals as ‘more than 4 times per week’ and 
this measurement of contact may have influenced the association (Gearry RB et al. 2010). 
Interaction with farm animals when defined as ‘four times or more’ versus ‘four times or less’ , 
for instance, could impact on these associations with regard to an individual and the protective 
effect conferred by the exposure. 
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Basson A also identified an independent risk association for never having consumed unpasteurised 
milk; it is likely that unpasteurized milk would increase antigen exposure, again supporting the 
hypothesis (Basson A. 2014). It is plausible that a significant association was not identified by 
Gearry RB et al because of the different livestock farming activity carried out in the place under 
study (Gearry RB et al. 2010). New Zealand is well known for sheep husbandry (Boutonnet JP. 
1999) and the microbial interaction may be different from those exposed to cattle. It is also 
possible that the microbial component of unpasteurised sheep milk differs to that of cow milk. 
Notably, there has not been a single study showing exposure to farm animals increasing the risk 
of developing CD. 
 
The method of categorization, along with the context in which an area is considered to be ‘urban’ 
or ‘rural’ may influence findings from studies that have identified an association between the 
place of upbringing and risk of CD (Basson A. 2014; Castiglione F et al. 2012; Malekzadeh F et 
al. 2009). For instance, in the South African context, the definition of city, suburb, town and 
village may differ compared to that in the European context. In addition, areas such as ‘informal 
settlements’ exist only in South Africa and this definition is not necessarily applicable in Europe 
and North America. Furthermore, some studies have categorised the settlements based on 
socioeconomic status, while others have considered only the size of the population. The other 
discrepancy is that some studies have been conducted in different regions of one nation, so 
although  the  categorization  of  a  may  be  similar,  there  may  be  regional  differences  in  the 
socioeconomic level between population groups. The other confounding factor worth mentioning 
is that the type of livestock varies between regions, including those present on individual farm. 
While some studies did examine the interaction on farms by clearly identifying the primary type 
of livestock farming activity conducted (Basson A. 2014; Bernstein CN et al. 2006; Timm S et al. 
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2014), others simply investigated the area of study as ‘farm’ (Hlavaty T et al. 2013). If the farm 
were to be a crop farm, this may potentially bias the outcome and contribute to inconsistent 
findings. Overall, despite the fact that some studies have found no significant association, there 
remains a general consensus that contact with farm animals is protective of the subsequent 
development of CD. 
 
The study conducted by Timm S et al. 2014 also brings to light a different perspective with regard 
to urban dwelling. Smoking has been is a well-recognized risk factor for CD (Loftus EV. 2004; 
Somerville KW et al. 1984). The study revealed that, farm dwellers were predominantly non-
smoking females, whereas city dwellers were predominantly males who smoked. It is worthy to 
note that city dwelling as a child has been associated with limiting the microbial exposure contact 
that may help stimulate an appropriate immune response, while at the same time increasing the 
risk of exposure to potent chemical agents such as cigarette smoke and other environmental 
pollutants. The subsequent development of CD would possibly due to a complex interaction of 
different risk factors, some being caused by exposure to them while others, being caused by lack 
of exposure to them. 
 
 
Pets 
 
 
Contact with pets has been generally accepted to be protective against developing CD. However 
findings from the studies on the association between exposure to pets and the subsequent 
development of CD have been largely inconsistent.  There is evidence suggesting that exposure 
to pets, namely cats appears to exert a greater impact during early childhood (0-5 years). Bernstein 
CN et al reported exposure to cats prior to the age of 5 years, as protective against CD, although 
other studies have reported conflicting findings. For example, López-Serrano P et al found having 
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a pet significantly increasing the risk of developing CD and Castiglione F et al and Malekzadeh 
F et al found that exposure to pets was not significantly associated with  CD, whereas Ng SC et 
al found having dogs decreased the risk and Hlavaty T et al found that not having cats and dogs 
was associated with an increased risk (Castiglione F et al. 2012; Malekzadeh F et al. 2009; Ng 
SC et al. 2014 (b); Hlavaty T et al. 2013; López-Serrano P et al.  2010; Bernstein CN et al. 2006). 
Notably, Bernstein CN et al also investigated the relationship between farm animal contact and 
found that CD patients had a lower likelihood of living on a farm, while not having farm animals 
was associated with an increased risk of CD.  Taken together these findings may indicate that 
while exposure to cats is a contributing factor, it is not an independent risk factor. Thus the positive 
association with cats may be a reflection of a concomitant exposure to other farm animals, thus 
greatly affecting the outcome (Bernstein CN et al. 2006).  
 
Intriguingly, the study by Han DY et al found that pet exposure significantly increased the risk 
for CD development, as this is in opposition to the majority of evidence and the hygiene 
hypothesis. Notably, Han DY et al only investigated CD risk and pet exposure and did not take 
into account other environmental factors; this may offer a potential explanation to their findings 
(Han DY et al. 2010). It is possible that having pet reflects a multifactorial interaction between 
various  other  environmental  variables  which  were  not  investigated  by  the  authors. Upon 
assessing the risk posed by exposure to pets, it is also imperative to quantify the amount of 
physical exposure associated with pets, or other animals on the property. It may be argued that the 
generalization of the pet exposure might have a great effect on the outcome; this also holds true 
for all exposure variables under investigation. In general, certain household pets, such as dogs and 
cats tend to have greater contact with humans, when compared with others, such as birds, rodents 
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and fish, which predominantly stay enclosed in cages. Such discrepancies may affect the outcome 
of the variable in question because of the pooling effect of the statistical analyses. 
 
 
Water Source and Hot Water Availability 
 
 
In line with the hygiene hypothesis, the availability of tap water was shown to be associated with 
the development of CD, particularly when exposure occurred below the age of 5 years. In addition, 
based on the studies included in the present review there appears to be a relationship between 
place of upbringing (rural, country and farm vs urban, suburban and city) and the availability of 
tap water. Furthermore, the notion that the programming of the immune system is associated with 
age-related intervals, including specific environmental exposures and antigens was supported in 
the report by Basson A. 2014 who identified a significant association between the availability of 
tap and the development of CD during the age intervals 0-5 and 6-10 years, but not during the age 
interval 11-18 years. According to Zinkernagel RM et al. 2001, the time soon before and after 
birth is crucial in understanding immunologic memory therefore exposure to environmental 
antigens helps creates this memory. It can therefore be inferred that immune system differentiation 
occurs during specific time periods, or ‘developmental windows’ during childhood, and that 
various microbial antigens may influence this intricate process. Similarly, the association between 
the availability of hot water and CD development was not consistently observed for all 3 of the 
age intervals. It is convincing to point that the availability of clean tap water entails an improved 
sanitary environment and this tends to dominate the influence of heated tap water. While studies 
that examined exposure in the broad ‘childhood’ sense have often revealed a significant 
association between availability of hot tap water and CD, it can be argued that the outcome is not 
representative of the actual time period when the risk exposure occurred and that it is a reflection 
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of a cumulative effect from multiple other environmental risk factors. In addition, availability of 
hot water may not necessarily equate to daily use of hot water. This may be particularly relevant 
if ‘availability’ has not been delineated in terms of whether hot water source originates from boiled 
water, or from a geyser, as well as frequency of use for the washing machines. Although this 
delineation was made in the study by Basson A, further studies are required to investigate this 
association. 
 
 
Sibship Size 
 
 
Contrary to common consensus, results of the present systematic review suggest that there is no 
association between sibship size and the risk of future CD development. All of the included studies 
failed to identify a significant association, including those which defined childhood by predefined 
age intervals. Notably however, it is likely that sibship size, as a single variable, does not influence 
CD development, and that it must be investigated in the context of multiple factors. For instance, 
many studies fail to examine sibship size together with other important household characteristics 
that may influence the ‘microbial impact’ of sibship size, such as total family size, number of 
bedrooms in the home, and number of bathrooms in the home. In addition, other important aspects, 
such as the type of toilet facility and bedroom sharing may have a direct impact on the absolute 
microbial contact of the individual. It is entirely plausible that many family members reside in 
one home; however each individual makes use of his or her own bedroom, as well as bathroom 
facilities. The latter household should not be compared to one, in which, fewer family members 
reside, yet where two or more individuals share bedrooms and multiple people may share a single 
bathroom facility. Thus, sibship size should not be considered in isolation, but rather in context to 
various household-related environmental factors. There are a number of possible other 
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confounding factors which are capable of greatly influencing the findings, such as preschool 
attendance, the regular use of swimming pools and other outdoor activities, surgical procedures 
(e.g., appendectomy, tonsillectomy), antibiotics use, vaccinations and childhood infections. While 
recall bias is often a strong limitation to the majority of the latter variables, overall, it appears that 
most studies fail to take into account these factors. 
 
 
Epidemiological Study Design 
 
 
Retrospective studies are typically engendered by a number of limitations when compared to 
prospective studies (Hess DR. 2004). Retrospective evaluation however allow easier evaluation 
of conditions which exhibit a long latency between exposure and disease, thus lend themselves 
for the generation of hypotheses, which can be evaluated  in more timely prospective research.  
Of the studies included in this present systematic review, 90% were retrospective in nature. 
However, CD is typically characterised by extended periods of latency between the exposure and 
the disease (Virta L et al. 2012) making retrospective evaluation one of the best suited methods 
for examining possible aetiological factors involved in the development of CD. 
 
Some of the disadvantages in retrospective evaluation include recall bias, unavailable ‘missing’ 
data, as well as the difficulties surrounding both the identification and control of potentially 
confounding factors (Hess DR. 2004). These factors are some of the limitations encountered by 
the present systematic review. Notably, any study that depends on a subject to recall information 
about a specific exposure is subject to recall bias. For example, studies which use a questionnaire 
to recall information such as dietary habits, childhood environmental exposures and medication 
use, are subject to recall bias. Retrospective studies predominantly rely on the recall of individuals, 
or the accuracy of written record, thus exposing them to potential recall bias (Hess DR. 2004).  
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However, it is possible that the recall bias pertaining to some information is lower than that of 
other information. For instance, when asking a 60 year old subject to recall information about 
his/her dietary habits at the age of 15, the recall bias is likely to be very high; but the same subject 
may easily and accurately recall information regarding the number of bedrooms in his/her home 
at age of 15, the number of people living in the home, types of pets, or number of people sharing 
a bathroom; for this information, the recall bias is likely to be lower. Notably, the same 60 year 
old subject may even be able to provide the latter type of information for his/her infant years, not 
because of a ‘cognitive’ memory during that time period, but because the subject has been made 
aware by family members, for example, of where he/she grew up, the type of home and how many 
siblings, relatives or other individuals were in the home; this may also be the case for information 
related to breastfeeding. Even if the subject does not personally recall this more ‘factual’ 
information, it may often be fairly accurately obtained, with the help of other family members. 
Nevertheless, recall bias is among the challenges encountered by many retrospective assessments 
with regards to environmental risk factors of CD. Such inconsistencies in methodology and other 
limitations surrounding retrospective studies however make it difficult to determine whether or 
not these inconsistencies actually represent the complex pathogenesis of CD. 
 
 
Limitations 
 
 
The primary limitation encountered during the critical appraisal process for the present systematic 
review was missing statistical data, including information pertaining to methodological 
approaches. For instance, some publications failed to include standard methodological 
information, such as; the age range of the subjects (Wurzelmann JI et al. 1994; Hampe J et al. 
2003; Hansen TS et al. 2011; Malekzadeh F et al. 2009; Guo AY et al. 2014; Halfvarson J et al. 
 
 
 
 
  
 
CHAPTER 4 
 
 
 CHILDHOOD ENVIRONMENTAL EXPOSURE AND CROHN’S DISEASE 132 
 
2006), the number of control subjects (Bernstein CN et al. 2006; Corrao G et al. 1998; Guo AY 
et al. 2014; Feeney MA et al. 2002); control selection (Guo AY et al. 2014), age categories 
pertaining to the relevant subjects under evaluation (Castiglione F et al. 2012; Hlavaty T et al. 
2013; López-Serrano P et al. 2010; Malekzadeh F et al. 2009; Ng SC et al.  2014 (b); Corrao G 
et al. 1998; Guo AY et al. 2014; Hildebrand H et al. 2008) and the specific study centre (Gearry 
RB et al. 2010; Han DY et al. 2010; Hampe J et al. 2003; Persson PG et al. 1993).  The second 
limitation was the number of variables included in the final systematic review in light of the 
staggering inconsistency between all identified studies with regard to the environmental variables 
investigated. 
 
 
Conclusion: 
 
 
It is critical to expose the body to early microbial sensitisation, thus stimulating it to develop an 
appropriate immune response (Francino MP. 2014). Modern “hygienic” lifestyles at birth and 
throughout early childhood tend to limit the exposure of the individual to microorganisms 
necessary for the programming and maturation of a healthy immune system therefore an 
individual becomes susceptible to subsequently develop disease (Stanwell-Smith R et al. 2012). 
It is of paramount importance to conduct investigation of the association of environmental risk 
factors with the development of CD, with a specific focus on defined age intervals during 
childhood. Assessing exposure at the different child developmental stage assists in rooting out 
diluting of the weight of the exposure variable under study and also aids in determining true 
interactions. 
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The following tables from this chapter are represented: 
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Table 10: Critical Appraisal Tool; Cohort Studies 
 
 
Table 11: Critical Appraisal Tool; Case-control Studies
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Table 6: Set of search entry terms 
 
SET 1 SET 2 SET3 
Inflammatory bowel  Environment  Hygiene hypothesis 
disease  Environmental exposure   
Inflammatory bowel  Environmental factors   
syndrome AND Environmental Risk factors AND  
Regional ileitis  Childhood exposure   
Terminal ileitis  Childhood risk factors   
Regional enteritis  Early exposure   
Granulomatous enteritis  Early childhood   
Crohn’s disease  Risk indicators   
Crohn’s colitis     
Crohn’s enteritis     
Crohn’s ileitis     
Ulcerative colitis     
Colitis Gravis     
Proctocolitis     
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Table 7: Flow Diagram Results 
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Table 8: Data Extraction Tool 
 
Author Study 
Centre 
Study 
Design 
Data 
Collection 
Methods 
Methodological 
approach 
Age 
intervals 
or range 
Subjects 
(n=?) 
Participant 
Selection 
Environmental 
Variables 
Results and 
analysis 
method 
Score 
A           
B           
C           
D           
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Table 9: Data Extraction Outcome 
 
 
 
Variables Feeney  Timm Wurzelmann Gearry  Han  Bernstein Hampe Corrao Hildebrand Hlavaty Hansen Basson  Duggan Malekzadeh Persson Guo  Lopez  Halfvarson Castillogne  Ng       TOTAL 
Breastfeeding X X Y Y Y Y X Y X Y Y Y X X Y Y Y X Y Y 13 
Exposure to pets Y X X Y Y Y X X X Y X Y X Y Y Y Y Y Y Y 13 
Farm animal contact X Y X Y X Y X Y X Y X Y X X X Y X X X X 7 
General Childhood Infections Y X Y Y X Y X Y Y Y Y Y X X Y X Y Y Y Y 14 
Helicobacter Pylori status Y X X X X X X X X X X X Y X X X X X X X 2 
Antibiotic use/regular medication X X Y Y Y Y X X Y X X X Y X X Y X Y Y Y 10 
Surgical history Y X Y Y X Y X Y X Y Y X Y X X X Y Y X Y 11 
Vaccination/Immunisation X X X Y Y Y X X X X Y X X X X X X Y Y Y 7 
Childhood Hospitalisation X X Y X X X X X X X X X X X X Y Y X X X 3 
Place of upbringing (Urban/Rural/Farm) Y Y Y Y X Y Y Y X Y X Y X Y X X Y X Y X 12 
Family size/household residence X X X Y X Y X X X Y X Y Y X X X X X Y X 6 
Sibship size Y X Y Y Y Y Y X X Y X X X Y Y X Y X Y X 11 
Sib rank Y X X Y  Y Y X X X X X X X X X X X   4 
Water source (tap water) X X Y Y X Y Y X X X Y Y Y Y X X Y X X Y 10 
Bathroom sharing X X X X X X X X X X X Y Y Y X X X X X X 3 
Toilet facility Y X X X X X X X X X X X Y X X X X X X Y 3 
Heated water Y X X Y X X Y X X X X Y Y Y X X X X X Y 7 
Cigarette smoke exposure Y Y X Y Y Y X Y X X X Y X X X Y X X X X 8 
Preschool/daycare attendance Y X X X Y X X X X X X Y Y X X Y X X X X 5 
Physical activity X X X X X X X Y X Y X X X X X X X Y X Y 4 
Use of swimming pool Y X X Y Y X X X X X X X X X X X X Y X X 4 
Home refrigerator X X X X X X X X X X X X X Y X X X X X X 1 
Sand pit X X X Y Y X X X X X X X X X X X X X X X 2 
Person to room ration in home Y X X X X X X X X X X X X X X X X X X X 1 
Number of house moves Y X X X X X X X X X X X Y X X X X X X X 2 
Number of family cars/Parents owned a car Y X X X X X X X X X X X Y X X X Y X X X 3 
Month and season of birth X X Y X X X X X X X X X X X X X Y X X X 2 
Feeding a pet X X X X Y X X X X X X X X X X X X X X X 1 
Having vegetable garden X X X Y X X X X X X X X X X X X X X X X 1 
Ethnicity X X X X X X X X X X X X X X X X X X X X  
Drinking unpasteurised milk X X X X X X X X X X X Y X X X X X X X X 1 
Eating chicken X X X X X X X X X X X X X X X X X X X X  
Type of toilet facility X X X X X X X X X X X Y Y X X X X X X X 2 
Raw beef consumption X X X X X X X X X X X Y X X X X X X X X 1 
Home shared with other family X X X X X X X X X X X X Y X X X X X X X 1 
Central heating installed X X X Y X X X X X X X X Y Y X X X X X X 3 
Delivery via caesarean section X X X X X X X X X X X X X X X Y X X X X 1 
Family income X X X X X X X X X X X X X X X X Y X X X 1 
Travelling abroad X X X X X X X X X X X X X X X X X Y X X 1 
Exposure to Allergens X X X X X X X X X X X X X X X X Y X X X 1 
Dental care history X X X X X X X X X X X X X X X X X X Y X 1 
Proportion of carpeting in the home X X X X Y X X X X X X X X X X X X X X X 1 
Parental occupation X X X X X X X X X X X X X X X X Y X X X 1 
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Table 10: Critical Appraisal Tool; Cohort Studies 
 
 
 
 
S I G N 
 
Methodology Checklist 3: Cohort studies 
Study identification  (Include author, title, year of publication, journal title, pages) 
Guideline topic: Key Question No: Reviewer: 
Before completing this checklist, consider: 
1. Is the paper really a cohort study? If in doubt, check the study design algorithm 
available from SIGN and make sure you have the correct checklist. 
2. Is the paper relevant to key question? Analyse using PICO (Patient or Population 
Intervention Comparison Outcome). IF NO REJECT (give reason below). IF YES 
complete the checklist. 
Reason for rejection: 1. Paper not relevant to key question □ 2. Other reason □ (please 
specify): 
Please note that a retrospective study (i.e. a database or chart study) cannot be 
rated higher than +. 
Section 1:  Internal validity 
In a well conducted cohort study: 
 
Does this study 
do it? 
1.1 The study addresses an appropriate and clearly focused 
question.i 
Yes □ No □ 
Can’t 
say □ 
SELECTION OF SUBJECTS 
1.2 The two groups being studied are selected from source 
populations that are comparable in all respects other than the 
factor under investigation.ii 
Yes □ No □ 
Can’t Does 
say □ not 
apply □ 
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1.3 The study indicates how many of the people asked to take part 
did so, in each of the groups being studied.iii 
Yes □ No □ 
Does 
not 
apply □ 
1.4 The likelihood that some eligible subjects might have the outcome 
at the time of enrolment is assessed and taken into account in the 
analysis.iv 
Yes □ No □ 
Can’t Does 
say □ not 
apply □ 
1.5 What percentage of individuals or clusters recruited into each arm 
of the study dropped out before the study was completed.v 
 
1.6 Comparison is made between full participants and those lost to 
follow up, by exposure status.vi 
Yes □ No □ 
Can’t Does 
say □ not 
apply □ 
ASSESSMENT 
1.7 The outcomes are clearly defined.vii Yes □ 
Can’t 
say □ 
No □ 
1.8 The assessment of outcome is made blind to exposure status. If 
the study is retrospective this may not be applicable.viii 
Yes □ 
Can’t 
say □ 
No □ 
Does 
not 
apply □ 
1.9 Where blinding was not possible, there is some recognition that 
knowledge of exposure status could have influenced the 
assessment of outcome.ix 
Yes □ 
Can’t 
say □ 
No □ 
□ 
1.1 The method of assessment of exposure is reliable.x Yes □ No □ 
0  
Can’t 
 
  say □  
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1.1 
1 
Evidence from other sources is used to demonstrate that the 
method of outcome assessment is valid and reliable.xi 
Yes □ No □ 
Can’t Does 
say □ not 
apply□ 
1.1 
2 
Exposure level or prognostic factor is assessed more than once.xii Yes □ No □ 
Can’t Does 
say □ not 
apply □ 
CONFOUNDING 
1.1 The main potential confounders are identified and taken into Yes □ No □ 
3 account in the design and analysis.xiii 
Can’t 
  say □ 
STATISTICAL ANALYSIS 
1.1 
4 
Have confidence intervals been provided?xiv Yes □ No □ 
SECTION 2:  OVERALL ASSESSMENT OF THE STUDY 
2.1 How well was the study done to minimise the risk of bias or High quality (++) 
 
 confounding?xv □  
  Acceptable (+) □  
  Unacceptable – 
  reject 0  
2.2 Taking into account clinical considerations, your evaluation of the 
methodology used, and the statistical power of the study, do you 
think there is clear evidence of an association between exposure 
and outcome? 
Yes  
Can’t 
say 
No 
2.3 Are the results of this study directly applicable to the patient 
group targeted in this guideline? 
Yes □ No □ 
2.4 Notes. Summarise the author’s conclusions. Add any comments on your own 
assessment of the study, and the extent to which it answers your question and mention 
any areas of uncertainty raised above. 
  
Unless a clear and well defined question is specified in the report of the review, it will be difficult to assess 
how well it has met its objectives or how relevant it is to the question you are trying to answer on the basis 
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of the conclusions. 
 
This relates to selection bias.* It is important that the two groups selected for comparison are as similar 
as possible in all characteristics except for their exposure status, or the presence of specific prognostic 
factors or prognostic markers relevant to the study in question. 
 
This relates to selection bias.* The participation rate is defined as the number of study participants divided 
by the number of eligible subjects, and should be calculated separately for each branch of the study. A 
large difference in participation rate between the two arms of the study indicates that a significant degree 
of selection bias* may be present, and the study results should be treated with considerable caution. 
 
If some of the eligible subjects, particularly those in the unexposed group, already have the outcome at 
the start of the trial the final result will be subject to performance bias.* A well conducted study will attempt 
to estimate the likelihood of this occurring, and take it into account in the analysis through the use of 
sensitivity studies or other methods. 
 
This question relates to the risk of attrition bias.*The number of patients that drop out of a study should 
give concern if the number is very high. Conventionally, a 20% drop out rate is regarded as acceptable, 
but in observational studies conducted over a lengthy period of time a higher dropout rate is to be expected. 
A decision on whether to downgrade or reject a study because of a high dropout rate is a matter of 
judgement based on the reasons why people dropped out, and whether dropout rates were comparable in 
the exposed and unexposed groups. Reporting of efforts to follow up participants that dropped out may be 
regarded as an indicator of a well conducted study. 
 
For valid study results, it is essential that the study participants are truly representative of the source 
population. It is always possible that participants who dropped out of the study will differ in some significant 
way from those who remained part of the study throughout. A well conducted study will attempt to identify 
any such differences between full and partial participants in both the exposed and unexposed groups. This 
relates to the risk of attrition bias.* Any unexplained differences should lead to the study results being 
treated with caution. 
 
This relates to the risk of detection bias.* Once enrolled in the study, participants should be followed until 
specified end points or outcomes are reached. In a study of the effect of exercise on the death rates from 
heart disease in middle aged men, for example, participants might be followed up until death, or until 
reaching a predefined age. If outcomes and the criteria used for measuring them are not clearly defined, 
the study should be rejected. 
 
This relates to the risk of detection bias.* If the assessor is blinded to which participants received the 
exposure, and which did not, the prospects of unbiased results are significantly increased. Studies in which 
this is done should be rated more highly than those where it is not done, or not done adequately. 
 
This relates to the risk of detection bias.* Blinding is not possible in many cohort studies. In order to assess 
the extent of any bias that may be present, it may be helpful to compare process measures used on the 
participant groups - e.g. frequency of observations, who carried out the observations, the degree of detail 
and completeness of observations. If these process measures are comparable between the groups, the 
results may be regarded with more confidence. 
 
This relates to the risk of detection bias.* A well conducted study should indicate how the degree of 
exposure or presence of prognostic factors or markers was assessed. Whatever measures are used must 
be sufficient to establish clearly that participants have or have not received the exposure under 
investigation and the extent of such exposure, or that they do or do not possess a particular prognostic 
marker or factor. Clearly described, reliable measures should increase the confidence in the quality of the 
study 
 
This relates to the risk of detection bias.* The primary outcome measures used should be clearly stated 
in the study. If the outcome measures are not stated, or the study bases its main conclusions on secondary 
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outcomes, the study should be rejected. Where outcome measures require any degree of subjectivity, 
some evidence should be provided that the measures used are reliable and have been validated prior to 
their use in the study. 
 
This relates to the risk of detection bias.* Confidence in data quality should be increased if exposure level 
is measured more than once in the course of the study. Independent assessment by more than one 
investigator is preferable. 
 
Confounding is the distortion of a link between exposure and outcome by another factor that is associated 
with both exposure and outcome. The possible presence of confounding factors is one of the principal 
reasons why observational studies are not more highly rated as a source of evidence. The report of the 
study should indicate which potential confounders have been considered, and how they have been 
assessed or allowed for in the analysis. Clinical judgement should be applied to consider whether all likely 
confounders have been considered. If the measures used to address confounding are considered 
inadequate, the study should be downgraded or rejected, depending on how serious the risk of confounding 
is considered to be. A study that does not address the possibility of confounding should be rejected. 
 
Confidence limits are the preferred method for indicating the precision of statistical results, and can be 
used to differentiate between an inconclusive study and a study that shows no effect. Studies that report 
a single value with no assessment of precision should be treated with extreme caution. 
 
Rate the overall methodological quality of the study, using the following as a guide: High quality (++): 
Majority of criteria met. Little or no risk of bias. Results unlikely to be changed by further research. 
Acceptable (+): Most criteria met. Some flaws in the study with an associated risk of bias, Conclusions 
may change in the light of further studies. Low quality (0): Either most criteria not met, or significant flaws 
relating to key aspects of study design. Conclusions likely to change in the light of further studies. 
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Table 11: Critical Appraisal Tool; Case-control Studies 
 
 
 
 
S I G N 
 
Methodology Checklist 4: Case-control studies 
Study identification  (Include author, title, year of publication, journal title, pages) 
Guideline topic: Key Question No: Reviewer: 
Before completing this checklist, consider: 
1. Is the paper really a case-control study? If in doubt, check the study design algorithm 
available from SIGN and make sure you have the correct checklist. 
2. Is the paper relevant to key question? Analyse using PICO (Patient or Population 
Intervention Comparison Outcome). IF NO REJECT (give reason below). IF YES 
complete the checklist. 
Reason for rejection: Reason for rejection: 1. Paper not relevant to key question □ 2. Other 
reason □ (please specify): 
 
Section 1:  Internal validity 
In an well conducted case control study: Does this study 
do it? 
1.1 The study addresses an appropriate and clearly focused 
question.xvi 
Yes   No 

Can’t 
say 
SELECTION OF SUBJECTS 
1.2 The cases and controls are taken from comparable populations.xvii Yes   No 

Can’t 
say 
1.3 The same exclusion criteria are used for both cases and controls.xviii Yes   No 

Can’t 
say 
1.4 What percentage of each group (cases and controls) participated in 
the study?xix 
Cases: 
Controls: 
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1.5 Comparison is made between participants and non-participants to 
establish their similarities or differences.xx 
Yes   No 

Can’t 
say 
1.6 Cases are clearly defined and differentiated from controls.xxi Yes   No 

Can’t 
say 
1.7 It is clearly established that controls are non-cases.xxii Yes   No 

Can’t 
say 
ASSESSMENT 
1.8 Measures will have been taken to prevent knowledge of primary 
exposure influencing case ascertainment.xxiii 
Yes 

Can’t 
say 
No 
Does 
not 
apply 

1.9 Exposure status is measured in a standard, valid and reliable 
way.xxiv 
Yes 

No 
  Can’t  
  say  
CONFOUNDING 
1.1 The main potential confounders are identified and taken into Yes  
Can’t 
say 
No 
0 account in the design and analysis.xxv 
STATISTICAL ANALYSIS 
1.1 
1 
Confidence intervals are provided.xxvi Yes   No 
SECTION 2:   OVERALL ASSESSMENT OF THE STUDY 
2.1 
How well was the study done to minimise the risk of bias or 
confounding? xxvii 
High quality (++) 
□ 
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  Acceptable (+) □ 
Unacceptable – 
reject 0 □ 
2.2 Taking into account clinical considerations, your evaluation of the 
methodology used, and the statistical power of the study, do you 
think there is clear evidence of an association between exposure 
and outcome? 
Yes  
Can’t say 

No 

2.3 Are the results of this study directly applicable to the patient group 
targeted by this guideline? 
Yes   No 

2.4 Notes. Summarise the authors’ conclusions. Add any comments on your own 
assessment of the study, and the extent to which it answers your question and mention 
any areas of uncertainty raised above. 
  
 
 
Unless a clear and well defined question is specified in the report of the review, it will be difficult to assess 
how well it has met its objectives or how relevant it is to the question you are trying to answer on the basis 
of the conclusions. 
 
Study participants may be selected from the target population (all individuals to which the results of the 
study could be applied), the source population (a defined subset of the target population from which 
participants are selected), or from a pool of eligible subjects (a clearly defined and counted group selected 
from the source population. If the study does not include clear definitions of the source population it should 
be rejected. 
 
All selection and exclusion criteria should be applied equally to cases and controls. Failure to do so may 
introduce a significant degree of bias into the results of the study. 
 
Differences between the eligible population and the participants are important, as they may influence the 
validity of the study. A participation rate can be calculated by dividing the number of study participants by 
the number of eligible subjects. It is more useful if calculated separately for cases and controls. If the 
participation rate is low, or there is a large difference between the two groups, the study results may well 
be invalid due to differences between participants and non-participants. In these circumstances, the study 
should be downgraded, and rejected if the differences are very large. 
 
Even if participation rates are comparable and acceptable, it is still possible that the participants selected 
to act as cases or controls may differ from other members of the source population in some significant 
way. A well conducted case-control study will look at samples of the non-participants among the source 
population to ensure that the participants are a truly representative sample. 
 
The method of selection of cases is of critical importance to the validity of the study. Investigators have 
to be certain that cases are truly cases, but must balance this with the need to ensure that the cases 
admitted into the study are representative of the eligible population. The issues involved in case selection 
are complex, and should ideally be evaluated by someone with a good understanding of the design of 
case-control studies. If the study does not comment on how cases were selected, it is probably safest to 
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reject it as a source of evidence. 
 
Just as it is important to be sure that cases are true cases, it is important to be sure that controls do not 
have the outcome under investigation. Control subjects should be chosen so that information on exposure 
status can be obtained or assessed in a similar way to that used for the selection of cases. If the methods 
of control selection are not described, the study should be rejected. If different methods of selection are 
used for cases and controls the study should be evaluated by someone with a good understanding of the 
design of case-control studies. 
 
If there is a possibility that case ascertainment can be influenced by knowledge of exposure status, 
assessment of any association is likely to be biased. A well conducted study should take this into account 
in the design of the study. 
 
The primary outcome measures used should be clearly stated in the study. If the outcome measures are 
not stated, or the study bases its main conclusions on secondary outcomes, the study should be rejected. 
Where outcome measures require any degree of subjectivity, some evidence should be provided that the 
measures used are reliable and have been validated prior to their use in the study. 
 
Confounding is the distortion of a link between exposure and outcome by another factor that is associated 
with both exposure and outcome. The possible presence of confounding factors is one of the principal 
reasons why observational studies are not more highly rated as a source of evidence. The study should 
indicate which potential confounders have been considered, and how they have been allowed for in the 
analysis. Clinical judgement should be applied to consider whether all likely confounders have been 
considered. If the measures used to address confounding are considered inadequate, the study should be 
downgraded or rejected. A study that does not address the possibility of confounding should be rejected. 
 
 
 
Confidence limits are the preferred method for indicating the precision of statistical results, and can be 
used to differentiate between an inconclusive study and a study that shows no effect. Studies that report 
a single value with no assessment of precision should be treated with extreme caution. 
 
Rate the overall methodological quality of the study, using the following as a guide: High quality (++): 
Majority of criteria met. Little or no risk of bias. Results unlikely to be changed by further research. 
Acceptable (+): Most criteria met. Some flaws in the study with an associated risk of bias, Conclusions 
may change in the light of further studies. Low quality (0): Either most criteria not met, or significant flaws 
relating to key aspects of study design. Conclusions likely to change in the light of further studies. 
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CHAPTER 5: ENVIRONMENTAL EXPOSURES DURING CHILDHOOD AND THE 
SUBSEQUENT DEVELOPMENT OF CROHN’S DISEASE IN THE WESTERN CAPE, 
SOUTH AFRICA 
 
 
5.1 Background 
 
 
While the aetiology of CD remains unclear, several theories have emanated in a bid to understand 
the underlying pathogenesis of the disease. The most widely accepted is the ‘hygiene hypothesis’ 
and the theory has received much academic speculation and attention. Numerous studies have 
been conducted on the basis of the hygiene hypothesis, including the recent case control 
investigation conducted in the 2 largest tertiary referral IBD centres in Cape Town, South Africa 
by Basson A. (Basson A. 2014). The methodological approaches of the study were previously 
described in Chapter 2.  
 
 
5.2 Aim and Objectives 
 
 
Aim 
 
 
The aim of the present study was to investigate the association between childhood environmental 
exposures and the risk of CD development in the Western Cape, South Africa based on a score 
analysis of a subset of data collected from the aforementioned completed study performed by 
Basson A. 2014. 
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Objectives 
 
 
The objectives of the study were: 
 
1. To perform a score analysis for the environmental exposures during the three age intervals; 
0-5, 6-10 and 11-18 years 
2. To investigate a number of childhood infections between the ages 0-20 years based on 
original data from a case control study design 
3. To perform a score analysis on data pertaining to childhood infections between the ages 
0-20 years 
4. To compare the difference in score analysis between case and control subjects for 
objectives 1 and 2 above 
 
 
5.3 Materials and Methods 
 
 
5.3.1 Study Data 
 
 
The results from Basson A of the multiple logistic regression analysis evaluating environmental 
risk factor exposure in 3 age groups (0-5 years, 6-10 years and 11-18 years) are shown in Table 
12. Fourteen environmental exposures were investigated, these include: Primary source of 
drinking water, Hot piped tap water, Community type, Total number of people in household, 
Number of people sharing a bathroom, Number of bedrooms in home, Type of toilet facility, 
Household pets, Donkey/horse/cow/sheep on property, Cigarette smoke exposure, Unpasteurized 
milk consumption, Raw beef consumption, Helminth infection, Treatment for helminths. 
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5.3.1.1 Methodology 
 
 
Environmental Exposures for the age intervals (0-5 years, 6-10 years and 11-18 years) 
 
 
To evaluate the environmental exposures during the 3 age intervals based on a score analysis, the 
fourteen environmental exposure variables (presented in Table 12) three different approaches 
were undertaken. In the first analysis approach, all variables were assigned a weighting score 
value equal to one. In the second and third analytical approach, two Groups were formed: Group 
A and Group B. While both Group A and Group B consisted of all fourteen exposure variables, 
the subgrouping of exposure variables differed between Group A and Group B. Methodology for 
subgrouping: environmental exposure variables of similar nature were combined in ‘subgroups’ 
within Group A and B. For instance, within Group A, the environmental exposure variables ‘water 
source’ and ‘hot water availability’ were grouped together, to form one subgroup within Group 
A, while the exposure variables ‘number of people in the household’, ‘number of bedrooms in the 
household’ and ‘pets in the home’ were combined to form another subgroup within Group A. The 
weighting for each individual subgroup was equal to the value of one. Thus, the weighting for 
each individual exposure variable with the subgroups was dependent upon the number of variables 
within the subgroup. For instance, the weighting of  each variable in the latter subgroup (‘number 
of people in the household’, ‘number of bedrooms in the household’ and ‘pets in the home’) was 
1/3 + 1/3 + 1/3, whereas the weighting for the former subgroup (‘water source’ and ‘hot water’) 
was 1/2 + 1/2. The grouping of exposure variables has been explained under Point 5.3.2, and the 
weighting of subgroups with Group A and Group B are shown in Table 13 and Table 14, 
respectively. 
 
 
The two different Groups (A and B) were created in an attempt to compare the difference in the 
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effect between the variations in weighting for the exposure variables within subgroups. It must be 
noted that for both group A and group B, the exposure variables ‘never having consumed 
unpasteurized milk’ and ‘passive cigarette smoke exposure’ were not combined with other 
exposures and their individual score remained equal to the value of one. As this component of  the 
study was a post-hoc analysis of published data, this weighting was determined based on several 
factors, namely; 1) a significant association was identified for unpasteurized milk during all 3 age 
intervals, including the identification of an independent risk association for 6-10 and 11-18 years, 
and 2) a significant association was identified for passive cigarette smoke exposure during 2 age 
intervals, including the identification of an independent risk association for 11-18 years, as well 
as that smoking is a well-established risk factor in CD. 
 
Group A and B consisted of individual subgroups and the lowest possible weighting within any 
subgroup was 1/5th, thus a subgroup consisted of no more than 5 exposure variables. Since the 
‘score value’ for every subgroup was equal to the value of one, the total possible score  for  Group 
A and B was equivalent to the total number of subgroups contained within that group.   For Group 
A, the total possible score was 8, and for Group B, the total possible score was five. A score 
analysis was performed based on these premises. The subgroups within Group A and Group B, 
respectively, were statistically analysed based on their single (i.e. unpasteurized milk) or pooled 
weighted score. 
 
Comparisons were performed between the cases and the controls using these predefined Groups 
(A and B), and the score analysis for environmental risk factors was performed over the 3 
childhood age intervals (0-5, 6-10 and 11-18 years). For each analysis (0-5, 6-10 and 11-18 years), 
score results have been represented as minimum, maximum, mean and median values for the case 
and control groups. The Odds Ratios and 95%CIs represents the significance of the difference 
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between the two groups, as well as the difference in proportion with regard to number of exposures 
based on the score. 
 
 
Frequency of Childhood Infections between ages 0-20 years 
 
 
While a similar methodological approach was used for the frequency of childhood infections, no 
grouping of exposure variables was performed (refer to Point 5.3.2.2; Objective 2). 
 
 
5.3.2 Score Analysis: Grouping of Variables 
 
 
5.3.2.1 Objective 1 
 
 
Group A: Environmental Exposure Subgroups 
 
 
Below represents the subgroups comprised within Group A (Table 
13): 
 
 Source of drinking water (Not piped) + Hot water source (No access) 
 
 Number of people in home (Less than 3) + Number of bedrooms in home (3 or more) + 
pets in home 
 Number of people sharing a bathroom (Less than 3) + Type of toilet facility (Bucket, pit 
latrine or no facility) 
 Raw beef consumption (once per year or more) 
 
 Unpasteurized milk consumption (once per year or more) 
 
 Helminth infection (not exposed) + Treatment for helminths 
 
 Community type (Suburban or Urban) + Donkey/horse/sheep/cow living permanently on 
property (not exposed) 
 
 
 
 
  
 
CHAPTER 5 
 
 
 CHILDHOOD ENVIRONMENTAL EXPOSURE AND CROHN’S DISEASE 152 
 
 Passive Cigarette smoke exposure (exposure) 
 
 
Group B: Environmental Exposure Subgroups 
 
Below represents the subgroups comprised within Group B (Table 14): 
 
 Source of drinking water (Not piped) + Hot water (No access) + Raw beef consumption 
(once per year or more) 
 Number of people in a home (Less than 3)  + Number of bedrooms in a home (3 or more) 
 
+ Number of people sharing a bathroom (Less than 3) + Type of toilet facility (Bucket, 
pit latrine or no facility) + pets in home 
 Community type (Suburban or Urban) + Donkey/horse/sheep/cow living permanently on 
property (no exposure) + Helminth infection (no exposure) + treatment for helminths 
 Unpasteurized milk consumption (once per year or more) 
 
 Passive Cigarette smoke exposure (exposure) 
 
 
5.3.2.2 Objective 2 
 
 
Frequency of Childhood Infections between Ages of 0-20 years 
 
 
A subset of unused, unpublished data from the original research study focusing on childhood 
infections during the age intervals 0-12 and 12-20 years was used. Regarding the frequency of 
childhood infections during the age intervals 0-12 years and 13-20 years, the data was combined, 
and evaluated as 0-20 years, because of the small cell size of some variables. The standard for 
significance for all analysis was P < 0.05. 
 
The frequency of 12 variables during the defined age intervals were evaluated on the basis of 
either ‘never’ or ‘once or more per year’, these included; tooth decay/cavity; periodontitis; sore 
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throat; respiratory infection; diarrhoea; gastritis; mouth ulcers; perianal disease; 
arthritis/arthralgia; eye disease (not myopia, hypermetropia, astigmatism or presbyopia); use of 
antibiotics; and the use of probiotics with or after antibiotic pills. For this score analysis, no 
grouping was performed and all variables were equal to the value of one. The reason for this is 
because the data collected was not supported by medical records and it was felt that recall bias 
was a strong limitation to the data. 
 
5.3.2.3 Score Analysis; Statistical Approach 
 
 
Demographic data for the cases and controls is presented as frequencies (percentages) for the 
childhood infection and as medians, and as medians (interquartile range (IQR)) and mean 
(standard deviation (SD)) for the environmental exposure variables (environmental risk factors). 
The score analysis was conducted for the environmental exposures over the three age intervals 
using logistics regression. The three age intervals were between 0 to 18 years (0-5 years, 6-10 
years and 11-18 years) for environmental exposures. The logistics regression was also used to 
conduct the score analysis for the frequency of childhood infections between ages 0 to 20 years 
old. 
5.4 Results 
 
 
5.4.1 Score analysis for environmental risk factors during the 3 age intervals 
 
 
The results of the score analysis evaluating environmental risk factor exposure in 3 age groups (0-
5 years, 6-10 years and 11-18 years) are shown in Table 15. In this model, all exposures were 
equal to the value of one, thus the total possible score was 14, given that there were 14 variables 
(Table 12). 
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0-5 years 
 
 
During the age interval 0-5 years, the mean and median scores for the case and control group were 
[4.39 (SD ± 1.93) vs 4.71 (SD ± 1.98); and 4.0 (IQR 3.0-5.0) vs 4.0 (IQR 3.0-6.0)], respectively. 
Both groups had a minimum score of zero, whereas cases had a maximum score of 10 and controls 
had a maximum score of 12. There was no significant difference in the exposure scores between 
the case and control groups (OR = 0.92; 95% CI, 0.83-1.02). 
 
 
6-10 years 
 
 
During the age interval 6-10 years, the mean and median scores for the case and control group 
were [4.39 (SD ± 1.80) vs 4.60 (SD ± 1.92); and 4.0 (IQR 3.0-6.0) vs 4.0 (IQR 3.0-6.0)], 
respectively. Both groups had a minimum score of zero, whereas cases had a maximum score of 
9 and controls had a maximum score of 11. There was no significant difference in the exposure 
scores between the case and control groups (OR = 0.94; 95% CI, 0.80-1.02). 
 
11-18 years 
 
 
During the age interval 11-18 years, the mean and median scores for the case and control group 
were [3.77 (SD ± 1.54) vs 4.02 (SD ± 1.65); and 4.0 (IQR 3.0-5.0) vs 4.0 (IQR 3.0-5.0)], 
respectively. The minimum and maximum scores for cases were 0 and 9, respectively, whereas 
the minimum and maximum scores for controls were 1 and 9, respectively. There was no 
significant difference in the exposure scores between the case and control groups (OR = 0.90; 
95% CI, 0.80-1.02). 
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5.4.2 Score Analysis for Environmental Risk Factors during the three Age Intervals: Group 
A and B 
 
 
5.4.2.1 Group A 
 
 
The results of the score analysis evaluating environmental risk factor exposure in 3 age groups 
(0-5 years, 6-10 years and 11-18 years) for Group A are shown in Table 16. 
 
0-5 years 
 
 
During the age interval 0-5 years, the mean and median scores for the case and control group were 
[2.08 (SD ± 0.98) vs 3.58 (SD ± 1.12); and 1.99 (IQR 1.33-2.66) vs 2.16 (IQR 1.66-3.16)], 
respectively. Both groups had a minimum score of zero, whereas cases had a maximum score of 
5.16 and controls had a maximum score of 6.46. The maximum possible score for Group A   was 
8. There was a significant difference in exposure scores between the case and control groups (OR  
= 0.74; 95% CI, 0.62-0.92), thus indicating that cases had 26% less exposure during this age 
interval when compared to the controls. 
 
 
6-10 years 
 
 
During the age interval 6-10 years, the mean and median scores for the case and control group 
were [1.30 (SD ± 0.79) vs 1.64 (SD ± 1.03); and 1.50 (IQR 0.5-2.0) vs 1.50 (IQR 1.0-2.5)], 
respectively. Both groups had a minimum score of zero, whereas cases had a maximum score of 
3.5 and controls had a maximum score of 6. There was a significant difference in exposure scores 
between the case and control groups (OR = 0.67; 95% CI, 0.53-0.83), thus indicating that cases 
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had 33% less exposure during this age interval when compared to the controls. 
 
 
11-18 years 
 
 
During the age interval 11-18 years, the mean and median scores for the case and control group 
were [1.81 (SD ± 0.85) vs 2.08 (SD ± 0.98); and 1.66 (IQR 1.16-2.33) vs 1.83(IQR 1.33-2.08)], 
respectively. The minimum and maximum scores for cases were 0 and 4.66, respectively, whereas 
the minimum and maximum scores for controls were 0.33 and 5.16, respectively. There was a 
significant difference in exposure scores between the case and control groups (OR = 0.72; 95% 
CI, 0.58-0.90), thus indicating that cases had 28% less exposure during this age interval when 
compared to the controls. 
 
5.4.2.2 Group B 
 
 
The results of the score analysis evaluating environmental risk factor exposure in 3 age groups 
(0-5 years, 6-10 years and 11-18 years) for Group B are shown in Table 17. 
 
0-5 years 
 
 
During the age interval 0-5 years, the mean and median scores for the case and control group were 
[1.20 (SD ± 0.63) vs 1.47 (SD ± 0.77); and 1.10 (IQR 0.73-1.60) vs 1.38 (IQR 0.85-1.98)], 
respectively. Both groups had a minimum score of zero, whereas cases had a maximum score of 
3.13 and controls had a maximum score of 3.93. The maximum possible score for Group B was  
5. There was a significant difference in exposure scores between the case and control groups (OR 
= 0.72; 95% CI, 0.58-0.90), thus indicating that cases had 42% less exposure during this age 
interval when compared to the controls. 
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6-10 years 
 
 
During the age interval 6-10 years, the mean and median scores for the case and control group 
were [1.22 (SD ± 0.60) vs 1.33 (SD ± 0.78); and 1.19 (IQR 0.73-1.60) vs 1.33 (IQR 0.81-1.98)], 
respectively. Both groups had a minimum score of zero, whereas cases had a maximum score of 
3.06 and controls had a maximum score of 4.26. There was a significant difference in exposure 
scores between the case and control groups (OR = 0.58; 95% CI, 0.43-0.78), thus indicating that 
cases had 42% less exposure during this age interval when compared to the controls. 
 
 
11-18 years 
 
 
During the age interval 11-18 years, the mean and median scores for the case and control group 
were [1.08 (SD ± 0.60) vs 1.31 (SD ± 0.71); and 0.93 (IQR 0.64-1.41) vs 1.19(IQR 0.73-1.80)], 
respectively. The minimum and maximum scores for cases were 0 and 3.13, respectively, whereas 
the minimum and maximum scores for controls were 0.2 and 3.63, respectively. There was a 
significant difference in exposure scores between the case and control groups (OR = 0.59; 95% 
CI, 0.43-0.79), thus indicating that cases had 41% less exposure during this age interval when 
compared to the controls. 
 
5.4.3 Frequency of childhood infections between ages of 0-20 years 
 
 
The results of the multiple logistic regression analysis evaluating frequency of infections before 
the age of 20 years are shown in Table 18. On multiple logistic regression analysis, subjects who 
never had tooth decay/cavity (OR = 1.78; 95% CI, 1.05-3.04), periodontitis (OR = 1.95; 95% CI, 
1.10, 3.48), diarrhoea (OR = 2.71; 95% CI, 1.62-4.62), gastritis (OR = 2.13; 95% CI, 1.30-3.35), 
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or mouth ulcers (OR = 2.02; 95% CI, 1.12-3.70), at least once per year or more, were at an 
increased risk for later development of CD, when compared to those who were exposed to these 
infections at least once per year or more. 
 
 
5.4.4 Score Analysis for the Frequency of Childhood Infections; 0-20 years 
 
 
The results of the score analysis evaluating childhood infections during the age interval 0-20 
years, is shown in Table 19. The mean and median scores for the case and control group were 
[6.43(SD ± 1.54) vs 7.54 (SD ± 3.26); and 7.0 (IQR 4.8-8.3) vs 8.0 (IQR 6.0-10.0)], respectively. 
Both groups had a minimum score of zero, as well as a maximum score of 12. The total possible 
score for this analysis was 12. There was a significant difference in exposure scores between the 
case and control groups (OR = 0.88; 95% CI, 0.82-0.94), thus indicating that cases had 12% less 
exposure to childhood infections from birth until the age of 20 years, when compared to the 
controls. 
 
 
 
5.5 Discussion 
 
 
The enteric flora is comprised of numerous microorganisms and the history of CD is “paved with” 
publications hypothesizing specific infectious agents behind the aetiology of CD. However the 
majority of studies have only focused on select environmental exposures during childhood, 
without accounting for the numerous potential confounding interactions which may compromise 
the true validity of what is being measured. Using a subset of previously collected data, the present 
study conducted a both a post-hoc score analysis, as well as a primary score analysis in an attempt 
to investigate the latter hypothesis, together with the paradigm of the hygiene hypothesis. 
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Results of the score analysis for the environmental exposures during 3 age intervals (0-5, 6-10 
and 11-18 years) revealed no significant difference between the case and control groups (Table 
15). Notably, all exposure variables were equal to a value of one, thus frequency of exposure was 
based on the individual effect of each variable. By contrast, a significant difference was observed 
during all 3 age intervals between the case and control groups, within both Group A and Group 
B, with cases having significantly lower exposure scores (approximately 30% and 40% lower, 
respectively), when compared with that of controls. These findings are in support of the hygiene 
hypothesis, and implicate the complex role in which multiple microbial-based environmental 
exposures function in the development of the intestinal immune system. The latter is further 
supported by the change in both the mean values and CIs observed between Group A and Group 
B, in that, during all 3 age intervals, the difference in mean values between the cases and controls 
in Group A, is consistently higher compared to the difference in mean values for cases and controls 
in Group B, as well as that smaller CIs are consistently observed for Group A, when compared 
with Group B, during all 3 age intervals. 
 
In the present study, subjects who did not experience tooth decay, periodontitis, diarrhoea, 
gastritis, or mouth ulcers, at least once per year or more prior to the age of 20, were significantly 
more likely to develop CD. However, these findings do not necessarily indicate that the latter 
factors trigger CD, but rather, that the dysbacteriosis which these conditions are likely to induce, 
plays a role in the pathogenesis of CD. It is possible that these results indicate specific 
microorganisms, but this could not be investigated. In the present study, antibiotic pill use was not 
associated with risk for future CD development. This is at odds with previous studies which have 
shown early antibiotic use in children to confer an increased risk for CD development (Kronman 
MP et al. 2012; Shaw SY et al. 2010), as well as that the strongest risk may be conferred by 
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several antibiotic courses, suggesting a dose-dependent effect (Virta L et al. 2012; Hviid A et al. 
2011). Furthermore, antibiotics used within the two to five years prior to CD diagnosis were 
associated with increasing risk of disease by 1.3-fold (Shaw SY et al. 2010; Card T et al. 2004).  
 
One possible explanation for the present findings is the broad age interval (0-20 years) in which 
antibiotic use was evaluated; in addition, antibiotic use was self-reported and not confirmed by 
medical records: it is thus subject to recall bias. Nevertheless, results of the score analysis suggest 
that cases experienced significantly fewer childhood infections (12%) when compared to controls. 
In the latter score analysis, all exposure variables were assigned a weighting value equal to one; 
it is possible that these positive results reflect the broader age  range evaluated as a result of having 
combining the original data sets (0-12 years and 12-20 years). 
 
Findings from the score analysis performed in the present study provide insight into the 
‘compound’ effects from environmental risk factors in the pathogenesis of CD. This has important 
implications for future IBD-related studies as it demonstrates the importance of accounting for 
environment as a ‘whole’ during epidemiological research, as opposed to the impact of individual 
factors. Indeed, it is likely that certain environmental risk factors may hold a greater ‘weight’ with 
regard to their effect on the gut microbiota in disease pathogenesis, together with timing of 
exposure. 
 
Another important caveat underlying the development of the gut microbiome is CD susceptibility 
mutations. While it is recognized that the gut microbiome is profoundly shaped by the microbial 
environment, there is now evidence that the converse is also true. For instance, it has been shown 
that the intricate array of PPRs, including the VDR, which equip the immune system to recognize 
microbial molecular patterns, have an impressive effect on both the diversity and functionality of 
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the gut microbiota (Cantorna MG et al 2014; Ooi JH et al 2013) Therefore, genetic alterations in 
these PPRs may influence this bidirectional interaction, in which immune activity can either 
suppress or promote pathogenic microbial blooms, in turn, affecting homeostasis of host intestinal 
immunity and the convergence of disease susceptibility. The NOD-like or nucleotide 
oligomerization domain receptors (encoded by NOD2 gene) is a pattern recognition receptor 
(PRR) that recognizes intracellular bacterial products and variants in the CARD15/NOD2/IBD1 
locus are associated with the development and phenotypic patterns of CD. The likelihood of a 
NOD2-dysregulating microbial community in immune-mediated disorders, such as CD is 
strengthened by data from recent NOD2-/- mice, in which unregulated inflammation of the gut 
results taxonomic shifts in bacterial phyla characteristic of the change in the microbiome during 
inflammation, and similar to those described in IBD patients compared with healthy controls.
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Tables Referred to in Chapter 5: 
 
The following tables from this chapter are represented: 
 
 
 
Table 12: Environmental risk factors over three age intervals; 0-5 years, 6-10 years and 11-
18 years (Basson A. 2014) 
Table 13: Score analysis for group A 
 
Table 14: Score analysis for group B 
 
Table 15: Score analysis for environmental risk factors over three age intervals 
 
Table 16: Score analysis for environmental risk factors over three age intervals for group A 
Table 17: Score analysis for environmental risk factors over three age intervals for group B 
Table 18: Frequency of childhood infections between ages of 0-20 years 
Table 19: Score analysis for the frequency of childhood infection between ages 0-20 years 
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Table 12: Environmental risk factors over three age intervals; 0-5 years, 6-10 years and 11-18 years (Basson A, 2014) 
 
 0-5 years 6-
10 
yea
rs 
11-18 years 
 Cases n 
(%) 
Control n 
(%) 
Adjusted 
OR (95% 
CI)* 
Cases 
n (%) 
Control 
n (%) 
Adjusted 
OR (95% 
CI)* 
Cases n 
(%) 
Control 
n (%) 
Adjusted OR 
(95% CI)* 
Primary source of drinking water          
Piped or bottled water 162 (84) 172 (80) 2.10 (1.20, 
4.00) 
171 (88) 183 (86) 2.05 (1.10, 
4.10) 
94 (194) 194 (91) 1.92 (0.80, 4.60) 
Outside tap/borehole/well/river/dam 31 (16) 42 (20)  23 (12) 31 (14)  6 (19) 19 (9)  
Hot piped tap water          
Access 59 (32) 85 (40) 1.18 (0.71, 
2.00) 
77 (40) 99 (46) 1.52 (0.92, 
2.54) 
112 (58) 129 (60) 1.52 (0.93, 2.51) 
No access 128 (68) 127 (60)  116 (60) 114 (54)  82 (42) 85 (40)  
Community type          
Suburban or Urban 136 (76) 146 (72) 1.21 (0.71, 
2.10) 
147 (80) 156 (74) 1.58 (0.91, 
2.76) 
152 (80) 168 (80) 0.97 (0.55, 1.70) 
Rural or farm or informal settlement 43 (24) 58 (28)  36 (20) 54 (26)  38 (20) 42 (20)  
Total number of people in household          
5 or less 77 (41) 123 (59) 0.68 (0.43, 
1.09) 
79 (41) 130 (62) 0.67 (0.42, 
1.06) 
100 (52) 129 (61) 1.05 (0.66, 1.69) 
6 or more 111 (59) 86 (41)  113 (59) 81 (38)  94 (48) 82 (39)  
Number of people sharing a 
bathroom 
         
3 or less 31 (17) 59 (29) 0.55 (0.31, 
0.97) 
27 (15) 62 (30) 0.51 (0.28, 
0.90) 
36 (19) 65 (31) 0.65 (0.38, 1.11) 
4 or more 151 (83) 147 (71)  159 (85) 146 (70)  157 (81) 147 (69)  
Number of bedrooms in home          
3 or more 82 (44) 110 (52) 0.87 (0.69, 
1.11) 
87 (46) 116 (55) 0.87 (0.69, 
1.10) 
110 (57) 131 (61) 0.91 (0.72, 1.14) 
2 or less 104 (56) 101 (48)  102 (54) 94 (45)  83 (43) 83 (39)  
Type of toilet facility          
Flush (own family or shared) 154 (81) 187 (89) 1.35 (0.69, 
2.63) 
166 (86) 190 (90) 1.62 (0.78, 
3.38) 
180 (94) 203 (95) 1.76 (0.60, 5.08) 
Bucket, pit latrine, no facility 36 (19) 24 (11)  26 (14) 21 (10)  11 (6) 10 (5)  
Household pets          
No 95 (51) 81 (39) 1.47 (0.92, 
2.34) 
91 (48) 96 (45) 1.13 (0.71, 
1.79) 
88 (46) 102 (48) 1.01 (0.64, 1.59) 
Yes 93 (49) 126 (61)  100 (52) 116 (55)  103 (54) 112 (52)  
Donkey/horse/cow/sheep on property          
No 172 (90) 179 (85) 1.67 (0.83, 
3.45) 
178 (94) 179 (84) 3.10 (1.42, 
7.21) 
187 (97) 199 (93) 4.31 (1.36, 16.14) 
Yes 19 (10) 32 (15)  12 (6) 34 (16)  5 (3) 15 (7)  
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Table 12 (continued) Environmental risk factors over three age intervals; 0-5 years, 6-10 years and 11-18 years 
 0-5 years 6-10 
years 
11-18 years 
 Cases n (%) Control 
n (%) 
Adjusted OR 
(95% CI)* 
Cases 
n (%) 
Control 
n (%) 
Adjusted OR 
(95% CI)* 
Cases 
n (%) 
Control 
n (%) 
Adjusted OR 
(95% CI)* 
Cigarette smoke exposure          
Yes 145 (78) 150 (71) 1.71 (1.01, 2.94) 149 (78) 158 (74) 1.63 (0.95, 2.83) 155 (80) 149 (70) 2.03 (1.20, 3.48) 
No 42 (22) 60 (29)  42 (22) 55 (26)  39 (20) 65 (30)  
Unpasteurized milk consumption          
Never 169 (96) 139 (78) 8.02 (3.19, 23.28) 169 (93) 149 (73) 6.43 (3.02, 14.81) 178 (93) 179 (85) 2.69 (1.23, 6.17) 
Once per year or more 7 (4) 39 (22)  12 (7) 54 (27)  13 (7) 32 (15)  
Raw beef consumption          
Never 164 (95) 163 (86) 2.84 (1.17, 7.56) 171 (92) 173 (85) 2.31 (1.00, 5.80) 174 (92) 184 (86) 1.48 (0.69,3.29) 
Once per year or more 9 (5) 27 (14)  11 (96) 29 (15)  15 (8) 29 (14)  
Helminth infection          
No 82 (52) 107 (56) 0.87 (0.53, 1.42) 104 (58) 125 (63) 0.85 (0.53, 1.37) 166 (88) 171 (81) 1.90 (1.00, 3.71) 
Yes 77 (48) 84 (44)  74 (42) 75 (38)  23 (12) 40 (19)  
Treatment for helminths          
No 72 (48) 88 (47) 0.99 (0.60, 1.63) 98 (57) 105 (53) 1.17 (0.73, 1.89) 152 (82) 155 (74) 1.70 (0.95, 2.97) 
Yes 79 (52) 98 (53)  74 (43) 95 (48)  33 (18) 55 (26)  
*OR odds ratio adjusted for age at study enrolment, ethnicity and gender, and 95% confidence interval. 
Subjects who responded ‘do not know’ were excluded from analysis 
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Table 13: Score analysis for group A 
 
 
Environmental Risk Factor Combination Score for each 
factor 
Total score 
for category 
Source of drinking water (Not piped) + Hot water 
source (No access) 
½+½ 1 
Number of people in home (Less than 3) + Number of 
bedrooms in home (3 or more) + pets in home 
 
1/3+1/3+1/3 
 
1 
Number of people sharing a bathroom (Less than  3) 
+ Type of toilet facility (Bucket, pit latrine or no 
facility) 
 
½+½ 
 
1 
Raw beef consumption (once per year or more)  
1 
 
1 
Unpasteurized milk consumption (once per year or 
more) 
 
1 
 
1 
Helminth infection (not exposed) + Treatment for 
helminths 
½+½ 1 
Community type + Donkey/horse/sheep/cow on 
property 
 
½+½ 
 
1 
Passive Cigarette smoke exposure (exposure) 1 1 
Total Possible Score 8 8 
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Table 14: Score analysis for group B 
 
 
 
Environmental Risk Factor Combination Score for each 
factor 
Total score for 
category 
Source of drinking water (Not piped) + Hot 
water (No access) + Raw beef consumption 
(once per year or more) 
 
 
1/3+1/3+1/3 
 
 
1 
Number of people in a home (Less than 3) + 
Number of bedrooms in a home (3 or more) + 
Number of people sharing a bathroom (Less 
than 3) + Type of toilet facility (Bucket, pit 
latrine or no facility) + pets in home 
 
 
 
1/5+1/5+1/5+1/5+1/5 
 
 
 
1 
Community type (Suburban or Urban) + 
Donkey/horse/sheep/cow living  permanently 
on property (no exposure) + Helminth infection 
(no exposure) + treatment for helminths 
 
 
¼+¼+¼+¼ 
 
 
1 
Unpasteurized milk consumption (once  per 
year or more) 
1 1 
Passive Cigarette smoke exposure (exposure) 1 1 
Total Possible Score 5 5 
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Table 15: Score analysis for environmental risk factors during the 3 age intervals 
 
0-5 Age group 
 Cases Control Overall OR (95% CI) 
Mean 4.39 4.71 4.56  
 
0.92 (0.83, 1.02) 
Median, IQR 4 (3.0,5.0) 4 (3.0,6.0) 4 (3.0, 6.0) 
SD 1.93 1.98 1.96 
Min 0 0 0 
Max 10 12 12 
 
6-10 Age group 
 Cases Control Overall OR (95% CI) 
Mean 4.39 4.6 4.5  
 
0.94 (0.80, 1.02) 
Median, IQR 4 (3.0, 6.0) 4 (3.0, 6.0) 4 (3.0, 6.0) 
SD 1.80 1.92 1.86 
Min 0 0 0 
Max 9 11 11 
 
11-18 Age group 
 Cases Control Overall OR (95% CI) 
Mean 3.77 4.02 3.90  
 
0.90 (0.80, 1.02) 
Median, IQR 4 (3.0, 5.0) 4 (3.0, 5.0) 4 (3.0, 5.0) 
SD 1.54 1.65 1.60 
Min 0 1 0 
Max 9 9 9 
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Table 16: Score analysis for environmental exposures during 3 age intervals; Group A 
 
 
0-5 years 
 Cases Control Overall OR (95% CI) 
Mean 2.08 3.58 3.40  
 
0.74 (0.62, 0.90) 
Median, IQR 1.99 (1.33, 2.66) 2.16 (1.66, 3.16) 2.16 (1.49, 2.83) 
SD 0.98 1.12 1.07 
Min 0 0 0 
Max 5.16 6.49 6.49 
 
6-10 years 
 Cases Control Overall OR (95% CI) 
Mean 1.30 1.64 1.48  
 
0.67 (0.53, 0.83) 
Median, IQR 1.5 (0.5, 2.0) 1.5 (1.0, 2.5) 1.5  (0.5, 2.0) 
SD 0.79 1.03 0.94 
Min 0 0 0 
Max 3.5 6 6 
 
11-18 years 
 Cases Control Overall OR (95% CI) 
Mean 1.81 2.08 1.95  
 
0.72 (0.58, 0.90) 
Median, IQR 1.66 (1.16, 2.33) 1.83 (1.33, 2.08) 1.83 (1.33, 2.49) 
SD 0.85 0.98 0.93 
Min 0 0.33 0 
Max 4.66 5.16 5.16 
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Table 17: Score analysis for environmental exposures during 3 age intervals; Group B 
 
 
0-5 years 
 Cases Control Overall OR (95% CI) 
Mean 1.20 1.47 1.34  
 
0.58 (0.43, 0.77) 
Median, IQR 1.10 (0.73, 1.6) 1.38 (0.85, 1.98) 1.22 (0.8, 1.78) 
SD 0.63 0.77 0.72 
Min 0 0 0 
Max 3.13 3.93 3.93 
 
6-10 years 
 Cases Control Overall OR (95% CI) 
Mean 1.22 1.48 1.36  
 
0.58 (0.43, 0.78) 
Median, IQR 1.19 (0.73, 1.60) 1.33 (0.81, 1.98) 1.23 (0.76, 1.8) 
SD 0.6 0.78 0.71 
Min 0 0 0 
Max 3.06 4.26 4.26 
 
11-18 years 
 Cases Control Overall OR (95% CI) 
Mean 1.08 1.31 1.21  
 
0.59 (0.43, 0.79) 
Median, IQR 0.93 (0.64, 1.41) 1.19 (0.73, 1.8) 0.98 (0.73, 1.65) 
SD 0.60 0.71 0.67 
Min 0 0.2 0 
Max 3.13 3.63 3.68 
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Table 18: Frequency of childhood infections before the age of 20 years 
 
 
 
 Cases 
n (%) 
Controls 
n (%) 
 
OR (95% CI)* 
Tooth decay/cavity 
Never 51 (29) 73 (37) 1.78 (1.05, 3.04) 
Once per year or more 127 (71) 126 (63)  
Periodontitis 
Never 114 (68) 157 (81) 1.95 (1.10, 3.48) 
Once per year or more 54 (32) 38 (19)  
Sore Throat 
Never 45 (25) 43 (20) 1.26 (0.70, 2.27) 
Once per year or more 138 (75) 167 (80)  
Respiratory infection 
Never 88 (51) 123 (62) 1.20 (0.74, 1.94) 
Once per year or more 84 (49) 75 (38)  
Diarrhoea 
Never 56 (31) 91 (44) 2.71 (1.62, 4.62) 
Once per year or more 123 (69) 115 (56)  
Gastritis 
Never 72 (40) 103 (51) 2.13 (1.30, 3.35) 
Once per year or more 106 (60) 98 (49)  
Mouth ulcers 
Never 126 (81) 173 (79) 2.02 (1.12, 3.70) 
Once per year or more 29 (19) 46 (21)  
Perianal Disease 
Never 163 (92) 200 (98.5) 9.08 (2.66, 42.31) 
Once per year or more 14 (8) 3 (1.5)  
Arthritis/Arthralgia 
Never 158 (88) 201 (98) 6.89 (2.32, 25.64) 
Once per year or more 21 (12) 4 (2)  
Eye Disease 
Never 163 (93) 187 (94) 1.22 (0.47, 3.15) 
Once per year or more 12 (7) 12 (6)  
Antibiotic pills 
Never 93 (55) 108 (54) 1.45 (0.88, 2.41) 
Once per year or more 76 (45) 93 (46)  
Probiotics use after antibiotic pills 
Never 132 (89) 154 (90) 1.28 (0.56, 2.91) 
Once per year or more 16 (11) 17 (10)  
*Adjusted for gender and ethnicity. 
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Table 19: Score analysis for the frequency of childhood infection between ages 0-20 years 
 
 
 
 Cases Control Overall OR (95% CI) 
Mean 6.43 7.54 7.01  
 
0.88 (0.82, 0.94) 
Median, IQR 7 (4.8, 8.3) 8 (6.0, 10,0) 7 (5.0, 9.0) 
SD 1.54 3.26 2.67 
Min 0 0 0 
Max 12 12 12 
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APPENDIX I 
 
Title of Project 
 
The association between serum pro-inflammatory cytokines with 25(OH)-Vitamin D 
concentrations in Crohn’s disease patients in the Western Cape, South Africa 
 
 
THE PROTOCOL: Clinical 
 
 
 
Background and Literature 
 
Crohn’s disease (CD) is a subtype of inflammatory bowel disease (IBD) characterized by a 
pronounced inflammation of the intestinal lining due to a deregulated immune response against 
antigenic stimulation that occurs in genetically predisposed individuals. The abnormal immune 
profile is characterized by an up-regulation of the type 1 T helper (Th1) cell, down-regulation of 
the type 2 T helper (Th2) cell and a deregulated type 17 T helper (Th17) cell immune-response 
(Basson A. 2014). This deregulation leads to an increased production of pro-inflammatory 
cytokines, tumour necrosis factor alpha (TNFα) and interferon gamma (INF-γ), which directly 
contribute to damage to the intestinal mucosa (Cantorna et al. 2004). Vitamin D is a steroid-like 
hormone that is metabolized in the body from 25-hydroxy vitamin D (25[OH]D), the major 
circulating form, to ‘1,25-hydroxy vitamin D’ [1,25(OH)₂D₃ or 1,25(OH)₂D], the bioactive forms, 
both of which perform a number of biological functions in the body via their genomic actions on 
the vitamin D receptor (VDR) (Cantorna et al. 2010). It is well known that vitamin D plays a 
significant role in bone health and up to 70% CD patient will experience a vitamin D deficiency 
at some point during the disease course (Basson et al. 2014). Recently however accumulating 
evidence suggests that the vitamin also plays a crucial role in the regulation of the general immune 
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system (Basson et al. 2014). The bioactive form of vitamin D regulates the functional 
differentiation of CD4+ T cells, as well as the differentiation of monocytes into macrophages. In 
vitro 1,25(OH)₂D has been shown to down-regulate the production of Th-1 associated pro-
inflammatory cytokines such as INF-γ and interleukin-2   (IL-2 produced by CD 4+ cells, 
(Cantorna and Mahon. 2004). In experimental IBD VDR knock out (KO) mice, meaning that 
vitamin D signalling was inhibited developed an accelerated form of IBD. An increase in the 
production of pro-inflammatory Th-1 response associated cytokine INF- γ and a subsequent 
decrease in the production of the anti-inflammatory Th-2 response cytokines interleukin-4 (IL-4) 
and interleukin-5 (IL-5) was observed in the KO mice, when compared to  the wild type mice 
(Cantorna et al. 2004). Similar findings were observed in interleukin-10 (IL-10) KO mice. IL-10 
is an anti-inflammatory cytokine produced by the Th-2 cells which has an inhibitory effect on Th-
1 cell mechanism. IL-10 KO mice develop IBD within 5-6 weeks exhibiting severe symptoms of 
enterocolitis and a 30% mortality rate. However, upon administration of 1,25(OH)₂D₃, the mice 
exhibited a drastic reduction of the inflammation, an improvement on the IBD symptoms and a 
decreased mortality rate (Garg et al. 2012). In humans a number of studies have found a significant 
association between low serum 25(OH)-vitamin D with increased disease activity (Joseph et al. 
2009; Grzanka et al. 2014; Javorsky et al. 2006). However there is limited data evaluating the 
association between pro-inflammatory cytokine levels and serum vitamin D in the CD patient. 
Aims and Objectives 
Aim 
The aim of this study is thus to evaluate the association between serum 25(OH)D concentration 
with 3 pro-inflammatory cytokines TNFα, IFNγ and IL-2 and their association with 25(OH)D 
concentrations in CD patients in the Western Cape, South Africa. 
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Primary Objectives 
 
To evaluate the association between serum 25(OH)-vitamin D concentrations with serum TNF-α 
concentrations 
To evaluate the association between serum 25(OH)-vitamin D concentrations with serum IL-2 
concentrations 
To evaluate the association between serum 25(OH)-vitamin D concentrations with serum IFN-γ 
concentrations 
Secondary Objectives 
 
To evaluate the association between serum 25(OH)-vitamin D concentrations with serum CRP 
concentrations 
To compare serum 25(OH)-vitamin D and cytokine concentrations in CD patients with healthy 
controls 
 
 
To evaluate if vitamin D deficiency is independently associated with; disease duration, body mass 
index (BMI), oral contraceptive use, smoking, medication use (immunosuppressants, biologics, 
corticosteroids), surgical resection, season of study enrolment and ethnicity 
 
Hypothesis to be tested 
Hypothesis 1: Lower serum 25(OH)-vitamin D concentration is associated with higher serum 
cytokine levels. 
 
Hypothesis 2: The former hypothesis will remain significant after adjusting for any significant 
independent predictors of vitamin D deficiency. 
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Summary of the Proposed Project 
 
The proposed research will use a subset of data collected from a larger case control study 
supervised by Dr. Gillian Watermeyer. Briefly, 186 CD patients and 199 healthy controls between 
the ages of 18-67 currently residing in the Western Cape were recruited. At time of study 
enrolment, demographic and clinical variables were extracted using an investigator administered 
questionnaire, a review of medical and pharmacy records and clinical examination by a consulting 
gastroenterologist. In addition, blood samples were collected. The investigators of the original 
project have granted permission for the current investigator to use a subset of the data for the 
proposed project. Analysis of 25(OH)-vitamin concentrations has been performed. The 
investigator will further analyse the serum samples for the proposed inflammatory markers, as 
well as investigate independent factors related to low serum 25(OH)D. 
 
 
Benefits of the study 
 
 
 
This research is not designed to explore the aetiology of CD and to help the principal researcher 
and gastrointestinal academic community understand more about the pathogenesis of CD in 
relation to vitamin D within the defined population. Outcomes from this study will add insight 
into the understanding of inflammatory bowel disease worldwide. In addition, the relapse- 
remitting nature of the disease is such that it demands expensive medications which often have 
many undesirable side effects and negatively impact the patients’ quality of life. Therefore 
exploring the role of vitamin D in the pathogenesis of CD is of paramount importance. 
 
 
Institutions where project would occur 
 
Groote Schuur Hospital (GSH) / Tygerberg Hospital (TBH) / University of Western 
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Cape (UWC). 
 
 
Definition of existing resources 
 
As per the original research, consecutive CD patients seen at GSH and TBH gastrointestinal 
clinics during normally scheduled appointments between September 2011 and January 2013 were 
recruited. Subjects with active disease, or inactive CD (i.e., ‘remission’) were included. The 
diagnosis of CD was defined according to the European consensus guidelines set out by the 
European Crohn’s and Colitis Organization (ECCO) (Stange, Travis et al. 2006). 
All participants provided written informed consent. Permission from the principal investigator of 
the original research project has been given allowing the use of a subset of the original data. The 
objectives of the current proposal are separate from those of the original research; however do fall 
under proposed outcomes of the original study. The outcome of the present proposal was included  
in  the  participant  consent  form  and  does  not  require  further  retrospective   ethical approval. 
The researcher has been granted access to UWC laboratory within the Medical Biosciences 
department for blood sample analysis. In addition, the Medical Biosciences department makes 
provision for desk space and computer use for all postgraduate students. Due to funding 
limitations, for the proposed research 160 patients and 120 controls will be included. 
 
 
Overview of available data from original research 
 
Complete data relating to disease characteristics, vitamin D supplementation and medication use 
for the subjects is available. This data has been cleaned and coded. Supplemental vitamin D is 
prescribed by GSH and TBH gastrointestinal clinics as weekly dose units of 50,000 IU calciferol 
for 8 weeks. Information on medical management included the recent or current use of; 
corticosteroids, immunomodulators (azathioprine, 6-mercaptopurine, methotrexate), anti-tumour 
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necrosis factor inhibitors (infliximab, adalimuamab), or 5-aminosalicylates. Seasonal variation at 
study enrolment was categorized as either “summer” or “winter”, and based on the average 
Ultraviolet Index (UVI) for Cape Town, South Africa (latitude 34ºS) (World Health 
Organization). The ‘summer months’ included September through March (UVI; 6-10) and ‘winter 
months’ included April through August (UVI; 2-5). Body mass index (BMI) was calculated as 
weight/height in meters squared; values >25 kg/m² were classified as overweight. 
 
 
Patients with a prior diagnosis of tuberculosis, kidney disease and liver disease were excluded. 
Only patients with complete data at diagnosis were included. Patients were excluded if disease 
duration was less than 5 years, or had a prior diagnosis of intestinal tuberculosis. In accordance 
with the paper published by Epstein et al.  2007 there is no gold standard in the differential 
diagnosis between CD and intestinal tuberculosis however as per the algorithm suggested by these 
authors every attempt was made to exclude a diagnosis of tuberculosis. 
 
 
Controls 
 
One hundred and ninety nine, healthy controls unrelated to the CD cases were included and 
identified in 3 ways; namely, 1) visiting family and friends of patients admitted to the referral 
based spinal injury ward of GSH and TBH, 2) outpatients from GSH and TBH orthopaedic wards, 
and 3) porter and security personnel of GSH. Two members of the same family were not included. 
Controls were excluded if any of the following were present; prior or current diagnosis of 
tuberculosis, IBD or any other gastrointestinal illness, any immune-mediated disease, or a family 
history of IBD. 
Blood Samples 
 
For the proposed research one 2ml aliquot Micro Tube currently being stored at minus 80°Celcius 
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is available to the researcher. The samples to be used in the proposed research have not been 
previously thawed for analysis. 
Statistical Analysis 
 
The statistical analysis will be performed under the guidance of a professional statistician from 
the Medical Research Council of South Africa. 
Ethical clearance 
 
Ethical clearance was accorded by the Ethics Research committee of the University of the Western 
Cape (UWC) (Reg No.11/3/16), the Human Research Ethics Committee of the University of Cape 
Town (UCT) (HREC REF: 122/2011), the Provincial Ethics Committee of the Department of 
Health as well as both the ethics committees of GSH and TGH. The ethical clearance 
permissions were accorded annually when required. The research was conducted according to the 
guidelines for ethics on medical research as published by the Medical Research Council of South 
Africa. 
Informed Consent 
 
After full disclosure of study details, written informed consent was obtained from participants 
prior to data collection. Only participants who fully understood the consent form and the 
conditions of the study were enrolled. Participation was voluntary and participants were informed 
of their right to withdraw from the study at any time, without any consequences. In the event that 
the participant decided to withdraw and questionnaires and samples had already been collected, 
questionnaires and blood samples would be appropriately discarded. Two different versions of the 
consent forms were available, one for the cases and one for the controls. Informed consent was 
obtained from all participants. If a signed consent was not provided, no data would be collected 
and the subject would be excluded from the study. 
Participant Anonymity 
 
 
 
 
  
 
APPENDIX I 
 
 
 CHILDHOOD ENVIRONMENTAL EXPOSURE AND CROHN’S DISEASE 216 
 
 
All materials were obtained for research purposes only, and all clinical and personal data was kept 
in strict confidence and remained anonymous. Removing identifiers from questionnaires was done 
to maintain anonymity and confidentiality of the participant information. Information sharing was 
strictly limited to co-investigators only on a need-to-know basis and no sharing of was acceptable 
for medical information given by a participant or acquired from medical records with other 
participants, with relatives or any other persons. Instead of participant identifiable information, 
questionnaires were coded using a unique number serving as an identifier. Identifiable information 
of participant was only found on the front page of the questionnaire and the rest of the 
questionnaire pages only contained the participant study code. The front page of the 
questionnaire was detached from the questionnaire and kept under lock and key to maintain the 
strictest patient confidentiality. Only the principle researcher had access to patient names and 
identifier code key which was at all times kept separately from the questionnaires in a locked file 
cabinet located in a locked office and maintained with the strictest confidentiality precautions of 
the principal researcher. Coded data was entered into a password protected computer. 
 
 
Methodology 
 
From the original research: Serum 25(OH)D concentrations have been measured using the 
SIEMENS CENTAUR XP immunoassay. The method was standardized to LC/MS/MS 
and performance was monitored according to the DEQAS external quality control. 
 
 
ADVIA Centaur® XP Vitamin D Assay System 
 
Validation of an assay is a process that determines whether the assay measures what it is intended 
to measure and includes estimates of the analytical and diagnostic performance characteristics of 
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a test (ed. Wild 2005). The analytical specificity, analytical sensitivity, linearity, dilution recovery 
and interferences of an assay are the primary parameters which determine the validity of an assay. 
These parameters have been described below as per the manufacturer specifications (Basson A. 
2014). 
 
 
Analytical Specificity 
 
The analytical specificity is the ability of the assay to distinguish the target analyte from other 
closely related substances (including matrix components), and represents the degree to which the 
assay does not cross-react with other analytes (ed. Wild 2005). 
 
The analytical specificity for the ADVIA Centaur® Vitamin D Assay System was tested with total 
25(OH)-Vitamin D concentrations of 20 and 50 ng/mL, for the following structurally  similar 
compounds: 1,25(OH)₂Vitamin D₂, 1,25(OH)₂ Vitamin D₃, Paricalcitol, 3-epi-25-OH- Vitamin 
D₃, Vitamin D₂, Vitamin D₃, 25(OH)-Vitamin D₂ and  25(OH)-Vitamin D₃. 
 
 
The percent change was calculated as: 
 
Percent cross-reactivity = (corrected assay value / amount of compound spiked) x 100 
 
 
 
The results are depicted in FIGURE 2.3 (located at the end of this chapter), which indicates that 
the assay has a high specificity for 25(OH)-Vitamin D₂ (106.2%) and 25(OH)-Vitamin D₃, with 
minimal interference from structurally related substances at equimolar amounts (97.4%) [Siemens 
Healthcare Diagnostics Inc., Tarrytown, NY, USA]. 
 
 
Analytical Sensitivity 
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The analytical sensitivity of an assay is the smallest amount of the analyte that the assay is able to 
detect. The detection limit is assessed in three ways: limit of blank (LoB); limit of detection (LoD); 
and limit of quantification (LoQ) (Westgard 1999). The LoB is the highest apparent measurement 
of an analyte that is likely to be observed for a blank sample, and is typically estimated as a 95% 
one-sided confidence limit by the mean blank value, plus 1.65 times the standard deviation of the 
blank (Armbruster and Pry 2008; Westgard 1999). The LoD is the lowest concentration of analyte 
in a sample that can be reliably distinguishable from the LoB, and at which detection is possible, 
and is estimated as a 95% one-sided confidence limit by the mean of the blank, plus 1.65 times 
the standard deviation of the blank, plus 1.65 times the standard deviation of a low concentration 
sample (Armbruster and Pry 2008; Westgard 1999). The LoQ is the lowest concentration at which 
the analyte can be reliably detected but at which some predefined goals for bias and imprecision 
are met, under stated experimental conditions; the analyte concentration at which the 95% limit 
of the total error (bias plus 2 times the standard deviation) meets the required or stated goal for 
allowable error (Armbruster and Pry 2008; Westgard 1999). The ‘functional sensitivity’ of an 
assay is defined as the analyte concentration at which results in a CV are equal to 20 percent 
(Westgard 1999). While the LoQ is somewhat similar to the functional sensitivity, estimating the 
LoQ is more complicated because it is more difficult to estimate method bias. 
 
 
The LoB, LoD, and LoQ for the ADVIA Centaur® Vitamin D Assay System were determined as 
described in the CLSI document EP17-A (Clinical and Laboratory Standards Institute [formerly 
NCCLS] 2004c). The ADVIA Centaur® Vitamin D Total Assay has an LoB of 1.6 ng/mL, an 
LoD of 3.20 ng/mL and a LoQ of 3.52 ng/mL. The LoD is defined as the lowest concentration of 
25(OH)-Vitamin D that can be detected with 95% probability [Siemens Healthcare Diagnostics 
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Inc., Tarrytown, NY, USA]. 
ADVIA Centaur® XP Vitamin D assay has a functional sensitivity of 3.33 ng/mL. The functional 
sensitivity was established using multiple samples in the range of 2 to 10 ng/mL. All samples were 
assayed twice a day, in replicates of 4 over 10 days, using two lots (n = 320 for each sample) of 
ADVIA Centaur® Vitamin D Total reagents [Siemens Healthcare Diagnostics Inc., Tarrytown, 
NY, USA]. 
 
 
Linearity 
 
The linearity of an analytical method is the ability to obtain test results which are directly 
proportional to the concentration of analyte in the sample (ed. Wild 2005). For the ADVIA 
Centaur® Vitamin D Assay, linearity was evaluated according to the CLSI protocol EP6-A 
(Clinical and Laboratory Standards Institute [formerly NCCLS] 2003). A sample containing high 
concentrations of total 25(OH)-Vitamin D was mixed in various proportions with a sample 
containing low concentrations of total 25(OH)-Vitamin D. The resulting sample mixtures were 
assayed for total vitamin D. On the ADVIA Centaur® System, the vitamin D assay is linear from 
3.7 ng/mL to 150 ng/mL, with an R² value of 0.9945 [Siemens Healthcare Diagnostics Inc., 
Tarrytown, NY, USA]. 
 
 
Dilution Recovery 
 
Five serum samples in the range of 118 ng/mL to 154 ng/mL of total 25(OH)-Vitamin D were 
diluted 1: 2, with the ADVIA Centaur® Vitamin D diluent and assayed for recovery and 
parallelism. The recoveries ranged from 83% to 100% with a mean of 93.5% [Siemens Healthcare 
Diagnostics Inc., Tarrytown, NY, USA]. 
 
 
 
 
 
  
 
APPENDIX I 
 
 
 CHILDHOOD ENVIRONMENTAL EXPOSURE AND CROHN’S DISEASE 220 
 
 
Interference 
 
Using the ADVIA Centaur® Vitamin D Assay, interfering substances were tested as described in 
the CLSI Document EP7-A2 (Clinical and Laboratory Standards Institute [formerly NCCLS] 
2005). Interference was evaluated for specimens that are haemolysed, lipemic or icteric, as well 
as for specimens containing cholesterol, uric acid or human immunoglobulin. For haemolysed, 
lipemic and icteric (conjugated and unconjugated bilirubin) specimens, a ≤10% change in results 
was demonstrated for concentrations up to; 155 mg/dL of haemoglobin; 360 mg/dL of 
triglycerides; 40 mg/dL of conjugated bilirubin; and 40 mg/dL of unconjugated bilirubin, 
respectively. For samples containing cholesterol, uric acid and human immunoglobulin, a ≤10% 
change in results was demonstrated for concentrations up to: 236 mg/dL; 20 mg/dL; and 6 mg/dL, 
respectively[Siemens Healthcare Diagnostics Inc., Tarrytown, NY, USA]. 
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APPENDIX II 
FACULTY OF LIFE 
SCIENCES 
DEPARTMENT OF MEDICAL BIOSCIENCES 
 
 
DATE 
 
My name is Dr. Abigail Raffner Basson and I am a lecturer at the University of the 
Western Cape. I am writing this letter on behalf of my Masters student Mr. Victor 
Sabe who is conducting a systematic review titled ‘The Association between 
Childhood Environmental Exposures and the Subsequent Development of Crohn’s 
Disease: A Systematic Review’. The student intends to submit the completed 
manuscript for peer-review process to the Journal of PLOS ONE. 
 
The primary aim of the paper is to focus on a number of exposures during various age 
intervals during ‘childhood’. We would like to include your paper titled 
“…………………” in our review and respectfully request for you to send us further 
information pertaining to the details of your study methodology, as well as all 
statistical results which may not have been included in your final publication. We 
would also greatly appreciate it if you could inform us about any additional variables, 
relative to our systematic review topic, which may have been considered during your 
study. . 
 
We thank you very much for your help, and look forward to your response. 
 
 
Kindest Regards, 
 
Dr. Abigail Raffner Basson and Mr. Victor 
Sabe University of the Western Cape 
Medical Biosciences Department 
 
 
Dr Abigail R. Basson, R.D. (RSA/USA) 
Lecturer and Hospital Internship 
Supervisor Office Tel: +27 21 959 2159 
Email: 311599@myuwc.ac.za 
ORCID ID: orcid.org/0000-0002-8369-919X 
 
Mr Victor T. Sabe 
Postgraduate Medical Biosciences 
Student Number 3410048 
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APPENDIX IV 
UNIVERSITY OF THE WESTERN CAPE 
Private Bag X 17, Bellville 7535, South Africa 
Tel: +27 21-959 2458, Fax: 27 21-959 2679, Cel: 079 135 4543 
E-mail: abbasson@uwc.ac.za 
 
PARTICIPANT INFORMATION DOCUMENT (Cases) 
 
Project Title: 
 
Environmental risk factors and the serological immune marker prevalence associated with 
Crohn’s disease development and phenotype in the Western Cape population, South Africa. 
What is the study about? 
 
This is a research project being conducted by Mrs. Abigail Basson, a lecturer from the 
University of the Western Cape. We are inviting you to participate in this research project 
because you are currently residing in the Western Cape, between the ages of 18-70 and have 
been diagnosed with 
Crohn’s Disease between the years 1994 and 2005 inclusive, and have recently been seen by 
your gastrointestinal doctor at either Groote Schuur Hospital or Tygerberg Hospital 
Gastrointestinal clinic. 
 
Crohn’s disease causes inflammation that can affect many areas of the gut, in particular the 
small and large intestine. This is a poorly understood illness and it is unclear why some 
people are affected but not others. Because of this it is important to perform testing on 
individual population groups in defined geographical areas. 
What will I be asked to do if I agree to participate? 
 
If you agree to take part in this study you will be asked to: 
 
1. Answer a detailed questionnaire with help of a trained study interviewer 
 
2. Allow us to draw samples of your blood: This will involve having 1-2 tubes of 
blood drawn from your arm (up to 10mls, or approximately two teaspoons worth). 
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APPENDIX V 
 
WE ARE RECRUITING STUDY 
PARTICIPANTS 
We are recruiting individuals for a research 
study looking at Inflammatory Bowel 
Disease in the Western Cape, South Africa 
YOU CAN PARTICIPATE IF YOU ARE: 
Between the ages of 18-70, with NO previous medical history 
of: Tuberculosis, Crohn’s disease, Ulcerative Colitis, Irritable 
bowel Syndrome, Rheumatoid arthritis, Psoriasis, Lupus, and 
NO family history of Inflammatory Bowel Disease. 
IF YOU PARTICIPATE YOU WILL BE REQUIRED TO: 
1. Complete a questionnaire. 
2. Allow us to take a blood sample. 
 
Participation will take approximately 45 
minutes 
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APPENDIX VI 
UNIVERSITY OF THE WESTERN CAPE  
Private Bag X 17, Bellville 7535, South Africa 
Tel: +27 21-959 2458, Fax: 27 21-959 2679,Cel: 079 135 4543 
E-mail: abbasson@uwc.ac.za 
 
CONSENT FORM: ADULTS OVER 18 YEARS (Cases) 
 
Title of Research Project: Environmental risk factors and the serological immune marker 
prevalence associated with Crohn’s disease development and phenotype in the Western Cape 
population, South Africa. 
 
What does your signature on this consent form mean? 
 
 You give us permission to enrol you into this study 
 
 You give us permission to administer the study questionnaire: 
 
The questionnaire will include questions on: General 
Information, Family History, Medical and Crohn’s disease 
History, Environmental Questions, and Smoking History. 
 
 Permission for the researcher to access your 
patient records for additional medical information. 
 
 You give us permission to draw samples of your blood. This will involve having 1-2 tubes 
of blood drawn from your arm (10 mls in total). This will be performed using sterile techniques 
by a trained nurse. The risks of drawing blood from a vein (the same procedure used in all laboratories) 
may be slight pain from the needle, and possibly some mild bruising. In rare instances redness of the 
skin may occur at the site. Some individuals may faint during blood taking. 
Firmly pressing down on the site where the needle entered the skin using the index and middle 
fingers over top of a clean gauze can reduce chance of bruising. If the sight of blood makes you 
want to faint, make sure you are sitting down during the blood draw procedure and turn your 
face away while they draw the blood. Also, make sure you are 
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Participant Code: 
APPENDIX VII 
 
CONFIDENTIAL STUDY QUESTIONNAIRE 
ALL INFORMATION WILL BE KEPT STRICTLY CONFIDENTIAL, AND WILL IN NO WAY AFFECT HOSPITAL 
  TREATMENTS OR PAYMENTS  
Name of Study Interviewer: 
Name of Study Translator (If 
Applicable): Date of Interview: 
  MEDICAL CHART NUMBER:  
PARTICIPANT DETAILS 
Title: 
Initials: 
First 
Name: 
  Surname:  
Postal Address: 
Postal 
Code: 
Physical Address: 
Postal 
Code: 
PARTICIPANT EMERGENCY CONTACT DETAILS 
 
 
 
 
 
 
Daytime Telephone Number: ( ) 
Work Telephone Number: ( ) 
Cell Phone Number: ( ) 
Primary Emergency Contact Person Name:  
Relation to Participant:  
Emergency Contact Person CELL Phone: ( ) 
Emergency Contact Person HOME Phone: ( ) 
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APPENDIX VIII 
MEDICAL CHART REVIEW FORM: SECTION 1 
PARTICIPANT CODE    
 
 
PARTICIPANT DETAILS 
CHART NUMBER  
Surname Initials: 
First Name  
Date of Birth Day: Month: Year: 
Gender  
 
 
CROHN’S DISEASE MEDICAL HISTORY: AT DIAGNOSIS 
Date of Diagnosis: Day:  Month:  Year: 
Diagnosis of TB or amoebiasis (circle one):  Yes  No  
 
METHOD OF DIAGNOSIS (circle all that apply): 
Gastroscopy Colonoscopy CT scan MRI Ultrasound 
Endoscopy with 
biopsy 
Endoscopy without 
biopsy 
Double Balloon 
Enteroscopy (DBE) 
Small bowel enema 
(SBE) with biopsy 
Small bowel enema 
(SBE) without biopsy 
Other: 
 
 
DISEASE BEHAVIOR: (write name)
NAME OF CHART REVIEWER:  
TODAYS DATE:  
Participant appointment date:  
 
Height (cm): 
Weight (kg): 
DISEASE  LOCATION  :  (write name) 
(circle all that apply) 
Ileal 
(Distal Small Intestine) 
Colonic: Ileocolonic Isolated Upper Disease 
(excludes disease distal to jejunum): 
Perianal 
Comments: 
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APPENDIX IX  
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APPENDIX X 
 
 
 
 
 
 
  
 
APPENDIX XI 
 
 
 CHILDHOOD ENVIRONMENTAL EXPOSURE AND CROHN’S DISEASE 234 
 
APPENDIX XI: Studies investigating childhood environmental risk factors using defined age intervals 
Author Study Centre Study 
Design 
Data Collection Age 
Range 
Categories 
(Age) 
Subjects Control selection Variables 
Basson A Major Tertiary Population Retrospective 18-64 0-5 N=194 CD Controls: orthopaedic outpatients, Source of drinking water 
2014 health referral 
centres 
 
GSH and TBH 
based 
Case-control 
Questionnaire 
 
Interviewer 
administered 
 6-10 
11-18 
213 
controls 
hospital porters/security and family 
friends visiting spinal injury patients 
Hot piped drinking water 
Suburban /urban/Rural /farm/ informal settlement 
Number of people in household 
Number of people sharing a bathroom 
Number of bedrooms in a home 
        Type of toilet facility 
 South Africa  and medical     Household pets 
   records     Farm animals Cigarette smoke exposure 
        Unpasteurized milk consumption 
        Raw beef consumption 
        Helminth infection 
        Treatment for helminths 
        Breastfeeding 
        Day care attendance 
Gearry RB et al Canterbury Population Retrospective 20-59 0-5 N=638 CD Randomly selected from the Electoral Birth place/ geography – local/ overseas 
2009  
New Zealand 
based 
Case-control 
Questionnaire 
 
Self – 
administered 
 6-11 
12-16 
N=653 UC 
600 
controls 
Roll for Electorates corresponding 
with the Canterbury district health 
Board 
Upbringing- city/town/country 
Immunizations/medications- measles/mumps/TB 
Antibiotics >4x/year 
Operations/ medical conditions 
Household characteristics: bedroom sharing bedroom number, sibling 
       Age and sex matched controls. number, older sibling number,  number  of home inhabitants , farm 
        animal contact, pets in home, sandpit, swimming pool 
        Vegetable garden 
        Home-heating (presence of each type of heating compared with 
        absence) Wood/Coal/electricity 
        Immunizations/medications 
        Breastfeeding 
        Exposure to smoke 
Han DY et al North Island Case-control Questionnaire 5-86 0-5 N=315 CD Volunteers who responded to media Antibiotic Use: Taking 4< antibiotics in a year 
2009  
New Zealand 
cohort  
Self-reported 
 6-11 
12-15 
536controls publicity Taking regular medications 
Having pet at home 
Regularly feed pets 
   And medical     
Proportion of carpeting in the home 
Swam in public swimming pool as a child: 
   records     Lived in a house with a public swimming pool for greater than a year 
        Immunization in infancy: measles/mumps/TB 
        Had a sandpit in the garden 
        Breastfeeding in infancy: yes/no 
        Medication (regular) use 
        Birth order 
        Number of siblings 
        Early exposure to allergens and microbes 
        Exposure to smoke 
        Attending preschool 
Wurzelmann JI Membership roll Case-control Questionnaire N.S 0-5 N=322 CD Controls were the patient’s closest Place of upbringing: Rural/Small town/Suburb/City 
et al 1994 North Carolina 
 
USA 
  
Self- 
administered 
 6-11 
12-15 
N= 
262 
controls 
neighbour Childhood infections: Bacterial infections/Viral infections 
Antibiotic treatment by illness: Otitis/Pharyngitis/Tonsillitis/Colds 
Urban living relative to farm living: Rural/Small town/Suburb/City 
Breastfeeding/bottle-feeding 
        Surgical history (tonsillectomy/Appendectomy) 
        Childhood Hospitalization 
        Bedroom sharing 
        Sibship Month and season of birth 
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APPENDIX XII: Studies broadly investigating childhood environmental exposures during ‘childhood’ (0-18 years) 
Author Study Centre Study Design Data 
Collection 
Age 
Range 
Categories 
(Age) 
Subjects Control selection Variables 
Bernstein CN Manitoba Population Questionnaire 18-50 0-12 N=364 CD Controls selected from Taking regular medications 
et al 2006 Health 
Registry 
 
Canada 
based 
Case-control (multi-item) 
Self- 
  
0-5 for cat 
as a pet 
N=217 UC the Manitoba health 
population registry 
Urban/rural 
Family size 
Birth order 
Primary water source 
Appendectomy 
   administered     Breast feeding 
        Vaccination 
        Exposure to smoke 
        Ethnicity 
        Household pet (Cat) 
        Lived on a farm (Y/N) and main farm type : Cattle/Pig/Poultry 
        Primary source of water being a well/ lake/other non-tap source as a 
        child 
        Frequency of drinking unpasteurized milk as a child: Low/Medium/High 
        Frequency of eating chicken as a child: Low/Medium/High 
Castiglione F et Multi-Centre Case-control Questionnaire 18-61 CD N.S N=468 CD Controls were Helminth infection 
al 2011  
Southern Italy 
 
Prospective 
  
16-63 UC 
  
N=527 UC 
physicians, nurses and 
support service 
professionals 
Pet exposure in childhood 
Antibiotic use in childhood 
Breastfeeding 
Family size 
    18-66 
Controls 
 562 controls  
Age/sex matched 
Sibship 
Vaccinations 
Allergens 
        Urban/rural dwelling 
        Dental care history 
Duggan AE et Nottingham Case-control Questionnaire 15-65 0-11 N=110 CD Controls were surgical Childhood hygiene 
al 1998 University 
hospital 
 
United 
  
Self- 
administered 
  N=213 UC 
337 controls 
inpatients with no 
history of IBD, having 
elective surgery 
H pylori status 
Surgical history 
Antibiotic use 
Bed shared with other child: Always or sometimes/Never 
Bedroom shared with other child: Always or sometimes/Never 
 Kingdom      Sex matched controls Running hot water: Never or sometimes/Always 
        Fixed bath or shower: Sometimes or never/Always 
        Inside Toilet: Sometimes or never/Always 
        Home shared with other family: Always or sometimes/Never 
        Central heating installed: Sometimes or never/Always 
        Parents owned a car: Sometimes or never/Always 
        Nursery school attendance 
Feeney MA et District Case-control Questionnaire 16-45 0-5 N=139 CD Outpatient controls Medical History: Helicobacter pylori/ Hepatitis A lg G status 
Appendectomy/ Tonsillectomy <17 years 
Eczema/ Hay fever <10 years 
Family characteristics: Number of siblings 
Number of older siblings 
Parental smoking 
Person to room ratio in home 
Social class 
Childhood circumstances:  Hot water tap 
Number of indoor toilets 
Nursery attendance 
Using swimming pool 
Number of family cars 
Number of house moves 
Environment (urban/ rural) 
Pets in home( cat, dog, bird, rodent) 
al 2002 general     N=137 UC  
 hospital  Self-    Sex/Age matched 
   administered     
 United       
 Kingdom       
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APPENDIX XII: Studies broadly investigating childhood environmental exposures during ‘childhood’ (0-18 years) 
Author Study Centre Study Design Data 
Collection 
Age 
Range 
Categories 
(Age) 
Subjects Control selection Variables 
Hampe J et al 
2003 
German 
Crohn’s and 
Colitis 
foundation 
 
Germany 
Population 
based 
Case-control 
Double blinded 
Questionnaire 
 
Interviewer 
administered 
N.S 0-3 N=1468 CD 
N=651 UC 
N=232 IC 
3364 
controls 
Controls were 
unaffected family 
members 
Childhood hygiene: tap water/warm tap water/water toilet/ central 
heating 
Sibship size: 2/>2 siblings 
Birth rank: 1/2/3/4/>4 
Community size for childhood and current place: 
Village <3000/town 3000-100000/city>100000 
Hansen TS et 
al 2011 
Herlev 
University 
hospital 
 
Denmark 
Case-control Questionnaire 
 
Self- 
administered 
N.S <20 N=123 CD 
N=144 UC 
267 
controls 
Orthopaedic controls 
Age/sex matched 
Breastfeeding: ever/>6months 
Operation: tonsillectomy/appendectomy <20yrs 
Vaccination: diphtheria/pertussis/measles/polio/rubella/tetanus/TB 
Infections: mumps/pertussis/rubella/scarlatina/chicken pox <20 
Running water 
Hlavaty T et al Bratislava Case-control Questionnaire 0-41+ N.S N=190 CD Controls were Breastfeeding duration (months) 
2013 University 
Hospital 
 
Slovakia 
  
Self- 
administered 
  N=148 UC 
355 
controls 
healthy volunteers 
Age/sex matched 
0-5 months/6-12 months/12+ months 
Size Family in childhood 
People in family/Children in family/Older siblings 
Infections in childhood (yes/no) 
Frequent respiratory/Ascaris infections/Any parasitic infection 
        Settlement in childhood 
        Village/Town <20, 000/City   >20, 000 
        Contact with animals in childhood 
        Dogs/Cats/Poultry/Cattle/Horses/Pigs/Small rodents 
        Sporting activity in childhood 
        Never/Once per week or less/Twice and more per week 
        Allergic disease/ Concomitant medication 
        Surgical history (Appendectomy/tonsillectomy) 
        Housing type 
Lopez-Serrano Spanish Hospital-based Questionnaire 18-80 N.S N=124 CD Controls chosen from Season of birth 
P et al 2010 University Case-control and medical   and 235 GI clinic Viral infections 
 hospital 
 
Spain 
 records 
 
Self- 
  controls 
 
N=146 UC 
 
Age/sex matched 
Hospitalization during childhood 
Breastfeeding 
Age of gluten introduction to diet 
Number of siblings 
   administered   and 238  Shared bedroom 
      controls  Household pet 
        Owned cars 
        Urban/Rural residence 
        Appendectomy 
        Parental occupation 
        Family income 
Malekzadeh F Tertiary Case-control Questionnaire N.S N.S N=199 CD Controls were Domestic hygiene/social status: 
et al 2009 referral      irritable bowel Refrigerator/Freezer/Runningwater/WC?/Hottapwater/Separatebathr 
 clinics in 
Tehran 
 Interviewer 
administered 
  207 
controls 
syndrome (IBS) 
patients 
oom/Television/Washingmachine/Car/Centralheating/Computer/Micr 
o-wave oven 
Urban/rural 
        Pets 
 Iran      Age matched No of siblings 
        No of sibs in the bedroom 
        Comfort at home 
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APPENDIX XII: Studies broadly investigating childhood environmental exposures during ‘childhood’ (0-18 years) 
Author Study Centre Study Design Data 
Collection 
Age 
Range 
Categories 
(Age) 
Subjects Control selection Variables 
Ng SC et al Multi-Centre 
Asia-Pacific 
Across 9 
countries 
Population Questionnaire 25-50 N.S N=186 CD Asymptomatic Breastfeeding 
2014 based  cases  N=256 UC subjects randomly Pet ownership: 
 Case-control Interviewer 26-53  940 selected and invited Dog/cat/rodents/birds/aquarium fish 
  administered controls  controls from streets or stores Antibiotic use <15yrs 
      within the same Surgical History: 
      residential areas as Tonsillectomy/Appendectomy/Eczema 
      cases Vaccination: 
       diphtheria/pertussis/measles/polio/rubella/tetanus/TB/poli 
      Age/ sex/ ethnicity o/diphtheria 
      and geographic Childhood Infections: 
      location matched mumps/pertussis/rubella/scarlatina/chicken pox/ mumps/ 
       scarlet fever/ measles 
       Sanitary conditions: 
       In-house water tap/hot water tap/flush toilet 
       Physical activity 
Persson PG et Stockholm Case-control Questionnaire 15-79 0-15 N=152 CD Controls randomly Infections in childhood (GI infection 0-10) 
al 1993 County  and medical   N=145 UC selected via Sibship (rank and size) 
 population  records   305 population register Breastfeeding 
      controls  Physical activity 
 Sweden  Self-    Age/sex matched Household pets 
   administered     Preschool attendance 
Timm S et al Multi-centre Cohort Questionnaire 20-44 0-5 Pop N.S Place of upbringing (0-5years) 
2014      N=10864  Farm with livestock 
 Northern  Self-   N=49 CD  Farm without livestock 
 Europe  administered   N=140 UC  Village in rural area 
      N=10 IC  Small town 
        Suburb of City 
        Inner City 
        Smoking status 
*N.S denotes Not Specified 
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APPENDIX XIII: Studies that were eliminated from the selection 
Author Study Centre Study Design Data 
Collection 
Age 
Range 
Categories 
(Age) 
Subjects Control selection Variables 
Corrao G et al 
1998 
Multiple 
centre study 
 
Italy 
Population 
based 
Case-control 
Questionnaire 18-65 N.S N=225 CD 
N=594 UC 
Controls had acute 
disease not related 
to smoking, OC use 
or immunological 
disorder 
 
Age/sex matched 
Breastfeeding 
Physical activity 
Dietary factors 
Illness history (such as psoriasis) 
Early infections 
Absence of appendectomy 
Contact with animals 
Urban/rural 
Exposure to smoke 
Guo AY et al 
2014 
Massachuset 
ts general 
hospital 
 
USA 
 Questionnaire 
and medical 
records 
N.S N.S N=333 CD 
N=270 UC 
N.S Breastfeeding 
Antibiotic use 
Delivery via caesarean section 
Hospitalization before the age of 5 
Childhood pets 
Exposure to farm animals 
Exposure to day-care during childhood 
Exposure to cigarette smoke 
Halfvarson J Orebro Population Questionnaire N.S <20 N=317 Controls were the co- Infections (GI & RT) 
et al 2006 University based cohort    twin pairs twin Surgical History: 
 hospital Case-control      
Age/sex matched 
Tonsillectomy/Cholecystectomy/Appendectomy 
Oral Contraceptive use 
 Sweden       Travelling abroad 
        Swimming habits 
        Childhood infections 
        Exposure to pets 
        Antibiotic therapy 
        Vaccinations 
        Physical activity 
Hildebrand H Multicentre Case-control Medical birth 0-15 N.S N=1098 Cases were matched Antibiotic therapy 
et al 2008   register 16-24  CD with controls at Childhood infections: 
 Sweden  records   6550 random among those (pneumonia/otitis/appendicitis/IRDS/sepsis/cystitis/tonsillit 
   (Swedish 0-5  controls without a diagnosis is) 
   population (antibiotic   of IBD  
   registers) use)  590ped   
      onset Age/sex matched  
      508adlt   
      onset   
*N.S denotes Not Specified 
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APPENDIX XIV: Availability of Tap Water and Heated Tap Water 
 0-5 6-10 11-18 ‘childhood’ (0-18) 
Basson  Having piped tap or bottled 
water was associated with CD 
development 
OR=2.10  95% CI (1.20-4.00), 
(К=0.63; 95% CI, 0.37-0.89) 
Having piped tap or bottled water 
was protective of CD development 
OR=2.05  95% CI (1.10-4.10), 
(К=0.69; 95% CI, 0.69-1.00) 
No significant association 
 
OR=1.92  95% CI (0.80-4.60) 
N/A 
 No significant association 
OR=1.18  95% CI (0.71-2.00) 
No significant association 
OR=1.52  95% CI (0.92-2.54) 
No significant association 
OR=1.52  95% CI (0.93-2.51) 
N/A 
Bernstein et al N/A N/A N/A 0-12 years: Primary source of water being well, lake 
or other non-tap source is not associated with CD 
development 
OR=0.77  95% CI (0.56-1.06) p=0.11 
Duggan et al N/A N/A No significant association 
OR=0.84  95% CI (0.3-1.4) 
Unadjusted 
OR=1.74  95% CI (0.8-3.8) Adjusted 
0-11 years and 11-16 years: Availability hot tap 
water associated with CD 
After adjustment for age and sex only it was a 
significant independent association at 5% level 
Unadjusted OR=0.55  95% CI (0.3-0.9) 
Adjusted OR=0.56  95% CI (0.3-0.9) p=0.02 
Feeney et al Significantly associated with 
developing CD 
Was reported by over 95% of all 
subjects (data not shown) 
N/A N/A N/A 
Hampe et al N/A N/A N/A No significant association 
OR=0.94  95% CI (0.53-1.66) 
 No significant association 
OR=1.25  95% CI (0.78-2.00) 
However a trend towards a high 
risk was associated 
N/A N/A N/A 
Hansen et al N/A N/A N/A No significant association 
OR=0.50  95% CI (0.05-5.51) 
Malekzadeh et al N/A N/A N/A No significant association 
(data not shown) 
Ng et al N/A N/A N/A No significant association 
OR=1.208 95% CI (0.803-1.819) p=1.208 Asia only 
unadjusted 
OR=0.763 95% CI (0.477-1.222) p=0.364 Asia only 
adjusted 
OR=0.847 95% CI (0.533-1.344) p=0.48 Asia and 
Australia 
 N/A N/A N/A Significantly associated with CD 
OR=1.478  95% CI (1.028-2.125) p=0.035 
* Non-shaded areas denote farm animal contact; shaded areas denote place of upbringing. 
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APPENDIX XV: Household Pets 
 0-5 years 6-10 years 11-18 years ‘childhood’ (0-18) 
Basson  No significant association 
OR=1.47  95% CI (0.92-2.34) 
No significant association 
OR=1.13  95% CI (0.71-1.79) 
No significant association 
OR=1.01  95% CI (0.64-1.59) 
N/A 
Bernstein et al Having pet cat protective against CD 
OR=0.66  95% CI (0.46-0.96) p=0.03 
CD patients less likely to have had a household pet 
than controls (71.9%) OR =0.73, 95% CI (0.53-1.0) 
p=0.05 
Fewer CD patients had pet cats (33.8%) than 
controls (44.1%) OR = 0.68 95% CI (0.50-0.92, 
p=0.012 
Among those with pets, CD patients (50.8%) were 
less likely to have cats than controls (61.3%) but the 
result was not significant OR = 0.72, 95% CI (0.51- 
1.03) p=0.07 
N/A N/A N/A 
Castiglione et al N/A N/A N/A No significant association 
OR=0.96 95% CI (0.75-1.24) 
Feeney et al No significant association with having a pet in the 
home 
Cat  OR=0.81 95% CI (0.41-1.63) p=0.561 
Dog OR=0.65 95% CI (0.34-1.24) p=0.190 
Bird OR=1.76 95% CI (0.75-4.14) p=0.194 
Rodent OR=0.89 95% CI (0.43-1.81) p=0.743 
N/A N/A N/A 
Gearry et al 
CD=638 
No significant association 
(data not shown) 
No significant association 
(data not shown) 
No significant association 
(data not shown) 
N/A 
Han et al No significant association 
OR=1.26  95% CI (0.92-1.73) 
Having a pet showed significant 
increased risk of developing CD 
OR=1.98  95% CI (1.28-3.06) p=0.002 
Regularly feeding pets was not 
sufficient to offer protection but 
somehow showed some decrease in 
risk 
Having a pet showed significant 
increased risk of developing CD 
OR=1.61  95% CI (1.07-2.42) p=0.02 
Regularly feeding pets was not 
sufficient to offer protection but 
somehow showed some decrease in 
risk 
N/A 
Hlavaty et al N/A N/A N/A Not having a pet cat showed significant 
increased risk of developing CD 
OR=0.6  95% CI (0.4-0.9) p<0.03 
CD patients had less frequent contact with dogs 
p=0.02, cats p=0.049 and cattle p=0.049 
Lopez et al N/A N/A N/A Having a pet showed significant increased risk 
of developing CD 
OR=0.5  95% CI (0.3-0.9) p=0.001 
Malekzadeh et al N/A N/A N/A No significant association 
(data not shown) 
Ng et al N/A N/A N/A Having dogs showed significant decreased risk 
of developing CD before 15 among Asians 
OR=0.54 95% CI (0.43-0.91) Cats, rodents, birds 
and aquarium fish had no significant association 
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APPENDIX XVI: Farm Animal Contact and Place of upbringing* 
 0-5 years 6-10 years 11-18 years ‘childhood’ (0-18) 
Basson  No significant association 
OR=1.67  95% CI (0.83-3.45) 
Never having had farm animals increased 
the risk of CD 
OR=3.10  95% CI (1.42-7.21) 
К=0.84; 95% CI (0.12-1.00) 
Never having had farm animals increased 
the risk of CD 
OR=4.31  95% CI (1.36-16.14) 
К=1.00; 95% CI (1.00-1.00) 
N/A 
 No significant association 
OR=1.21  95% CI (0.71-2.10) 
No significant association 
OR=1.58  95% CI (0.91-2.76) 
No significant association 
OR=0.97  95% CI (0.55-1.70) 
N/A 
Bernstein et al N/A N/A N/A Not having farm animal contact increased the 
risk of CD 
OR=0.62  95% CI (0.46-0.85) 
 N/A N/A N/A Lower likelihood of farm living associated with 
CD OR=0.62  95% CI (0.46-0.85) 
Castiglione et al N/A N/A N/A Insignificant association 
OR=0.73  95% CI (0.52-1.02) [urban upbringing] 
Feeney et al No significant association 
OR=0.59  95% CI (0.28-1.24) [urban 
environment] 
N/A N/A N/A 
Gearry et al No significant association 
(data not shown) 
(farm animal contact >4x/week) 
No significant association 
(data not shown) 
(farm animal contact >4x/week) 
No significant association 
(data not shown) 
(farm animal contact >4x/week) 
N/A 
 No significant association 
Town     OR=0.88  95% CI (0.67-1.16) 
Country OR=0.86  95% CI (0.65-1.14) 
Town and country dwellers were at a 
significantly decreased rate of 
developing CD than city dwellers 
Town     OR=0.69  95% CI (0.51-0.94) 
adjusted 
Country OR=0.67 95% CI(0.50- 
0.90)unadjusted 
Country OR=0.64  95% CI (0.46-0.89) 
adjusted 
Town and country dwellers were at a 
significantly decreased rate of 
developing CD than city dwellers 
Town     OR=0.69  95% CI (0.51-0.94) 
adjusted 
Country OR=0.67 95% CI(0.50- 
0.90)unadjusted 
Country OR=0.64  95% CI (0.46-0.89) 
adjusted 
N/A 
Hlavaty et al N/A N/A N/A Having no farm animals increased the risk of 
CD 
CD patients had less frequent contact with dogs 
p=0.02, cats p=0.049 and cattle p=0.049 
Lopez et al N/A N/A N/A Urban dwelling associated with  risk of CD 
OR=4.58  95% CI (2.17-10.0) 
Malekzadeh et al N/A N/A N/A No significant association 
Urban/rural 
Cases 89%/11% 
Controls 85%/15% 
Timm et al Living on a livestock farm was protective 
compared to city and village life 
OR=0.54  95% CI (0.31-0.94) 
N/A N/A N/A 
Wulzermann et al City dwellers significantly associated 
with CD development 
OR=1.80  95% CI (1.1-3.0) p=0.031 
Suburbanites most significantly 
associated with CD development 
OR=1.70  95% CI (1.0.-3.0) p=0.048 
City dwellers significantly associated 
with CD development 
OR=2.0  95% CI (1.1-3.8) p=0.047 
N/A 
* Non-shaded areas denote farm animal contact; shaded areas denote place of upbringing. 
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APPENDIX XVII: Sibship Size 
 0-5 years 6-10 years 11-18 years ‘childhood’ (0-18) 
Bernstein et al N/A N/A N/A CD patients were less likely to have 
brothers (mean=1.67) than controls 
(mean=2.12) OR=0.78, 95% CI (0.67- 
0.9) p<0.0001 or sisters (1.77) than 
controls (mean=2.11) OR=0.82 95% CI 
(0.7-0.96) p=0.0126 
Castiglione et al N/A N/A N/A No significant association 
Number of brothers /sisters (≤1vs≥2) 
OR=1.02 (0.76-1.37) 
Feeney et al No significant association 
OR=0.59, 95% CI (0.28-1.24 ) p=0.164 
N/A N/A N/A 
Gearry et al No significant association 
(data not shown) 
No significant association 
(data not shown) 
No significant association 
(data not shown) 
N/A 
Hampe et al    No significant association 
Χ2 =0.48, 1df, P>0.20 
Han et al No significant association 
(data not shown) 
No significant association 
(data not shown) 
No significant association 
(data not shown) 
N/A 
Hlavaty et al N/A N/A N/A CD patients had significantly less 
number of siblings compared to 
controls 
1.6+/-1.3 vs 1.9+/-1.3 respectively at 
p<0.05 
Lopez et al N/A N/A N/A No significant association 
OR 0.6, 95% CI (0.2-1.7 ) p=0.31 
Malekzadeh et al N/A N/A N/A No significant association 
Median of CD patients vs controls 
5(4-7) and 6(5-7) respectively 
Persson et al N/A N/A N/A No significant association 
OR 1.8, 95% CI (1.0-3.4) 
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APPENDIX XVIII: PRISMA-E 2012 Checklist 
Checklist of Items for Reporting Equity-Focused Systematic Reviews 
Section Item Standard PRISMA Item Extension for Equity-Focused Reviews 
Title    
Title 1 Identify the report as a systematic review, meta-analysis, or both. Identify equity as a focus of the review, if relevant, using the term equity 
Abstract    
 
Structured 
summary 
 
2 
2. Provide a structured summary including, as applicable: background; 
objectives; 
data sources; study eligibility criteria, participants, and interventions; study 
appraisal 
and synthesis methods; results; limitations; conclusions and implications of key 
findings; systematic review registration number. 
 
State research question(s) related to health equity. 
 2A  Present results of health equity analyses (e.g. subgroup analyses or meta-regression). 
 2B  Describe extent and limits of applicability to disadvantaged populations of interest. 
Introduction    
Rationale 3 Describe the rationale for the review in the context of what is already known. Describe assumptions about mechanism(s) by which the intervention is assumed to 
have an impact on health equity. 
 3A  Provide the logic model/analytical framework, if done, to show the pathways through 
which the intervention is assumed to affect health equity and how it was developed. 
Objectives 4 Provide an explicit statement of questions being addressed with reference to 
participants, interventions, comparisons, outcomes, and study design (PICOS). 
Describe how disadvantage was defined if used as criterion in the review (e.g. for 
selecting studies, conducting analyses or judging applicability). 
 4A  State the research questions being addressed with reference to health equity 
Methods    
Protocol and 
registration 
5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web 
address), and, if available, provide registration information including 
registration 
number. 
 
Eligibility 
criteria 
 
6 
 
6. Specify study characteristics (e.g., PICOS, length of follow-up) and report 
characteristics (e.g., years considered, language, publication status) used as 
criteria 
for eligibility, giving rationale. 
 
Describe the rationale for including particular study designs related to equity research 
questions. 
 6A  Describe the rationale for including the outcomes - e.g. how these are relevant to 
reducing inequity. 
 
Information 
sources 
 
7 
Describe all information sources (e.g., databases with dates of coverage, 
contact 
with study authors to identify additional studies) in the search and date last 
searched. 
 
Describe information sources (e.g. health, non-health, and grey literature sources) that 
were searched that are of specific relevance to address the equity questions of the 
review. 
 
Search 
 
8 
Present full electronic search strategy for at least one database, including any 
limits 
used, such that it could be repeated. 
 
Describe the broad search strategy and terms used to address equity questions of the 
review. 
Study 9 State the process for selecting studies (i.e., screening, eligibility, included in  
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selection   
systematic review, and, if applicable, included in the meta-analysis). 
 
Data 
collection 
process 
 
10 
Describe method of data extraction from reports (e.g., piloted forms, 
independently, in duplicate) and any processes for obtaining and 
confirming data from investigators. 
 
 
Data items 
 
11 
List and define all variables for which data were sought (e.g., PICOS, funding 
sources) and any assumptions and simplifications made. 
 
List and define data items related to equity, where such data were sought (e.g. 
using PROGRESS-Plus or other criteria, context). 
Risk of bias in 
individual 
studies 
12 Describe methods used for assessing risk of bias of individual studies (including 
specification of whether this was done at the study or outcome level), and how 
this information is to be used in any data synthesis. 
 
Summary 
measures 
13 State the principal summary measures (e.g., risk ratio, difference in means).  
 
Synthesis of 
results 
 
14 
Describe the methods of handling data and combining results of studies, if 
done, including measures of consistency (e.g., I2) for each meta-analysis. 
 
Describe methods of synthesizing findings on health inequities (e.g. presenting both 
relative and absolute differences between groups). 
 
Risk of bias 
across studies 
Additional 
analyses 
 
 
15 
16 
15. Specify any assessment of risk of bias that may affect the cumulative 
evidence 
(e.g., publication bias, selective reporting within studies). 
Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, 
meta-regression), if done, indicating which were pre-specified. 
 
 
 
Describe methods of additional synthesis approaches related to equity questions, if 
done, indicating which were pre-specified 
Results    
Study 
selection 
 
17 Give numbers of studies screened, assessed for eligibility, and included in the 
review, with reasons for exclusions at each stage, ideally with a flow diagram. 
 
Study 
characteristics 
 
18 
For each study, present characteristics for which data were extracted (e.g., 
study size, PICOS, follow-up period) and provide the citations. Present the population characteristics that relate to the equity questions across the 
relevant PROGRESS-Plus or other factors of interest. 
Risk of bias 
within studies 
19 Present data on risk of bias of each study and, if available, any outcome level 
assessment (see item 12). 
 
 
Results of 
individual 
studies 
 
20 
For all outcomes considered (benefits or harms), present, for each study: (a) 
simple summary data for each intervention group (b) effect estimates and 
confidence intervals, ideally with a forest plot. 
 
Synthesis of 
results 
21 Present results of each meta-analysis done, including confidence intervals and 
measures of consistency. 
Present the results of synthesizing findings on inequities (see 14). 
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Risk of bias 
across studies 
22 Present results of any assessment of risk of bias across studies (see Item 15).  
Additional 
analysis 
 
23 
Give results of additional analyses, if done (e.g., sensitivity or subgroup 
analyses, meta-regression [see Item 16]). Give the results of additional synthesis approaches related to equity objectives, if 
done, (see 16). 
Discussion    
Summary of 
evidence 
24 Summarize the main findings including the strength of evidence for each main 
outcome; consider their relevance to key groups (e.g., healthcare providers, 
users, and policy makers). 
 
 
Limitations 
 
25 
Discuss limitations at study and outcome level (e.g., risk of bias), and at review- 
level (e.g., incomplete retrieval of identified research, reporting bias). 
 
 
Conclusions 
 
26 
Provide a general interpretation of the results in the context of other evidence, 
and implications for future research. Present extent and limits of applicability to disadvantaged populations of interest and 
describe the evidence and logic underlying those judgments. 
 26A  Provide implications for research, practice or policy related to equity where relevant 
(e.g. types of research needed to address unanswered questions). 
Funding    
Funding 27 Describe sources of funding for the systematic review and other support (e.g., 
supply of data); role of funders for the systematic review. 
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APPENDIX XIX: What question (PICO) did the systematic review address? 
What is best? Where do I find the information? 
The main question being addressed should be clearly 
stated. The exposure, such as a therapy or diagnostic 
test, and the outcome(s) of interest will often be 
expressed in terms of a simple relationship. 
The Title, Abstract or final paragraph of the Introduction should clearly state the question. If you 
still cannot ascertain what the focused question is after reading these sections, search for another 
paper! 
This paper: Yes 
Comment: 
No  Unclear   
F - Is it unlikely that important, relevant studies were missed? 
What is best? Where do I find the information? 
The starting point for comprehensive search for all 
relevant studies is the major bibliographic databases 
(e.g., Medline, Cochrane, EMBASE, etc) but should also 
include a search of reference lists from relevant studies, 
and contact with experts, particularly to inquire about 
unpublished studies. The search should not be limited to 
English language only. The search strategy should 
include both MESH terms and text words. 
The Methods section should describe the search strategy, including the terms used, in some detail. 
The Results section will outline the number of titles and abstracts reviewed, the number of full-text 
studies retrieved, and the number of studies excluded together with the reasons for exclusion. This 
information may be presented in a figure or flow chart. 
This paper: Yes 
Comment: 
No  Unclear   
A - Were the criteria used to select articles for inclusion appropriate? 
What is best? Where do I find the information? 
The inclusion or exclusion of studies in a systematic 
review should be clearly defined a priori. The eligibility 
criteria used should specify the patients, interventions or 
exposures and outcomes of interest. In many cases the 
type of study design will also be a key component of the 
eligibility criteria. 
The Methods section should describe in detail the inclusion and exclusion criteria. Normally, this 
will include the study design. 
This paper: Yes 
Comment: 
No  Unclear   
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A - Were the included studies sufficiently valid for the type of question asked? 
What is best? Where do I find the information? 
The article should describe how the quality of each study 
was assessed using predetermined quality criteria 
appropriate to the type of clinical question (e.g., 
randomization, blinding and completeness of follow-up) 
The Methods section should describe the assessment of quality and the criteria used. The Results 
section should provide information on the quality of the individual studies. 
This paper: Yes 
Comment: 
No  Unclear   
T - Were the results similar from study to study? 
What is best? Where do I find the information? 
Ideally, the results of the different studies should be 
similar or homogeneous. If heterogeneity exists the 
authors may estimate whether the differences are 
significant (chi-square test). Possible reasons for the 
heterogeneity should be explored. 
The Results section should state whether the results are heterogeneous and discuss possible 
reasons. The forest plot should show the results of the chi-square test for heterogeneity and if 
discuss reasons for heterogeneity, if present. 
This paper: Yes 
Comment: 
No  Unclear   
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“The ultimate measure of a man is not where he stands in moments of 
comfort and convenience, but where he stands at times of challenge and 
controversy.” 
 
Dr Martin Luther King Jr 
 
 
 
 
 
 
 
